
<html lang="en"     class="pb-page"  data-request-id="623c5976-3573-4e8b-9ab8-7d10cd94bbd7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-4;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.0c01863;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate" /></meta><meta name="dc.Creator" content="Yu  Zhou" /></meta><meta name="dc.Creator" content="Yan  Fu" /></meta><meta name="dc.Creator" content="Wanchao  Yin" /></meta><meta name="dc.Creator" content="Jian  Li" /></meta><meta name="dc.Creator" content="Wei  Wang" /></meta><meta name="dc.Creator" content="Fang  Bai" /></meta><meta name="dc.Creator" content="Shengtao  Xu" /></meta><meta name="dc.Creator" content="Qi  Gong" /></meta><meta name="dc.Creator" content="Tao  Peng" /></meta><meta name="dc.Creator" content="Yu  Hong" /></meta><meta name="dc.Creator" content="Dong  Zhang" /></meta><meta name="dc.Creator" content="Dan  Zhang" /></meta><meta name="dc.Creator" content="Qiufeng  Liu" /></meta><meta name="dc.Creator" content="Yechun  Xu" /></meta><meta name="dc.Creator" content="H. Eric  Xu" /></meta><meta name="dc.Creator" content="Haiyan  Zhang" /></meta><meta name="dc.Creator" content="Hualiang  Jiang" /></meta><meta name="dc.Creator" content="Hong  Liu" /></meta><meta name="dc.Description" content="The acetylcholinesterase (AChE) inhibitors remain key therapeutic drugs for the treatment of Alzheimer’s disease (AD). However, the low-safety window limits their maximum therapeutic benefits. Here..." /></meta><meta name="Description" content="The acetylcholinesterase (AChE) inhibitors remain key therapeutic drugs for the treatment of Alzheimer’s disease (AD). However, the low-safety window limits their maximum therapeutic benefits. Here..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 11, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01863" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01863" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01863" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01863" /></link>
        
    
    

<title>Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01863" /></meta><meta property="og:title" content="Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0012.jpeg" /></meta><meta property="og:description" content="The acetylcholinesterase (AChE) inhibitors remain key therapeutic drugs for the treatment of Alzheimer’s disease (AD). However, the low-safety window limits their maximum therapeutic benefits. Here, a novel kinetics-driven drug design strategy was employed to discover new-generation AChE inhibitors that possess a longer drug-target residence time and exhibit a larger safety window. After detailed investigations, compound 12 was identified as a highly potent, highly selective, orally bioavailable, and brain preferentially distributed AChE inhibitor. Moreover, it significantly ameliorated cognitive impairments in different mouse models with a lower effective dose than donepezil. The X-ray structure of the cocrystal complex provided a precise binding mode between 12 and AChE. Besides, the data from the phase I trials demonstrated that 12 had good safety, tolerance, and pharmacokinetic profiles at all preset doses in healthy volunteers, providing a solid basis for its further investigation in phase II trials for the treatment of AD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01863"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01863">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01863&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01863&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01863&amp;href=/doi/10.1021/acs.jmedchem.0c01863" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1844-1855</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01489" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.0c01886" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yu Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div><div class="loa-info-affiliations-info">School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Zhou">Yu Zhou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7684-2939" title="Orcid link">http://orcid.org/0000-0002-7684-2939</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yan Fu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yan Fu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Fu">Yan Fu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wanchao Yin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wanchao Yin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wanchao++Yin">Wanchao Yin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jian Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div><div class="loa-info-affiliations-info">School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Qixia District, Nanjing 210023, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Li">Jian Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wei Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Wang">Wei Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fang Bai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fang Bai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fang++Bai">Fang Bai</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1468-5568" title="Orcid link">http://orcid.org/0000-0003-1468-5568</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shengtao Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shengtao Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shengtao++Xu">Shengtao Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qi Gong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qi Gong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Gong">Qi Gong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tao Peng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tao Peng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Peng">Tao Peng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yu Hong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu Hong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Hong">Yu Hong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dong Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dong Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dong++Zhang">Dong Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dan Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dan Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Zhang">Dan Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qiufeng Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiufeng Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiufeng++Liu">Qiufeng Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yechun Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yechun Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</div><div class="loa-info-affiliations-info">School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yechun++Xu">Yechun Xu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1581-6155" title="Orcid link">http://orcid.org/0000-0002-1581-6155</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">H. Eric Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">H. Eric Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</div><div class="loa-info-affiliations-info">School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, People’s Republic of China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=H.+Eric++Xu">H. Eric Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haiyan Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haiyan Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</div><div class="loa-info-affiliations-info">School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, People’s Republic of China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +86 21 50806600. E-mail: <a href="/cdn-cgi/l/email-protection#127a687a737c7552617b7f7f3c73713c717c"><span class="__cf_email__" data-cfemail="d1b9abb9b0bfb691a2b8bcbcffb0b2ffb2bf">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haiyan++Zhang">Haiyan Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2877-2040" title="Orcid link">http://orcid.org/0000-0002-2877-2040</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hualiang Jiang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hualiang Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div><div class="loa-info-affiliations-info">School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, People’s Republic of China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +86 21 50806600. E-mail: <a href="/cdn-cgi/l/email-protection#0d656167646c636a4d7e646060236c6e236e63"><span class="__cf_email__" data-cfemail="543c383e3d353a3314273d39397a35377a373a">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hualiang++Jiang">Hualiang Jiang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Hong Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</div><div class="loa-info-affiliations-info">School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, People’s Republic of China</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: +86 21 50807042. E-mail: <a href="/cdn-cgi/l/email-protection#e98185809ca99a808484c7888ac78a87"><span class="__cf_email__" data-cfemail="365e5a5f4376455f5b5b185755185558">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Liu">Hong Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3685-6268" title="Orcid link">http://orcid.org/0000-0003-3685-6268</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01863&amp;href=/doi/10.1021%2Facs.jmedchem.0c01863" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1844–1855</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 11, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 October 2020</li><li><span class="item_label"><b>Published</b> online</span>11 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01863" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01863</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1844%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYu%2BZhou%252C%2BYan%2BFu%252C%2BWanchao%2BYin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D4%26contentID%3Dacs.jmedchem.0c01863%26title%3DKinetics-Driven%2BDrug%2BDesign%2BStrategy%2Bfor%2BNext-Generation%2BAcetylcholinesterase%2BInhibitors%2Bto%2BClinical%2BCandidate%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1855%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01863"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1654</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01863" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Wanchao&quot;,&quot;last_name&quot;:&quot;Yin&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Fang&quot;,&quot;last_name&quot;:&quot;Bai&quot;},{&quot;first_name&quot;:&quot;Shengtao&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Gong&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Dong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Qiufeng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yechun&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;H.&quot;,&quot;last_name&quot;:&quot;Eric Xu&quot;},{&quot;first_name&quot;:&quot;Haiyan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Hualiang&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;1844-1855&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01863&quot;},&quot;abstract&quot;:&quot;The acetylcholinesterase (AChE) inhibitors remain key therapeutic drugs for the treatment of Alzheimer’s disease (AD). However, the low-safety window limits their maximum therapeutic benefits. Here, a novel kinetics-driven drug design strategy was employed to discover new-generation AChE inhibitors that possess a longer drug-target residence time and exhibit a larger safety window. After detailed investigations, compound 12 was identified as a highly potent, highly selective, orally bioavailable, and brain preferentially distributed AChE inhibitor. Moreover, it significantly ameliorated cognitive impairments in different mouse models with a lower effective dose than donepezil. The X-ray structure of the cocrystal complex provided a precise binding mode between 12 and AChE. Besides, the data from the phase I trials demonstrated that 12 had good safety, tolerance, and pharmacokinetic profiles at all preset doses in healthy volunteers, providing a solid basis for its further investigation in phase II trials for &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01863&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01863" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01863&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01863" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01863&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01863" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01863&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01863&amp;href=/doi/10.1021/acs.jmedchem.0c01863" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01863" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01863" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01863%26sid%3Dliteratum%253Aachs%26pmid%3D33570950%26genre%3Darticle%26aulast%3DZhou%26date%3D2021%26atitle%3DKinetics-Driven%2BDrug%2BDesign%2BStrategy%2Bfor%2BNext-Generation%2BAcetylcholinesterase%2BInhibitors%2Bto%2BClinical%2BCandidate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D4%26spage%3D1844%26epage%3D1855%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/jmcmar.2021.64.issue-4/20210225/jmcmar.2021.64.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The acetylcholinesterase (AChE) inhibitors remain key therapeutic drugs for the treatment of Alzheimer’s disease (AD). However, the low-safety window limits their maximum therapeutic benefits. Here, a novel kinetics-driven drug design strategy was employed to discover new-generation AChE inhibitors that possess a longer drug-target residence time and exhibit a larger safety window. After detailed investigations, compound <b>12</b> was identified as a highly potent, highly selective, orally bioavailable, and brain preferentially distributed AChE inhibitor. Moreover, it significantly ameliorated cognitive impairments in different mouse models with a lower effective dose than donepezil. The X-ray structure of the cocrystal complex provided a precise binding mode between <b>12</b> and AChE. Besides, the data from the phase I trials demonstrated that <b>12</b> had good safety, tolerance, and pharmacokinetic profiles at all preset doses in healthy volunteers, providing a solid basis for its further investigation in phase II trials for the treatment of AD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a complex and multifactorial, age-related, chronic neurodegenerative disease that often leads to cognitive dysfunction accompanied by severe behaviors such as irritability, anxiety, and depression.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1−7)</a> An increasing number of people worldwide are living with dementia, but unfortunately, its pathogenesis is hitherto unknown. As different hypotheses are reported, such as the cholinergic hypothesis, amyloid hypothesis, tau hypothesis, neuroinflammation, and oxidative stress,<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> many potential drugs targeting these hypotheses have been tested for treating AD. However, acetylcholinesterase (AChE) is currently one of the only two well-validated molecular targets for AD. The AChE inhibitors reduce the hydrolysis of acetylcholine (ACh) into acetate and choline and consequently increase the ACh levels at the synaptic cleft which can stimulate cholinergic receptors and further promote memory function.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Therefore, AChE inhibitors such as donepezil, rivastigmine, galantamine, and huperzine A remain the main choice for the treatment of AD today (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Approved AChE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among the existing medications, donepezil was approved for the treatment of mild, moderate, and severe AD,<a onclick="showRef(event, 'ref5 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref8">(5,8)</a> which is a blood–brain barrier permeable, reversible and noncompetitive AChE inhibitor. At one point, it was the world’s best-selling Alzheimer’s drug. However, its clinical benefits have been limited due to excessive side effects, including nausea, vomiting, and bradycardia.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Moreover, the incidence and severity of the side effects are augmented with an increase in the dose.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The poor tolerance renders difficulty in sustaining its efficacy and requires a constant dose-titration as the disease progresses.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This low-safety margin has largely limited its maximum therapeutic application for AD patients. Huperzine A (HupA), a sesquiterpene alkaloid extracted from <i>Huperzia serrata</i>, has been approved for use as a drug for the treatment of Alzheimer’s disease in China and marketed in the USA as a dietary supplement.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> It can increase the cortical ACh levels with an 8- and 2-fold higher molar potency as compared to donepezil and rivastigmine, respectively. Moreover, it also showed a longer duration of action and a lower oral dose.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Previous studies from our team showed that HupA could bind to the active site of AChE faster than its disassociation from it, which for the first time interpreted at the atomic level the experimental result that HupA equilibrated with free enzyme AChE in several minutes while HupA-inhibited AChE complex dissociated at a much lower rate (several hours) to restore enzyme activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This finding might be a valid interpretation for HupA having a longer duration of action.</div><div class="NLM_p last">Inspired by these results, our current efforts were to design a new generation of AChE inhibitors by a binding kinetics-driven drug design strategy<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and to overcome the unmet clinical needs of the therapy of AD, especially aiming to reduce the dose of administration and enlarge the safety margins of the current drugs. For this purpose, 44 new compounds were designed and synthesized by this strategy. Fortunately, a drug candidate <b>12</b> was discovered, and its detailed preclinical evaluations demonstrated it to be a highly potent, selective, orally bioavailable, and brain penetrant AChE inhibitor. Moreover, it significantly ameliorated the cognitive impairments in different mice models with a lower effective dose than donepezil. Also, the subsequent phase I trials in a single ascending dose study (CTR20181428) and a multiple ascending dose study (CTR20190664) demonstrated that drug candidate <b>12</b> exhibited good safety, tolerance, and pharmacokinetic profiles at all preset doses in healthy volunteers. These results motivated us to explore its further therapeutic values for AD patients in Phase II trials.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10843" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10843" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Design of Novel AChE Inhibitors</h3><div class="NLM_p">Compared with the well-known AChE inhibitor donepezil, HupA is a natural-origin AChE inhibitor and displays a lower oral dose and longer duration of AChE inhibitory action.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10−13)</a> This was most probably because it can quickly equilibrate with the free enzyme AChE in several minutes, while the HupA-AChE complex dissociates at a much lower rate (maybe several hours) to restore enzyme activity.<a onclick="showRef(event, 'ref14 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref17">(14,16,17)</a> Indeed, several reports have demonstrated that the kinetics of the drug–receptor binding process (i.e., the dissociation rate constant, <i>k</i><sub>off</sub>) is more important than the binding affinity (i.e., <i>K</i><sub>d</sub> and IC<sub>50</sub>/EC<sub>50</sub>) in determining the drug efficacy,<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18−21)</a> and a longer drug-target residence time is helpful to reduce the dose of administration, enlarge the safety margins, and further alleviate the side effects.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> It was reported that HupA was 8-fold more potent than donepezil in increasing the cortical ACh levels with a longer-lasting effect. Meanwhile, it has a higher efficacy than tacrine and donepezil if given orally.<a onclick="showRef(event, 'ref12 ref13 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref22 ref23">(12,13,22,23)</a></div><div class="NLM_p last">Recently, selectively fluorinating bioactive molecules has become a well-established strategy in the design of new drugs because they improve their physicochemical characteristics, pharmaceutical effectiveness, and pharmacokinetic profiles.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28 ref29">(24−29)</a> On the basis of these findings, we attempted the introduction of fluorine atoms into the piperidine scaffold and/or phenyl group of donepezil and performed further structural optimization to design and synthesize 44 new compounds (<b>1</b>–<b>44</b>), expecting this modification to prolong their residence time on the target and give a larger safety margin to alleviate the undesirable side effects.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2.  Synthesis of All Target Compounds</h3><div class="NLM_p">The synthetic routes of the target compounds <b>1</b>–<b>44</b> are depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. First, the key intermediate <i>N</i>-Boc-4-fluoropiperidine-4-carbaldehyde (<b>48</b>) was synthesized through a Corey–Chaykovsky reaction, a ring-opening reaction by HF in pyridine, and a classical Swern-oxidation reaction from <i>N</i>-Boc-piperidin-4-one (<b>45</b>). The resulting intermediate <b>48</b> was further coupled with 5,6-dimethoxy-inden-1-one (<b>49</b>) in the presence of CH<sub>3</sub>ONa in THF to provide the coupled product <b>50</b>, which was further reduced into compound <b>51</b> with 10% Pd/C in the presence of H<sub>2</sub>. Next, the deprotection of the Boc group gave another key intermediate <b>52</b> with 50% trifluoroacetic acid (TFA) in CH<sub>2</sub>Cl<sub>2</sub>. The resulting intermediate <b>52</b> was directly used to synthesize the target products <b>1</b>–<b>24</b> with diversified benzyl bromides and phenyl ethyl bromides under different reaction conditions, as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (CH<sub>3</sub>)<sub>3</sub>SI, <i>t</i>-BuOK, DMSO; (b) 70% HF in pyridine, CH<sub>2</sub>Cl<sub>2</sub>; (c) oxalyl chloride, DMSO, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (d) CH<sub>3</sub>ONa, THF; (e) 10% Pd/C, H<sub>2</sub>, THF; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (g) substituted benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF; (h) substituted phenethyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>25</b>–<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) malonic acid, pyridine, toluene; 10% Pd/C, H<sub>2</sub>, THF; (b) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (c) AlCl<sub>3</sub>, CS<sub>2</sub>; (d) K<sub>2</sub>CO<sub>3</sub>, DMF; (e) BBr<sub>3</sub>, −78 °C; (f) Na<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><div class="NLM_p last">As shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, the target compounds <b>25</b>–<b>44</b> were synthesized by similar strategies as those of compounds <b>1</b>–<b>24</b> after using different indenones (<b>56b</b>–<b>e</b>, <b>57a</b>–<b>b</b>, and <b>59a</b>–<b>b</b>) as the key intermediates. Initially, after treatment of the commercially available substituted benzaldehydes (<b>53a</b>–<b>e</b>) with malonic acid in toluene in the presence of pyridine, further hydrogenation reduction easily prepared the substituted phenylpropanoic acids (<b>54a</b>–<b>e</b>). They were converted into substituted phenylpropionyl chlorides <b>55a</b>–<b>e</b> with SOCl<sub>2</sub> in CH<sub>2</sub>Cl<sub>2</sub>. The key indenone intermediates <b>56a</b>–<b>e</b> were prepared by further Friedel–Crafts reaction from compounds <b>55a</b>–<b>e</b> under the catalysis of AlCl<sub>3</sub>. Subsequently, the resulting intermediate <b>56a</b> was converted into the other two indenones (<b>57a</b> and <b>57b</b>), which may be further used to synthesize the target products <b>25</b>–<b>30</b>. The 5,6-disubstituted indenones <b>59a</b> and <b>59b</b> were prepared via deprotection of the dimethyl group of compound <b>49</b> and further substitution reaction with propyl and n-butyl bromide under Na<sub>2</sub>CO<sub>3</sub> in DMF. The resulting intermediates <b>59a</b> and <b>59b</b> were converted into the target products <b>31</b>–<b>34</b> by a similar strategy as that of compound <b>1</b>. The other intermediates with different substituent groups on the R<sub>2</sub> and R<sub>3</sub> position (<b>56b</b>–<b>e</b>) were also converted into the target products <b>35</b>–<b>44</b> with different benzyl bromides by a similar synthetic strategy as for compound <b>1</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.3.  Evaluation of the AChE Inhibitory Activity and the Structure–Activity Relationships for All Compounds</h3><div class="NLM_p">Enzymatic assays against AChE for all target compounds were performed, and the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The values of the determination of the surface plasmon resonance (SPR) for the selected compound-AChE binding at 298.15 K are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Modification of the R<sup>1</sup> Group and Their Inhibitory Activities against AChE</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0009.gif" alt="" id="GRAPHIC-d7e918-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">inhibitory potency</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM) or % inhibition<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="left">0.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>2</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">4-F</td><td class="colsep0 rowsep0" align="left">2.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>3</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">75.3%<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">4-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">51.7%<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">4-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8780</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">69.1%<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>7</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">3-F</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>8</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">348</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>9</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">3-Br</td><td class="colsep0 rowsep0" align="left">4.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="left">67.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>11</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">3-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">11.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>12</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2-F</td><td class="colsep0 rowsep0" align="left">0.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>13</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1640</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>14</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2-Br</td><td class="colsep0 rowsep0" align="left">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>15</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2-CN</td><td class="colsep0 rowsep0" align="left">163</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>16</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2,4-di-F</td><td class="colsep0 rowsep0" align="left">8.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">3,5-di-F</td><td class="colsep0 rowsep0" align="left">226</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>18</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2,3,4-tri-F</td><td class="colsep0 rowsep0" align="left">75.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>19</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2,3,5-tri-F</td><td class="colsep0 rowsep0" align="left">306</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2,4,5-tri-F</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>21</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">2,3,4,5,6-penta-F</td><td class="colsep0 rowsep0" align="left">/<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>22</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="center">2-F</td><td class="colsep0 rowsep0" align="left">74.7%<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>23</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="center">3-F</td><td class="colsep0 rowsep0" align="left">59.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>24</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="center">4-F</td><td class="colsep0 rowsep0" align="left">404</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">donepezil</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left">2.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The data indicate the inhibition ratio against AChE at 40 μM.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">The compound is insoluble.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Modification of the R<sup>2</sup> and R<sup>3</sup> Groups and Their Inhibitory Activities against AChE</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0011.gif" alt="" id="gr9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0010.gif" alt="" id="GRAPHIC-d7e1381-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The data are the inhibition ratio against AChE at 40 μM.</p></div></div><div></div></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) The SPR data for the binding of selected compound-AChE at 298.15 K; (B) surface plasmon resonance (SPR) sensorgrams for the binding of compound <b>12</b> to rhAChE; (C) the time-dependent effect of compound <b>12</b> (i.g.) and donepezil (i.g.) in the cortex of mice; (D) the time-dependent effect of compound <b>12</b> and donepezil in the hippocampus of mice via i.g. administration. Data were represented as the percentage of vehicle control that was set to 100% and expressed as mean ± SEM (<i>N</i> = 11–12); <sup>##</sup><i>P</i> < 0.01, <sup>###</sup><i>P</i> < 0.001 vs the vehicle control group; *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the donepezil treatment group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">According to the above design, we first introduced a fluorine atom into the piperidine scaffold of donepezil. As expected, the resulting compound <b>1</b> was endowed with a more potent inhibitory activity against AChE than donepezil; its IC<sub>50</sub> was 0.96 nM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Meanwhile, it also offered a smaller <i>K</i><sub>off</sub> value than donepezil (0.01764 vs. 0.02914, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) in SPR binding determination, which means that compound <b>1</b> displayed a slower dissociation behavior from its target AChE.</div><div class="NLM_p">Encouraged by these results, we further introduced either a second fluorine atom or other groups containing fluorine atoms (-CF<sub>3</sub> and -OCF<sub>3</sub>) into the <i>para</i>-position of the benzyl group (R<sup>1</sup> position) of compound <b>1</b> to give compounds <b>2</b>–<b>4</b>. However, only the 4-fluorine atom-substituted compound <b>2</b> displayed excellent inhibition against AChE with an IC<sub>50</sub> of 2.67 nM. Further introduction of other groups such as the nitro group (<b>5</b>) or a <i>tert</i>-butyl group (<b>6</b>) into the <i>para</i>-position of the benzyl group appeared harmful for the inhibition against AChE. Subsequently, we explored the influence of different substituents on the <i>meta</i>-position of the benzyl group (compounds <b>7</b>–<b>11</b>). We found that the 3-F group (<b>7</b>) and 3-Br group (<b>9</b>) could give strong inhibitory potencies against AChE with IC<sub>50</sub> values of 3.0 nM and 4.33 nM, respectively. Likewise, the <i>ortho</i>-position of the benzyl group was explored to obtain compounds <b>12</b>–<b>15</b>. The 2-fluoro-substituted compound <b>12</b> displayed the most potent inhibitory action against AChE with IC<sub>50</sub> of 0.86 nM among all derivatives. These results indicated that the fluorine atom, irrespective of its location, could provide better activities for this scaffold than that provided by other groups. Inspired by these findings, we attempted to explore the influence of adding varying numbers of fluorine atoms on the benzyl group and designed derivatives <b>16</b>–<b>21</b>. We found that the introduction of 2,4-difluoro (<b>16</b>) or 2,4,5-trifluoro (<b>20</b>) groups into the R<sup>1</sup> position of the benzyl group yielded excellent inhibition against AChE. However, other substituted styles did not result in better biological activities as expected. These results indicated that more fluorine atoms might not be necessary for improving the inhibitory potential of this scaffold against AChE. Meanwhile, the solubility of these compounds became an obstacle as the number of fluorine atoms on the phenyl ring of R<sup>1</sup> increased (<b>21</b>). Overall, a single fluorine atom on the phenyl ring of R<sup>1</sup> was the best choice. Therefore, we attempted to maintain only one fluorine atom at the R<sup>1</sup> position. We further prolonged the linker (<i>n</i> = 2) between the phenyl ring and piperidine ring from one carbon to two carbons and designed three new derivatives <b>22</b>–<b>24</b>. Unfortunately, this dramatically decreased the inhibitory activities against AChE.</div><div class="NLM_p last">The X-ray cocrystal structure of donepezil in the human acetylcholinesterase (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>) displayed that the indanone ring stacks against the Trp 286 residue to form a π–π interaction, and its two methoxy groups reached the outside of the pocket (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf" class="ext-link">Figure S3a</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This phenomenon meant that more modifications could be launched on the indanone ring. Therefore, by positioning one fluorine atom or the 2,4-difluoro group on the R<sup>1</sup> position, we further designed and synthesized a new class of derivatives <b>25</b>–<b>44</b> to explore the influence of different R<sup>2</sup> and R<sup>3</sup> groups on AChE inhibition. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, we first replaced the methoxy group at the R<sup>2</sup> position with the cyclopropylmethoxyl group or the propoxy group and screened the different fluoro substituted benzyl groups to obtain derivatives <b>25</b>–<b>30</b>. As expected, most of them displayed excellent inhibition against AChE; the IC<sub>50s</sub> values of compounds <b>26</b>, <b>27</b>, and <b>28</b> were below 10 nM. However, it seemed that the introduction of the propoxy group at position R<sup>2</sup> was detrimental to the improvement of inhibitory action (<b>29</b> and <b>30</b>). Similarly, simultaneous introduction of the propoxy group (<b>31</b> and <b>32</b>) and butoxy group (<b>33</b> and <b>34</b>) into the R<sup>2</sup> and R<sup>3</sup> groups proved unfavorable. Further investigations showed that removing the methoxy group of R<sup>2</sup> (<b>35</b> and <b>36</b>) was more beneficial in improving the AChE inhibitory potency than removing the methoxy group of R<sup>3</sup> (<b>37</b> and <b>38</b>); the IC<sub>50</sub> values reached 6.29 nM (<b>35</b>) and 14.1 nM (<b>36</b>), respectively. Subsequently, we kept R<sup>3</sup> or R<sup>2</sup> as the methoxy group and attempted to introduce another fluorine atom into the R<sup>2</sup> or R<sup>3</sup> position to yield compounds <b>39</b>–<b>44</b>. The results demonstrated that their activities against AChE could be maintained largely, indicating the small groups at the R<sup>2</sup> and R<sup>3</sup> positions are important for inhibition against AChE.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.4.  Determination of the Dissociation Behavior of the Selected Compounds</h3><div class="NLM_p">To explain the superior biological activities observed earlier, we further determined the kinetic (<i>k</i><sub>on</sub> and <i>k</i><sub>off</sub>) and thermodynamic (<i>K</i><sub>d</sub>) parameters of the highly active compounds (<b>1</b>, <b>2</b>, <b>7</b>, <b>12</b>, <b>16</b>, and <b>20</b>) upon binding to their target, the recombinant human AChE (rhAChE), using the surface plasmon resonance (SPR) technology. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, all selected compounds significantly reduced the <i>K</i><sub>off</sub> values and displayed <i>K</i><sub>off</sub> smaller than that of donepezil. This indicated that they had longer residence times (<i>t</i> = 1/<i>K</i><sub>off</sub>) on their target compared to donepezil, and almost comparable to that of HupA. These results indicate that introducing the fluorine atoms was very important for enhancing the binding affinities and prolonging the residence time of the target compound on its target; this may give a larger safety margin. It appeared that compound <b>12</b> offered a more desirable <i>K</i><sub>on</sub> and <i>K</i><sub>off</sub> behavior that was in agreement with its inhibitory potency against AChE (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p last">We further explored the time-course of the AChE inhibitory action <i>ex vivo</i> for compound <b>12</b>, and donepezil served as the control. Initially, cortical and hippocampal samples of ICR mice were collected at 0.5, 1, 2, 3, 4, 5, and 6 h after administration of compound <b>12</b> (2 mg/kg, i.g.) or donepezil (12 mg/kg, i.g.). The peak inhibition was detected in the cortex and hippocampus at 30–60 min for both compounds. Compound <b>12</b> maintained a significant inhibition of AChE activity in the cortex and hippocampus from 30 to 240 min (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). However, donepezil maintained its inhibition in the cortex from 30 to 180 min only. Moreover, its inhibitory potency seemed to decline rapidly after reaching the peak as compared to that of compound <b>12</b>. Meanwhile, AChE activities were significantly inhibited in the mice treated with compound <b>12</b> as compared to those of donepezil-treated mice at 120, 180, and 240 min time point. These results indicated that compound <b>12</b> had a longer duration of drug efficacy and better inhibitory potency than donepezil as we expected, which is consistent with the results of SPR data shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B. All these results demonstrated that a slower dissociation behavior of a compound from its target might bring better efficacy and longer duration of action <i>in vivo</i>, further enlarging its safety margin.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.5.  Crystal Structures of Compounds Bound to the Catalytic Domain of rhAChE</h3><div class="NLM_p">To understand the binding mode of these new inhibitors with acetylcholinesterase, the crystal structures of compounds <b>2</b>, <b>7</b>, and <b>12</b> (with a single fluorine atom on different R<sup>1</sup> positions) were determined in complex with rhAChE at resolutions of 2.45 Å, 2.66 Å, and 2.85 Å, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf" class="ext-link">Figure S3C–E</a>, see Supporting Information). The complete diffraction data and refinement statistics are given in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf" class="ext-link">Table S1</a>. All complexes belonged to space group <i>P</i>3121 and were isomorphous to each other; each contained two molecules in the asymmetric unit (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf" class="ext-link">Figure S3B</a>). The overall structures of the complexes formed between each of these compounds and rhAChE were similar to each other; their RMSD values were less than 0.2 Å for all Cα atoms of rhAChE. All three structures also resembled the previous donepezil-bound rhAChE complex (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Active site-bound ligands and their interactions. (A) The superposition of AChE/compound <b>2</b> complex (green, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9O">7D9O</a>), AChE/compound <b>7</b> complex (magenta, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9Q">7D9Q</a>), and AChE/<b>12</b> complex (cyan, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9P">7D9P</a>) with the AChE/donepezil complex (yellow, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>); (B) the binding mode of compound <b>2</b> in AChE; (C) the binding mode of compound <b>7</b> in AChE; (D) the binding mode of compound 1<b>2</b> in AChE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Structurally, there is a deep and narrow active site gorge consisting of two separated ligand-binding sites: the peripheral anionic binding site (PAS) and the acylation (or active) site (AS).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The PAS is located close to the mouth of the active site gorge with an aromatic residue W286 as the important anionic site; the AS contains the AChE catalytic triad (S203/E334/H447) and the important aromatic residue W86 at the bottom of the gorge. Similar to donepezil, all three compounds were in the same configuration and oriented along the entire gorge composed of the PAS and AS sites.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p last">Structural comparison of these structures with the donepezil-bound rhAChE structure revealed similar positions for the aromatic groups at the two ends: the indanone ring stacked against W286 in the PAS, while the fluorinated benzyl ring stacked against W86 in the AS. The π–π stacking of the fluorinated benzyl ring with W86 was enhanced because of the electron-withdrawing effect of the fluorine atom<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> and the interactions of the fluorine substituent with the rhAChE (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The piperidine rings in the middle were flexile and adopted slightly different conformations, thus facilitating a favorable geometry of the fluorobenzene moiety to produce additional interactions (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). For the fluorinated benzyl ring, the 4-fluoro substituent of compound <b>2</b> interacted with the side chains of Y133 and E202 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The 3-fluoro substituent of compound <b>7</b> interacted with the side chain of Y133 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C), while the 2-fluoro substituent of compound <b>12</b> formed an important multipolar fluorine–backbone interaction with the main chain C═O of the H447<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). The fluoro atom in the piperidine ring faced a relatively more open direction. It exhibited characteristics of a negatively charged and hydrophilic environment that was supported by the side chains of D74, Y124, S125, Y133, E202, and S203 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B–D). It was speculated that additional interactions might be bridged by some potentially bound water molecules as found in the structure of the donepezil-bound rhAChE (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>) at a higher resolution. These interactions, especially the formation of additional interactions between the C–F from the fluorinated benzyl ring and the residues from the rhAChE, give a plausible explanation for the much longer dissociation of these fluorinated donepezil derivatives from their target and their enhanced biological activities compared to that of donepezil.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">2.6.  Selectivity of AChE Inhibition of the Cholinesterase Inhibitors</h3><div class="NLM_p">Current clinical AChE inhibitors usually produce several undesirable side effects, such as nausea, vomiting, bradycardia, etc., which are reported to be associated with the inhibition of peripheral cholinergic receptors.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Therefore, we further compared the butyl cholinesterase (BuChE) inhibitory activity of compound <b>12</b> with donepezil as the reference drug. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, compound <b>12</b> displayed a lesser inhibition against BuChE as compared to that against AChE. Thus, it exhibited a much better selectivity index (SI = 36899) than the reference drug donepezil (SI = 5417).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selectivity of Cholinesterase Inhibition by Compound <b>12</b> and Donepezil <i>in Vitro</i></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">BuChE IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">SI<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">31733.33 ± 2000</td><td class="colsep0 rowsep0" align="left">36899</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">donepezil</td><td class="colsep0 rowsep0" align="left">10833.33 ± 100</td><td class="colsep0 rowsep0" align="left">5417</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> data were expressed as mean ± SEM of three experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">SI means selectivity index, the ratio of IC<sub>50</sub> (BuChE/AChE).</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">2.7.  Preclinical Pharmacokinetic Evaluation of Compound <b>12</b></h3><div class="NLM_p">The <i>in vitro</i> inhibitory activities against AChE demonstrated that compound <b>12</b> exhibited the desirable inhibitory potency and selectivity for AChE. We thus chose compound <b>12</b> for further exploration. First, the pharmacokinetics profiles of compound <b>12</b> were evaluated in Sprague–Dawley (SD) rats and beagle dogs (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Here, compound <b>12</b> displayed a good oral bioavailability in the rats (<i>F</i> = 45.3%) and dogs (<i>F</i> = 61.3%). In Sprague–Dawley rats, a <i>T</i><sub>max</sub> of 0.6 ± 0.69 h, a <i>C</i><sub>max</sub> of 35.7 ± 15.1 ng/mL, an AUC<sub>0-∞</sub> of 179 ± 127 ng·h/mL, a <i>t</i><sub>1/2</sub> of 4.17 ± 2.32 h were obtained after an oral administration of 0.5 mg/kg dose of compound <b>12</b>. And in dogs, a <i>T</i><sub>max</sub> of 0.92 ± 0.2 h, a <i>C</i><sub>max</sub> of 16.9 ± 3.46 ng/mL, an AUC<sub>0-∞</sub> of 157 ± 34 ng·h/mL, a <i>t</i><sub>1/2</sub> of 23.2 ± 2.4 h were obtained after an oral administration of 0.25 mg/kg dose of compound <b>12</b>. The same experiments were also performed after an intravenous administration of compound <b>12.</b> The results showed that compound <b>12</b> had moderate clearance in rats and dogs; their clearance ratios were 23.7 ± 9.8 mL/min/kg and 17.5 ± 5.3 mL/min/kg, respectively. Comparatively speaking, a much lower plasma clearance ratio and a much bigger volume of distribution could be observed in dogs, thus leading to a longer half-life (<i>t</i><sub>1/2</sub> = 23.2 ± 2.4 h) in dogs than that in rats.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Parameters for Compound <b>12</b> in Rat, Dog, and Human<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">human<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">dog<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">1 mg</th><th class="colsep0 rowsep0" align="center">2 mg<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">4 mg</th><th class="colsep0 rowsep0" align="center">8 mg</th><th class="colsep0 rowsep0" align="center">12 mg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h), po</td><td class="colsep0 rowsep0" align="left">0.63 ± 0.69</td><td class="colsep0 rowsep0" align="left">0.92 ± 0.2</td><td class="colsep0 rowsep0" align="left">1.50</td><td class="colsep0 rowsep0" align="left">1.50</td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="left">1.13</td><td class="colsep0 rowsep0" align="left">1.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL), po</td><td class="colsep0 rowsep0" align="left">35.7 ± 15.1</td><td class="colsep0 rowsep0" align="left">16.9 ± 3.46</td><td class="colsep0 rowsep0" align="left">1.19 ± 0.23</td><td class="colsep0 rowsep0" align="left">2.43 ± 0.78</td><td class="colsep0 rowsep0" align="left">8.61 ± 3.59</td><td class="colsep0 rowsep0" align="left">16.4 ± 8.62</td><td class="colsep0 rowsep0" align="left">23.5 ± 8.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0-∞</sub> (ng·h/mL), po</td><td class="colsep0 rowsep0" align="left">179 ± 127</td><td class="colsep0 rowsep0" align="left">157 ± 34</td><td class="colsep0 rowsep0" align="left">14.7 ± 4.47</td><td class="colsep0 rowsep0" align="left">29.8 ± 8.05</td><td class="colsep0 rowsep0" align="left">69.4 ± 12.4</td><td class="colsep0 rowsep0" align="left">135 ± 45.2</td><td class="colsep0 rowsep0" align="left">220 ± 80.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0-∞</sub> (ng·h/mL), iv</td><td class="colsep0 rowsep0" align="left">395 ± 131</td><td class="colsep0 rowsep0" align="left">256 ± 75</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT<sub>0-∞</sub> (h), iv</td><td class="colsep0 rowsep0" align="left">5.21 ± 1.96</td><td class="colsep0 rowsep0" align="left">23.6 ± 8.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h), po</td><td class="colsep0 rowsep0" align="left">4.17 ± 2.32</td><td class="colsep0 rowsep0" align="left">23.2 ± 2.4</td><td class="colsep0 rowsep0" align="left">14.2 ± 5.48</td><td class="colsep0 rowsep0" align="left">20.7 ± 6.83</td><td class="colsep0 rowsep0" align="left">30.8 ± 5.18</td><td class="colsep0 rowsep0" align="left">27.6 ± 6.40</td><td class="colsep0 rowsep0" align="left">32.1 ± 4.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg), iv</td><td class="colsep0 rowsep0" align="left">23.7 ± 9.8</td><td class="colsep0 rowsep0" align="left">17.5 ± 5.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">6.52 ± 0.85</td><td class="colsep0 rowsep0" align="left">23.2 ± 6.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">45.3</td><td class="colsep0 rowsep0" align="left">61.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Average of six animals.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">0.5 mg/kg for po and iv.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">0.25 mg/kg for po and iv.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Eight healthy subjects in every group unless otherwise specified.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Seven healthy subjects.</p></div></div></div><div class="NLM_p">Because the drug target was located in the central nervous system (CNS), adequate drug delivery into the brain was a very important and prerequisite criterion for a drug to illustrate <i>in vivo</i> biological activities. Thus, a brain penetration study was performed for compound <b>12</b> that displayed adequate oral exposure in the pharmacokinetic studies in SD rats and beagle dogs (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Compound <b>12</b> displayed excellent brain penetration after an oral administration of 10 mg/kg dose in SD rats, and the <i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> ratio reached 5.4-fold. This indicated that the concentration of the drug in the brain was much higher than that in the plasma. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, the permeability of compound <b>12</b> was evaluated in the Caco-2 cell line wherein it displayed high permeability (5.74 ± 0.70 nm/s–11.2 ± 0.89 nm/s). In addition, the low efflux ratio of <i>P</i><sub>appB-A</sub> and <i>P</i><sub>appA-B</sub> (0.67–0.95) indicated that compound <b>12</b> had little interaction with efflux transporters such as P-glycoprotein. Additionally, compound <b>12</b> displayed high plasma protein binding, which reached 97.8 ± 0.4% in humans, 96.5 ± 0.3% in dogs, and 96.9 ± 0.1% in rats. Briefly, these excellent pharmacokinetic properties of compound <b>12</b> in rat and dog, especially high brain penetration capacity, warrant its therapeutic potential in AD and relative diseases.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Brain Penetration Study for Compound <b>12</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissues</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0-t</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0-∞</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">MRT (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">831</td><td class="colsep0 rowsep0" align="char" char=".">5843</td><td class="colsep0 rowsep0" align="char" char=".">6433</td><td class="colsep0 rowsep0" align="char" char=".">8.90</td><td class="colsep0 rowsep0" align="char" char=".">6.99</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">215</td><td class="colsep0 rowsep0" align="char" char=".">1082</td><td class="colsep0 rowsep0" align="char" char=".">1136</td><td class="colsep0 rowsep0" align="char" char=".">6.81</td><td class="colsep0 rowsep0" align="char" char=".">5.57</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Average value of three animals after an oral administration at 10 mg/kg dose in SD rats. <i>C</i><sub>b</sub>/<i>C</i><sub>p</sub> ratio means the drug concentration ratio in the brain and plasma.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Partial <i>in Vitro</i> Profiling Data for Compound <b>12</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">result</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein binding (bound)</td><td class="colsep0 rowsep0" align="left">97.8 ± 0.4% human</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">96.5 ± 0.3% dog</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">96.9 ± 0.1% rat</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 permeability (2.0–50.0 μM)</td><td class="colsep0 rowsep0" align="left">5.74 ± 0.70 nm/s ∼11.2 ± 0.89 nm/s</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ratio of Papp<sub>B-A</sub> and Papp<sub>A-B</sub></td><td class="colsep0 rowsep0" align="left">0.67–0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aqueous solubility</td><td class="colsep0 rowsep0" align="left">0.014–12.309 mg/mL (pH 2.0–7.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG</td><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> = 9.23 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMES</td><td class="colsep0 rowsep0" align="left">negative<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mutagenicity</td><td class="colsep0 rowsep0" align="left">negative<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>in vivo</i> micronucleus assay</td><td class="colsep0 rowsep0" align="left">negative<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Not induced mutagenesis in strains TA97, TA98, TA100, TA102, and TA1535 in the range from 50 to 5000 μg/plate of compound <b>12</b>.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">CHL cell.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">ICR mice, oral administration of 7.5, 15, and 30 mg/kg of compound <b>12</b> once a day for two consecutive days.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">2.8.  <i>Ex Vivo</i> Inhibitory Activities against AChE</h3><div class="NLM_p">On the basis of the superior <i>in vitro</i> inhibitory potencies as well as pharmacokinetic parameters, ICR mice were used to assess further the <i>ex vivo</i> inhibitory activities of compound <b>12</b> against AChE. For assessment of a dose-dependent effect, the AChE activities in the cortex and hippocampus were tested at 1 h following i.g. administration with compound <b>12</b> or donepezil. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, compound <b>12</b> (0.25, 0.5, 1, and 2 mg/kg) and donepezil (4, 8, 10, and 12 mg/kg) both inhibited the activities of AChE in a dose-dependent manner in the cortex (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) and hippocampus (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) of mice. The AChE inhibitory activity of compound <b>12</b> at 2 mg/kg was approximately equal to (or even more potent than) that of donepezil at 12 mg/kg, suggesting that the <i>ex vivo</i> central AChE inhibitory activity of compound <b>12</b> was about six times more potent than that of donepezil.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose-dependent AChE inhibitory effects of compound <b>12</b> (i.g.) in the cortex (A) and hippocampus (B) of ICR mice. Data were represented as the percentage of vehicle control mice; they were set to 100% and presented as mean ± SEM (<i>N</i> = 6–12). **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the control group (vehicle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">2.9.  Ameliorative Effect of Compound <b>12</b> on Scopolamine-Induced Cognitive Deficits in Mice</h3><div class="NLM_p">Scopolamine, a muscarinic receptor antagonist, induces significant central cholinergic deficiency and consequent cognitive deficit. The scopolamine-induced amnestic mice model is widely used to assess the pharmacological effects of cholinergic agents, especially AChE inhibitors.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35−38)</a> In the present study, a channel water maze (80 cm × 50 cm × 20 cm, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf" class="ext-link">Figure S1</a>) was employed to assess the cognitive behavior of mice. Mice injected with scopolamine showed significantly increased escape latency (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A) and errors of entering no-exit areas (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). In contrast, compound <b>12</b> (0.5, 1, and 2 mg/kg; <i>P</i> < 0.05, <i>P</i> < 0.05, and <i>P</i> < 0.001, respectively) and donepezil (8, 10, and 12 mg/kg; <i>P</i> < 0.01, <i>P</i> < 0.05, and <i>P</i> < 0.001, respectively) significantly reversed the increased escape latencies in the scopolamine-stimulated mice. Similarly, the number of errors in the scopolamine-treated mice was also reduced after administration of compound <b>12</b> at doses of 1 and 2 mg/kg (<i>P</i> < 0.05 and <i>P</i> < 0.01, respectively), or donepezil at 8 and 12 mg/kg (<i>P</i> < 0.05 and <i>P</i> < 0.01, respectively). Thus, compound <b>12</b> could ameliorate the scopolamine-induced cognitive impairment in mice at a lower dose (about one-eighth) than that achieved by donepezil.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of compound <b>12</b> (i.g.) on scopolamine-induced cognitive deficits in the mouse channel water maze. (A) Escape latencies (time to find the escape platform); (B) the number of errors (entering the no-exit in the channel maze). Data were presented as mean ± SEM (<i>N</i> = 32–36). <sup>###</sup><i>P</i> < 0.001 vs the control group (vehicle + saline); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the scopolamine group (vehicle + scopolamine).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">2.10.  Ameliorative Effect of Compound <b>12</b> on Cognitive Impairments in APP/PS1 Mice</h3><div class="NLM_p">Next, the performances in the Y-maze and Morris water maze were assessed in order to determine the ameliorative effects of compound <b>12</b> on the cognitive deficits in APP/PS1 mice, a rodent AD model widely used for evaluating pharmacological effects of anti-AD drug candidates.<a onclick="showRef(event, 'ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40 ref41">(38−41)</a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A illustrated that the levels of spontaneous alternation in the APP/PS1 mice were significantly reduced as compared to that of the wild type littermates (<i>P</i> < 0.05). Compound <b>12</b> rescued the spontaneous working memory impairment in the APP/PS1 mice in a dose-dependent manner. This resulted in significantly higher spontaneous alternations than those observed in the vehicle-treated APP/PS1 mice at 0.5 and 1 mg/kg (<i>P</i> < 0.01 and <i>P</i> < 0.001, respectively). The Morris water maze was further employed to assess the ameliorative effects of compound <b>12</b> on spatial learning and memory impairment in the APP/PS1 mice. In the probe trial, APP/PS1 mice showed statistically lesser time in the target quadrant compared with the age-matched control group (<i>P</i> < 0.05), while compound <b>12</b> significantly increased the time spent in the target quadrant (<i>P</i> values <0.05 vs the vehicle-treated APP/PS1 mice) at 0.5 mg/kg and 1 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). In addition, we found that a 3-month oral administration with compound <b>12</b> at 0.5 mg/kg and 1 mg/kg significantly increased the number of platforms crossed in the probe trial (<i>P</i> values <0.05 vs the vehicle-treated APP/PS1 mice) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf" class="ext-link">Figure S2</a>). These results indicated that treatment with compound <b>12</b> significantly ameliorated the impairments of cognition in the APP/PS1 mice.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of compound <b>12</b> (i.g.) on behavioral changes in the APP/PS1 mice. (A) Y maze performance (4 weeks of drug treatment); (B) time spent in the target quadrant of the probe trial of Morris water maze (6 weeks of drug treatment). Data were presented as mean ± SEM (<i>N</i> = 15–17). <sup>#</sup><i>P</i> < 0.05 vs the vehicle-treated wild type mice; *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the vehicle-treated APP/PS1 (Tg) mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">2.11.  Safety Evaluations for Compound <b>12</b></h3><div class="NLM_p">Inhibition of the I<sub>kR</sub> channel encoded by the human Ether-A-Go-Go gene (hERG) is implicated in QT prolongation and can lead to cardiac arrhythmia and sudden death.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Hence, the role of compound <b>12</b> was evaluated, and an IC<sub>50</sub> value of 9.23 μM was detected for the inhibition of the hERG channel (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). This value was 10732-fold higher than the IC<sub>50</sub> value for the <i>in vitro</i> inhibition of AChE and indicated that compound <b>12</b> was unable to cause QT prolongation, cardiac arrhythmia, and sudden death. We further assessed compound <b>12</b> in a multiple-dose cardiovascular study in beagle dogs. The results demonstrated that compound <b>12</b> did not affect the ECG (including H, PR, QRS, and QT), blood pressure, body temperature, and respiration after administration of 0.1, 0.3, and 1.0 mg/kg of compound <b>12</b>. Besides, compound <b>12</b> showed negative results in the Ames, mutagenicity, and <i>in vivo</i> micronucleus assessments, thus indicating good safety (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><div class="NLM_p">The inhibition of human CYP isoforms (1A2, 2B6, 2C8, 2C9, 2C19, 2D6, and 3A4) by compound <b>12</b> was also assessed using human hepatocytes. The results displayed that compound <b>12</b> exhibited a moderate inhibition toward CYP2C9 (IC<sub>50</sub> = 4.77 μM), while it did not inhibit other human CYP isoforms (IC<sub>50</sub> > 30 μM); this indicated a low probability of drug–drug interactions. Moreover, compound <b>12</b> (up to 10.0 μM) did not induce the CYP1A2 or CYP3A4 expression in human hepatocytes at the tested concentrations.</div><div class="NLM_p last">In a 4-week long-term toxicity study in the SD rats, no deaths were recorded after administering up to 30 mg/kg oral dose of compound <b>12</b>. However, in a 13-week long-term toxicity study in the SD rats administered donepezil, deaths of 1 male and three females were reported in the 20 mg/kg group and of 4 females in the 10 mg/kg group.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Likewise, in a 4-week long-term toxicity study of compound <b>12</b> in beagle dogs, no deaths occurred after an oral administration of 1, 3, and 20 mg/kg, respectively. Five deaths were reported in the group administered 8 mg/kg of donepezil.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> These results indicated that compound <b>12</b> may possess lower toxicity and a much larger safety margin than donepezil.</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">2.12.  Phase I Clinical Trials for Compound <b>12</b> in Healthy Volunteers</h3><div class="NLM_p last">The pharmacokinetics, safety, and tolerance of compound <b>12</b> were first evaluated in phase I clinical trials in healthy volunteers by a single ascending dose (SAD) study with doses of 1 mg, 2 mg, 4 mg, 8 mg, and 12 mg (CTR20181428), respectively.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> These trials displayed that single oral doses of up to 12 mg of compound <b>12</b> were safe and well-tolerated; the compound could be rapidly absorbed, and the maximum plasma concentration (<i>C</i><sub>max</sub>) was generally reached within 0.75–1.5 h. The area under the curve (AUC), as well as <i>C</i><sub>max</sub>, appeared to increase in a dose-proportional manner, and the terminal plasma half-life was 14.2–32.1 h (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Further, another multiple ascending dose (MAD) study (CTR20190664) using oral doses of 2 mg and 6 mg once daily for 7 days was initiated, and the results showed good pharmacokinetic profiles and safety.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Overall, compound <b>12</b> displayed good safety, tolerance, and pharmacokinetic profiles at all preset doses in healthy volunteers. These results warrant further evaluation of its therapeutic potential for the treatment of Alzheimer’s disease in phase II clinical trials.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">3.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The small safety window of current AChE inhibitors has limited their maximum therapeutic application in the therapy of AD. Here, we have attempted to employ a new kinetics-driven drug design strategy to design desirable compounds to overcome this deficiency. By this new strategy, 44 novel derivatives containing an important fluorine atom were synthesized, and 14 of them displayed excellent inhibitory effects against AChE. As expected, their dissociation rate constant (<i>k</i><sub>off</sub>) was much lower than that of donepezil, and the studies on the X-ray cocrystal complexes for three highly potent compounds (<b>2</b>, <b>7</b>, and <b>12</b>) provided a precise binding mode between the individual compounds and AChE. In multiple animal models, compound <b>12</b> demonstrated a much better efficacy and a lower effective dose than that of donepezil, indicating that slowing down the dissociation from its target may to improve its efficacy and safety. Actually, compound <b>12</b> exhibited excellent safety in hERG, Ames, mutagenicity, micronucleus (CHO cells) studies, as well as the 4-week long-term toxicity studies. Overall, compound <b>12</b> was a highly potent, selective, orally bioavailable, and brain-penetrating AChE inhibitor. It could significantly ameliorate the cognitive impairments in different mice models with a low effective dose. More importantly, the phase I trials of compound <b>12</b> in healthy volunteers with a single ascending dose study (CTR20181428) and a multiple ascending dose study (CTR20190664) also offered good safety, tolerance, and enhanced pharmacokinetic profiles. These favorable outcomes motivate us to explore its further therapeutic values in phase II clinical trials, more efforts for the therapy of AD patients are currently underway.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All commercially available materials and solvents were used without further purification. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance III 400, 500, or 600 MHz spectrometer (Bruker Biospin AG) with tetramethylsilane (TMS) as an internal standard, and chemical shifts were reported in parts per million (ppm, δ). Low-resolution mass spectra (LRMS) were obtained with a Finnigan LTQ, and HRMS were measured on Agilent G6520 Q-TOF. The purity of all compounds was determined by Agilent 1260 HPLC with a binary pump, photodiode array detector (DAD), using Waters Xbridge C18 (4.6 mm × 150 mm, 3.5 μm). Mobile phase A is a mixed solution (20 mM KH<sub>2</sub>PO<sub>4</sub> solution at pH 6.0/CH<sub>3</sub>CN/Et<sub>3</sub>N = 90/10/0.3, v/v/v), mobile phase B is CH<sub>3</sub>CN, and the flow rate is 1 mL/min. The purity of all target products is more than 95%.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">4.1.  General Procedure for the Synthesis of Target Compound <b>1</b>–<b>24</b></h3><div class="NLM_p">To a solution of 33 g of (CH<sub>3</sub>)<sub>3</sub>SI in 100 mL of DMSO in a 500 mL of round-bottom flask was added 25 g of <i>N</i>-Boc-piperidin-4-one (<b>45</b>), followed by the addition of 17 g of <i>t</i>-BuOK slowly (keeping reaction temperature below 10 °C). After stirring for 5 min, the resulting mixture was dropped into 100 mL of ice water, stirred for 5 min, and extracted by petroleum ether (PE). The organic phase was washed successively by H<sub>2</sub>O (50 mL × 2) and saturated brine (20 mL × 1), then dried by anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated off to dryness to give the white solid <b>46</b> (20 g) without further purification. The resulting intermediate <b>46</b> was dissolved into 100 mL of CH<sub>2</sub>Cl<sub>2</sub> with a plastic bottle and cooled to −15 °C. Then 10 mL of 70% HF in pyridine solution was added dropwise into the above mixture, and the reaction mixture was stirred until the starting material disappeared. The resulting mixture was added into 100 mL of ice water, extracted by CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was washed successively by H<sub>2</sub>O (50 mL × 2) and saturated brine (20 mL × 1), then dried by anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated off to dryness to give crude <b>47</b> as an oil, which could be purified by flash chromatography to give pure target intermediate <b>47</b>. Pale yellow oil. <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 4.0–3.9 (m, 2H), 3.6 (s, 1H), 3.6 (s, 1H), 3.1–3.0 (m, 2H), 1.9 (s, 1H), 1.9–1.8 (m, 2H), 1.6–1.5 (m, 2H), 1.4 (s, 9H). <sup>13</sup>C NMR (150 MHz, chloroform-<i>d</i>) δ 154.7, 94.5 (d, <i>J</i> = 171.1 Hz), 79.8, 68.3 (d, <i>J</i> = 23.4 Hz), 39.3, 31.2 (d, <i>J</i> = 21.5 Hz), 28.4.</div><div class="NLM_p">Compound <b>47</b> could convert into <i>N</i>-Boc-4-fluoropiperidine-4-carbaldehyde (<b>48</b>) via a classic swern oxidation, and the resulting crude <b>48</b> did not need further purification to be used in the next step. After coupling with 5,6-dimethoxy-2,3-dihydroinden-1-one (<b>49</b>) under the presence of CH<sub>3</sub>ONa in THF gave the key intermediate <b>50</b>, which could be purified by recrystallization with isopropanol. Off-white solid. <sup>1</sup>H NMR (600 MHz, chloroform-<i>d</i>) δ 7.3 (s, 1H), 6.9 (s, 1H), 6.6 (dt, <i>J</i> = 26.5, 2.0 Hz, 1H), 4.0 (s, 5H), 3.9 (s, 3H), 3.8 (t, <i>J</i> = 2.7 Hz, 2H), 3.3–3.0 (m, 2H), 1.9–1.7 (m, 4H), 1.5 (s, 9H). <sup>13</sup>C NMR (150 MHz, chloroform-<i>d</i>) δ 192.7, 155.8, 154.7, 149.6, 146.0, 136.2, 133.9 (d, <i>J</i> = 20.1 Hz), 130.5, 107.2, 105.0, 94.0 (d, <i>J</i> = 177.0 Hz), 79.9, 56.3, 56.2, 39.2, 34.5 (d, <i>J</i> = 22.3 Hz), 30.3 (d, <i>J</i> = 7.1 Hz), 28.4. HRMS calcd. for C<sub>22</sub>H<sub>28</sub>FNO<sub>5</sub>Na [M + Na]<sup>+</sup>: 428.1844, found 428.1841.</div><div class="NLM_p">To a solution of 15 g of <b>50</b> in 150 mL of THF was added 1.5 g of 10% Pd/C, and the resulting mixture was reacted for overnight under the presence of H<sub>2</sub> until the material <b>50</b> disappears. After the reaction mixture was filtered, the solvent was evaporated off to dryness to give off-white intermediate <b>51</b>, which could also be purified by recrystallization with isopropanol. <sup>1</sup>H NMR (600 MHz, Chloroform-<i>d</i>) δ 7.2 (s, 1H), 6.8 (s, 1H), 4.0–3.9 (m, 5H), 3.9 (s, 3H), 3.3 (dd, <i>J</i> = 17.1, 7.6 Hz, 1H), 3.1–3.0 (m, 2H), 2.9 (dd, <i>J</i> = 17.1, 4.0 Hz, 1H), 2.8–2.8 (m, 1H), 2.4–2.3 (m, 1H), 2.0–1.9 (m, 1H), 1.8–1.8 (m, 1H), 1.7–1.6 (m, 3H), 1.4 (s, 9H). <sup>13</sup>C NMR (150 MHz, Chloroform-<i>d</i>) δ 206.6, 155.7, 154.7, 149.5, 149.2, 128.8, 107.3, 104.4, 94.1 (d, <i>J</i> = 172.5 Hz), 79.7, 56.3, 56.1, 43.2, 41.7 (d, <i>J</i> = 21.0 Hz), 39.7, 39.6, 36.0 (d, <i>J</i> = 21.8 Hz), 34.3 (d, <i>J</i> = 3.0 Hz), 33.9 (d, <i>J</i> = 21.9 Hz), 28.4. HRMS calcd. for C<sub>22</sub>H<sub>30</sub>FNO<sub>5</sub>Na [M + Na]<sup>+</sup>: 430.2, found 430.2003.</div><div class="NLM_p last">Then, removing the Boc group of <b>51</b> with a mixed solvent of TFA in CH<sub>2</sub>Cl<sub>2</sub> and reacting with various substituted benzyl bromide or phenylethyl bromide under K<sub>2</sub>CO<sub>3</sub> in DMF prepared target compounds <b>1</b>–<b>24</b>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">4.2.  General Procedure for the Synthesis of Target Compounds <b>25</b>–<b>44</b></h3><div class="NLM_p last">According to the similar reports,<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> we prepared successfully the key intermediates <b>56a</b>–<b>e</b>, <b>57a</b>–<b>b</b>, and <b>59a</b>–<b>b</b>. The target compounds <b>25</b>–<b>44</b> were further synthesized from these key intermediates <b>56b</b>–<b>e</b>, <b>57a</b>–<b>b</b>, and <b>59a</b>–<b>b</b> by procedures similar to compound <b>1.</b></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01863" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01863?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01863</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplemental figures and tables; characterization data for all target compounds <b>1</b><b>–44</b> and key intermediates; experimental operation description for all bioassay; X-ray crystal structure study and surface plasmon resonance determination; <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and HPLC spectra of all target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula stings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf">jm0c01863_si_001.pdf (10.84 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_002.csv">jm0c01863_si_002.csv (2.94 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">All data are available in the main text or the Supporting Information. Compounds <b>2</b>, <b>7</b>, and <b>12</b> are available from H.L. under a material transfer agreement with Shanghai Institute of Materia Medica. The PDB accession number for the coordinates of rhAChE in complex with compound <b>2</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9O">7D9O</a>, for the coordinates of rhAChE in complex with compound <b>7</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9Q">7D9Q</a>, and for the coordinates of rhAChE in complex with compound <b>12</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9P">7D9P</a>. Authors will release the atomic coordinates upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c01863" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiyan Zhang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Chinese Academy
of Sciences, No. 19A
Yuquan Road, Beijing 100049, People’s Republic of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2877-2040" title="Orcid link">http://orcid.org/0000-0002-2877-2040</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#523a283a333c3512213b3f3f7c33317c313c"><span class="__cf_email__" data-cfemail="5d3527353c333a1d2e343030733c3e733e33">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hualiang Jiang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Chinese Academy
of Sciences, No. 19A
Yuquan Road, Beijing 100049, People’s Republic of China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2c444046454d424b6c5f454141024d4f024f42"><span class="__cf_email__" data-cfemail="b8d0d4d2d1d9d6dff8cbd1d5d596d9db96dbd6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Liu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Chinese Academy
of Sciences, No. 19A
Yuquan Road, Beijing 100049, People’s Republic of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3685-6268" title="Orcid link">http://orcid.org/0000-0003-3685-6268</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d6bebabfa396a5bfbbbbf8b7b5f8b5b8"><span class="__cf_email__" data-cfemail="a7cfcbced2e7d4cecaca89c6c489c4c9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Zhou</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Chinese Academy
of Sciences, No. 19A
Yuquan Road, Beijing 100049, People’s Republic of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7684-2939" title="Orcid link">http://orcid.org/0000-0002-7684-2939</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Fu</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wanchao Yin</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Chinese Materia Medica, Nanjing University
of Chinese Medicine, Qixia District, Nanjing 210023, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Wang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fang Bai</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Institute for Advanced Immunochemical Studies and School of Life Science
and Technology, ShanghaiTech University, Shanghai 201210, People’s Republic of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1468-5568" title="Orcid link">http://orcid.org/0000-0003-1468-5568</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shengtao Xu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Gong</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Peng</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Hong</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiufeng Liu</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yechun Xu</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Chinese Academy
of Sciences, No. 19A
Yuquan Road, Beijing 100049, People’s Republic of China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1581-6155" title="Orcid link">http://orcid.org/0000-0002-1581-6155</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">H. Eric Xu</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, People’s Republic of China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, University of Chinese Academy
of Sciences, No. 19A
Yuquan Road, Beijing 100049, People’s Republic of China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.Z., Y.F., and W.Y. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to the National Natural Science Foundation of China (81102307, 21632008), National S&T Major Projects (2015ZX09103003, 2018ZX09711002), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12040207, XDA12040106), Youth Innovation Promotion Association CAS, and Jiangsu Kanion Pharmaceutical Co. Ltd. for financial support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">rhAChE</td><td class="NLM_def"><p class="first last">recombinant human AChE</p></td></tr><tr><td class="NLM_term">BuChE</td><td class="NLM_def"><p class="first last">butyrocholinesterase</p></td></tr><tr><td class="NLM_term">HupA</td><td class="NLM_def"><p class="first last">huperzine A</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human Ether-A-Go-Go gene</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. B.</span></span> <span> </span><span class="NLM_article-title">Novel phosphodiesterase inhibitors for cognitive improvement in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5467</span>– <span class="NLM_lpage">5483</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01370</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5467-5483&author=Y.+Wuauthor=Z.+Liauthor=Y.+Y.+Huangauthor=D.+Wuauthor=H.+B.+Luo&title=Novel+phosphodiesterase+inhibitors+for+cognitive+improvement+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b01370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease</span></div><div class="casAuthors">Wu, Yinuo; Li, Zhe; Huang, Yi-You; Wu, Deyan; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5467-5483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is one of the greatest public health challenges.  Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).  Since several PDE subfamilies are highly expressed in the human brain, the inhibition of PDEs is involved in neurodegenerative processes by regulating the concn. of cAMP and/or cGMP.  Currently, PDEs are considered as promising targets for the treatment of AD since many PDE inhibitors have exhibited remarkable cognitive improvement effects in preclin. studies and over 15 of them have been subjected to clin. trials.  The aim of this review is to summarize the outstanding progress that has been made by PDE inhibitors as anti-AD agents with encouraging results in preclin. studies and clin. trials.  The binding affinity, pharmacokinetics, underlying mechanisms, and limitations of these PDE inhibitors in the treatment of AD are also reviewed and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom1l9eMNKCt7Vg90H21EOLACvtfcHk0lig1WhujHfvsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGqu7w%253D&md5=87cd22fa21c661f4cb5dc2155368bd7c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01370%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DY.%2BY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26atitle%3DNovel%2520phosphodiesterase%2520inhibitors%2520for%2520cognitive%2520improvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5467%26epage%3D5483%26doi%3D10.1021%2Facs.jmedchem.7b01370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagginapally, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kancharla, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middekadi, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogaraju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravella, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birangal, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, structure-activity relationships, and preclinical evaluation of heteroaromatic amides and 1,3,4-oxadiazole derivatives as 5-HT4 receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4993</span>– <span class="NLM_lpage">5008</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00457</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00457" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVChsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4993-5008&author=R.+Nirogiauthor=A.+R.+Mohammedauthor=A.+K.+Shindeauthor=S.+R.+Gagginapallyauthor=D.+M.+Kancharlaauthor=V.+R.+Middekadiauthor=N.+Bogarajuauthor=S.+R.+Ravellaauthor=P.+Singhauthor=S.+R.+Birangalauthor=R.+Subramanianauthor=R.+C.+Palacharlaauthor=V.+Benadeauthor=N.+Muddanaauthor=P.+Jayarajan&title=Synthesis%2C+structure-activity+relationships%2C+and+preclinical+evaluation+of+heteroaromatic+amides+and+1%2C3%2C4-oxadiazole+derivatives+as+5-HT4+receptor+partial+agonists&doi=10.1021%2Facs.jmedchem.8b00457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists</span></div><div class="casAuthors">Nirogi, Ramakrishna; Mohammed, Abdul Rasheed; Shinde, Anil K.; Gagginapally, Shankar Reddy; Kancharla, Durga Malleshwari; Middekadi, Vanaja Reddy; Bogaraju, Narsimha; Ravella, Srinivasa Rao; Singh, Pooja; Birangal, Sumit Raosaheb; Subramanian, Ramkumar; Palacharla, Raghava Choudary; Benade, Vijay; Muddana, Nageswararao; Jayarajan, Pradeep</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4993-5008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder that has a higher prevalence and incidence in people older than 60 years.  The need for improved AD therapies is unmet as the current therapies are symptomatic with modest efficacy.  Partial agonists of the 5-HT4 receptor (5-HT4R) offer both symptomatic and disease-modifying treatments as they shift amyloid-precursor-protein (APP) processing from the amyloidogenic pathway to the nonamyloidogenic pathway by activating the α-secretase enzyme.  In addn., they also offer symptomatic treatment by increasing levels of the neurotransmitter acetylcholine in the brain.  Because of this fascinating dual mechanism of action, several chem. scaffolds having 5-HT4R pharmacophores were designed and evaluated.  Most of the synthesized compds. showed potent in vitro affinities and in vivo efficacies.  Upon anal. of focused structure-activity relationships, compd. 4o was identified as a potent 5-HT4R partial agonist with favorable ADME properties and good in vivo efficacy.  GR-125487, a selective 5-HT4R antagonist, attenuated the activity of compd. 4o in the novel-object-recognition-test cognition model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk2z2YiR_ja7Vg90H21EOLACvtfcHk0lgALqgP0R8L2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVChsLk%253D&md5=b8bacee142c07a4dbb433e95b86b1d07</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00457%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DShinde%26aufirst%3DA.%2BK.%26aulast%3DGagginapally%26aufirst%3DS.%2BR.%26aulast%3DKancharla%26aufirst%3DD.%2BM.%26aulast%3DMiddekadi%26aufirst%3DV.%2BR.%26aulast%3DBogaraju%26aufirst%3DN.%26aulast%3DRavella%26aufirst%3DS.%2BR.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DBirangal%26aufirst%3DS.%2BR.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DMuddana%26aufirst%3DN.%26aulast%3DJayarajan%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520preclinical%2520evaluation%2520of%2520heteroaromatic%2520amides%2520and%25201%252C3%252C4-oxadiazole%2520derivatives%2520as%25205-HT4%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4993%26epage%3D5008%26doi%3D10.1021%2Facs.jmedchem.8b00457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molinuevo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batrla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielke, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Bryant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zetterberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span> <span> </span><span class="NLM_article-title">Current state of Alzheimer’s fluid biomarkers</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1007/s00401-018-1932-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1007%2Fs00401-018-1932-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=30488277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlCls7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2018&pages=821-853&author=J.+L.+Molinuevoauthor=S.+Aytonauthor=R.+Batrlaauthor=M.+M.+Bednarauthor=T.+Bittnerauthor=J.+Cummingsauthor=A.+M.+Faganauthor=H.+Hampelauthor=M.+M.+Mielkeauthor=A.+Mikulskisauthor=S.+O%E2%80%99Bryantauthor=P.+Scheltensauthor=J.+Sevignyauthor=L.+M.+Shawauthor=H.+D.+Soaresauthor=G.+Tongauthor=J.+Q.+Trojanowskiauthor=H.+Zetterbergauthor=K.+Blennow&title=Current+state+of+Alzheimer%E2%80%99s+fluid+biomarkers&doi=10.1007%2Fs00401-018-1932-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current state of Alzheimer's fluid biomarkers</span></div><div class="casAuthors">Molinuevo, Jose Luis; Ayton, Scott; Batrla, Richard; Bednar, Martin M.; Bittner, Tobias; Cummings, Jeffrey; Fagan, Anne M.; Hampel, Harald; Mielke, Michelle M.; Mikulskis, Alvydas; O'Bryant, Sid; Scheltens, Philip; Sevigny, Jeffrey; Shaw, Leslie M.; Soares, Holly D.; Tong, Gary; Trojanowski, John Q.; Zetterberg, Henrik; Blennow, Kaj</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">821-853</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disease with a complex and heterogeneous pathophysiol.  The no. of people living with AD is predicted to increase; however, there are no disease-modifying therapies currently available and none have been successful in late-stage clin. trials.  Fluid biomarkers measured in cerebrospinal fluid (CSF) or blood hold promise for enabling more effective drug development and establishing a more personalized medicine approach for AD diagnosis and treatment.  Biomarkers used in drug development programs should be qualified for a specific context of use (COU).  These COUs include, but are not limited to, subject/patient selection, assessment of disease state and/or prognosis, assessment of mechanism of action, dose optimization, drug response monitoring, efficacy maximization, and toxicity/adverse reactions identification and minimization.  The core AD CSF biomarkers Aβ42, t-tau, and p-tau are recognized by research guidelines for their diagnostic utility and are being considered for qualification for subject selection in clin. trials.  However, there is a need to better understand their potential for other COUs, as well as identify addnl. fluid biomarkers reflecting other aspects of AD pathophysiol.  Several novel fluid biomarkers have been proposed, but their role in AD pathol. and their use as AD biomarkers have yet to be validated.  In this review, we summarize some of the pathol. mechanisms implicated in the sporadic AD and highlight the data for several established and novel fluid biomarkers (including BACE1, TREM2, YKL-40, IP-10, neurogranin, SNAP-25, synaptotagmin, α-synuclein, TDP-43, ferritin, VILIP-1, and NF-L) assocd. with each mechanism.  We discuss the potential COUs for each biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEfy0WGH51zLVg90H21EOLACvtfcHk0lgALqgP0R8L2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlCls7bK&md5=7a9182d19735345a67eb1590986c4a79</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00401-018-1932-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-018-1932-x%26sid%3Dliteratum%253Aachs%26aulast%3DMolinuevo%26aufirst%3DJ.%2BL.%26aulast%3DAyton%26aufirst%3DS.%26aulast%3DBatrla%26aufirst%3DR.%26aulast%3DBednar%26aufirst%3DM.%2BM.%26aulast%3DBittner%26aufirst%3DT.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DMielke%26aufirst%3DM.%2BM.%26aulast%3DMikulskis%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Bryant%26aufirst%3DS.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DSevigny%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DSoares%26aufirst%3DH.%2BD.%26aulast%3DTong%26aufirst%3DG.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DCurrent%2520state%2520of%2520Alzheimer%25E2%2580%2599s%2520fluid%2520biomarkers%26jtitle%3DActa%2520Neuropathol.%26date%3D2018%26volume%3D136%26spage%3D821%26epage%3D853%26doi%3D10.1007%2Fs00401-018-1932-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucke, L.</span></span> <span> </span><span class="NLM_article-title">Alzheimer mechanisms and therapeutic strategies</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1222</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.cell.2012.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=22424230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=1204-1222&author=Y.+Huangauthor=L.+Mucke&title=Alzheimer+mechanisms+and+therapeutic+strategies&doi=10.1016%2Fj.cell.2012.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer Mechanisms and Therapeutic Strategies</span></div><div class="casAuthors">Huang, Yadong; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1204-1222</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  There are still no effective treatments to prevent, halt, or reverse Alzheimer's disease, but research advances over the past three decades could change this gloomy picture.  Genetic studies demonstrate that the disease has multiple causes.  Interdisciplinary approaches combining biochem., mol. and cell biol., and transgenic modeling have revealed some of its mol. mechanisms.  Progress in chem., radiol., and systems biol. is beginning to provide useful biomarkers, and the emergence of personalized medicine is poised to transform pharmaceutical development and clin. trials.  However, investigative and drug development efforts should be diversified to fully address the multifactoriality of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx4Jw1D9na57Vg90H21EOLACvtfcHk0lgALqgP0R8L2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D&md5=4f44f2d5019321a668029282777946d1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAlzheimer%2520mechanisms%2520and%2520therapeutic%2520strategies%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D1204%26epage%3D1222%26doi%3D10.1016%2Fj.cell.2012.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mozaffarnia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teimuri-Mofrad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M.-R.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">112140</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.ejmech.2020.112140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=32088494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1OnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2020&pages=112140&author=S.+Mozaffarniaauthor=R.+Teimuri-Mofradauthor=M.-R.+Rashidi&title=Design%2C+synthesis+and+biological+evaluation+of+2%2C3-dihydro-5%2C6-dimethoxy-1H-inden-1-one+and+piperazinium+salt+hybrid+derivatives+as+hAChE+and+hBuChE+enzyme+inhibitors&doi=10.1016%2Fj.ejmech.2020.112140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors</span></div><div class="casAuthors">Mozaffarnia, Sakineh; Teimuri-Mofrad, Reza; Rashidi, Mohammad-Reza</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112140pp.</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">2,3-Dihydro-5,6-dimethoxy-2-[4-(4-alkyl-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one halide salt derivs. I [R = Pr, pentyl, allyl, benzyl, etc.; X = Cl, Br] as a novel donepezil hybrid analogs with the property of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzyme inhibition were designed and synthesized via N-alkylation reaction of 2,3-dihydro-5,6-dimethoxy-2-[4-(4-methylpiperazin-1-yl)benzylidene]-1H-inden-1-one with some alkyl halides.  Biol. tests demonstrated that most of the synthesized compds. I have moderate to good inhibitory activities effect on cholinesterase enzymes.  Among them, I [R = 3-chlorobenzyl] showed the best profile as a selected compd. for inhibition of hAChE (IC50 = 0.32) and hBuChE (IC50 = 0.43μM) enzymes.  Kinetic anal. and mol. docking led to a better understanding of this compd. I.  Kinetic studies disclosed that I [R = 3-chlorobenzyl] inhibited acetylcholinesterase in mixed-type and butyrylcholinesterase in non-competitive type.  The toxicity results showed that I [R = 3-chlorobenzyl] was less toxic than donepezil and has better inhibitory activity against hBuChE when compared to donepezil or Galantamine.  Other performed expts. revealed that I [R = 3-chlorobenzyl] has an anti-β amyloid effect which was capable of reducing ROS, LDH and MDA also possing pos. effect on TAC.  On the other hand, it was showed a good anti-inflammation effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnInIUobDxO7Vg90H21EOLACvtfcHk0lj2HCg5Rxw78w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1OnsLk%253D&md5=c4d778c468d6af502be5d66ebd2bfd2c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112140%26sid%3Dliteratum%253Aachs%26aulast%3DMozaffarnia%26aufirst%3DS.%26aulast%3DTeimuri-Mofrad%26aufirst%3DR.%26aulast%3DRashidi%26aufirst%3DM.-R.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%25202%252C3-dihydro-5%252C6-dimethoxy-1H-inden-1-one%2520and%2520piperazinium%2520salt%2520hybrid%2520derivatives%2520as%2520hAChE%2520and%2520hBuChE%2520enzyme%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D191%26spage%3D112140%26doi%3D10.1016%2Fj.ejmech.2020.112140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapposelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, R.</span></span> <span> </span><span class="NLM_article-title">A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.bmc.2017.12.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=29310862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslOltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=543-550&author=X.+Zhangauthor=X.+Heauthor=Q.+Chenauthor=J.+Luauthor=S.+Rapposelliauthor=R.+Pi&title=A+review+on+the+hybrids+of+hydroxycinnamic+acid+as+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2017.12.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease</span></div><div class="casAuthors">Zhang, Xiao; He, Xixin; Chen, Qiuhe; Lu, Junfeng; Rapposelli, Simona; Pi, Rongbiao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">543-550</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), a complex chronic progressive central nervous system degenerative disease and a public health problem of the world, often characters cognitive dysfunction accompanying aggression and depression, and may lead to death.  More attentions should be paid on it because there is no modified strategy against AD till now.  AD is featured with the loss of cholinergic neurons, the amyloid-beta peptide (Aβ) plaques and the neurofibrillary tangles and several hypotheses were established to explain the pathogenesis of AD.  Hydroxycinnamic acids, including caffeic acid (CA) and ferulic acid (FA) are widely distributed in natural plants and fruits.  CA and FA exert various pharmacol. activities, including anti-inflammatory, antioxidant, neuroprotection, anti-amyloid aggregation and so on.  All these pharmacol. activities are assocd. with the treatment of AD.  Here we summarized the pharmacol. activities of CA and FA, and their hybrids as multi-target-directed ligands (MTDLs) against AD.  The future application of CA and FA was also discussed, hoping to provide beneficial information for the development of CA- and FA-based MTDLs against AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi4-lyK8HNyrVg90H21EOLACvtfcHk0lj2HCg5Rxw78w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslOltg%253D%253D&md5=876d012130ef30122caaca8bccd2c44e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.042%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DRapposelli%26aufirst%3DS.%26aulast%3DPi%26aufirst%3DR.%26atitle%3DA%2520review%2520on%2520the%2520hybrids%2520of%2520hydroxycinnamic%2520acid%2520as%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D543%26epage%3D550%26doi%3D10.1016%2Fj.bmc.2017.12.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambhampati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraf, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badange, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyala, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojja, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reballi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasti, V.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (SUVN-502): a novel, potent, selective and orally active serotonin 6 (5-HT6) receptor antagonist for potential treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1843-1859&author=R.+Nirogiauthor=A.+Shindeauthor=R.+S.+Kambhampatiauthor=A.+R.+Mohammedauthor=S.+K.+Sarafauthor=R.+K.+Badangeauthor=T.+R.+Bandyalaauthor=V.+Bhattaauthor=K.+Bojjaauthor=V.+Reballiauthor=R.+Subramanianauthor=V.+Benadeauthor=R.+C.+Palacharlaauthor=G.+Bhyrapuneniauthor=P.+Jayarajanauthor=V.+Goyalauthor=V.+Jasti&title=Discovery+and+development+of+1-%5B%282-Bromophenyl%29sulfonyl%5D-5-methoxy-3-%5B%284-methyl-1-piperazinyl%29methyl%5D-1H-indole+dimesylate+monohydrate+%28SUVN-502%29%3A+a+novel%2C+potent%2C+selective+and+orally+active+serotonin+6+%285-HT6%29+receptor+antagonist+for+potential+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Nirogi, Ramakrishna; Shinde, Anil; Kambhampati, Rama Sastry; Mohammed, Abdul Rasheed; Saraf, Sangram Keshari; Badange, Rajesh kumar; Bandyala, Thrinath Reddy; Bhatta, Venugopalarao; Bojja, Kumar; Reballi, Veena; Subramanian, Ramkumar; Benade, Vijay; Palacharla, Raghava Choudary; Bhyrapuneni, Gopinadh; Jayarajan, Pradeep; Goyal, Vinod; Jasti, Venkat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1843-1859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a novel series of 3-(piperazinylmethyl) indole derivs. as 5-hydroxytryptamine-6 receptor (5-HT6R) antagonists resulted in identification of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (5al, SUVN-502) as a clin. candidate for potential treatment of cognitive disorders.  It has high affinity at human 5-HT6R (Ki = 2.04 nM) and selectivity over 100 target sites which include receptors, enzymes, peptides, growth factors, ion channels, steroids, immunol. factors, second messengers, and prostaglandins.  It has high selectivity over 5-HT2A receptor.  It is orally bioavailable and brain penetrant with robust preclin. efficacy.  The combination of 5al, donepezil, and memantine (triple combination) produces synergistic effects in extracellular levels of acetylcholine in the ventral hippocampus.  Preclin. efficacy in triple combination and high selectivity over 5-HT2A receptors are the differentiating features which culminated in selection of 5al for further development.  The Phase-1 evaluation of safety and pharmacokinetics has been completed, allowing for the initiation of a Phase-2 proof of concept study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_gw476vRgPbVg90H21EOLACvtfcHk0lj2HCg5Rxw78w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D&md5=26e4f0c1c34255ce2c2ef3bbf3c06a85</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01662%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DKambhampati%26aufirst%3DR.%2BS.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DSaraf%26aufirst%3DS.%2BK.%26aulast%3DBadange%26aufirst%3DR.%2BK.%26aulast%3DBandyala%26aufirst%3DT.%2BR.%26aulast%3DBhatta%26aufirst%3DV.%26aulast%3DBojja%26aufirst%3DK.%26aulast%3DReballi%26aufirst%3DV.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DJasti%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520development%2520of%25201-%255B%25282-Bromophenyl%2529sulfonyl%255D-5-methoxy-3-%255B%25284-methyl-1-piperazinyl%2529methyl%255D-1H-indole%2520dimesylate%2520monohydrate%2520%2528SUVN-502%2529%253A%2520a%2520novel%252C%2520potent%252C%2520selective%2520and%2520orally%2520active%2520serotonin%25206%2520%25285-HT6%2529%2520receptor%2520antagonist%2520for%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1843%26epage%3D1859%26doi%3D10.1021%2Facs.jmedchem.6b01662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, M. L.</span></span> <span> </span><span class="NLM_article-title">Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients</span>. <i>Clin. Interventions Aging</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1963</span>– <span class="NLM_lpage">1970</span>, <span class="refDoi"> DOI: 10.2147/CIA.S159920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.2147%2FCIA.S159920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=30349215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVyjurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1963-1970&author=N.+Zhangauthor=M.+L.+Gordon&title=Clinical+efficacy+and+safety+of+donepezil+in+the+treatment+of+Alzheimer%E2%80%99s+disease+in+Chinese+patients&doi=10.2147%2FCIA.S159920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients</span></div><div class="casAuthors">Zhang, Nan; Gordon, Marc L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1963-1970</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1178-1998</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Donepezil, an acetylcholinesterase inhibitor (AChEI), has been widely used to treat Alzheimer's disease (AD) in China.  However, there are few studies focusing on the efficacy and safety of donepezil in Chinese patients.  In this review, we discuss 1) the efficacy of donepezil and its comparison with other AChEIs or memantine, 2) the therapeutic responses to donepezil and its influencing factors, and 3) the safety and tolerability of donepezil in Chinese patients with different stages of AD and amnestic mild cognitive impairment, and further compare the similarities and differences of the results between Chinese studies and previous Western studies that predominantly enrolled Caucasian subjects.  We include Chinese clin. trials and other well-designed studies investigating donepezil or using donepezil as a pos. control, in which the efficacy and/or safety of donepezil have been analyzed.  Based on these studies, donepezil has been shown to be effective and safe in Chinese AD patients and may impact AD biomarkers, such as hippocampal atrophy, Aβ, and tau.  In addn., the therapeutic response to donepezil may be influenced by apolipoprotein E or cytochrome P 450 2D6 polymorphism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoacKXwJxhDhLVg90H21EOLACvtfcHk0liilNE1A-IsNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVyjurvL&md5=59a7b358463ffee1fae05ecba4787ad9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2147%2FCIA.S159920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCIA.S159920%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DGordon%26aufirst%3DM.%2BL.%26atitle%3DClinical%2520efficacy%2520and%2520safety%2520of%2520donepezil%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520Chinese%2520patients%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2018%26volume%3D13%26spage%3D1963%26epage%3D1970%26doi%3D10.2147%2FCIA.S159920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Drugs.com</span>. <a href="https://www.drugs.com/mtm/donepezil.html" class="extLink">https://www.drugs.com/mtm/donepezil.html</a> (accessed Oct 25, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Drugs.com.+https%3A%2F%2Fwww.drugs.com%2Fmtm%2Fdonepezil.html+%28accessed+Oct+25%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, D.</span></span> <span> </span><span class="NLM_article-title">Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional chinese medicine origin for the treatment of Alzheimers disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2231</span>– <span class="NLM_lpage">2252</span>, <span class="refDoi"> DOI: 10.2174/0929867033456747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.2174%2F0929867033456747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=14529340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=2231-2252&author=H.+Jiangauthor=X.+Luoauthor=D.+Bai&title=Progress+in+clinical%2C+pharmacological%2C+chemical+and+structural+biological+studies+of+huperzine+A%3A+a+drug+of+traditional+chinese+medicine+origin+for+the+treatment+of+Alzheimers+disease&doi=10.2174%2F0929867033456747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in clinical, pharmacological, chemical and structural biological studies of Huperzine A: A drug of traditional Chinese medicine origin for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Jiang, Hualiang; Luo, Xiaomin; Bai, Donglu</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2231-2252</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biol. half-life.  It has been approved as the drug for the treatment of AD in China, and marketed in the USA as a dietary supplement.  HupA has been the subject of investigations by an ever-increasing no. of researchers since the 1980's.  In the last 4 yr, HupA has been further studied in many aspects such as its chem. synthesis, structural modification, structure-activity relationship, various biol. effects, and mechanisms of action.  A no. of papers dealing with the computational modeling and x-ray crystallog. studies of HupA-AChE complex have also been published.  This review represents a comprehensive documentation of the progress in the studies on HupA during the period of 1999-2002.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDUGGTz1zcD7Vg90H21EOLACvtfcHk0liilNE1A-IsNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKls78%253D&md5=4843f2c8f717447186972a0ef3adfdae</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F0929867033456747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033456747%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DD.%26atitle%3DProgress%2520in%2520clinical%252C%2520pharmacological%252C%2520chemical%2520and%2520structural%2520biological%2520studies%2520of%2520huperzine%2520A%253A%2520a%2520drug%2520of%2520traditional%2520chinese%2520medicine%2520origin%2520for%2520the%2520treatment%2520of%2520Alzheimers%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D2231%26epage%3D2252%26doi%3D10.2174%2F0929867033456747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. C.</span></span> <span> </span><span class="NLM_article-title">Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2003.12.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.neulet.2003.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=15135892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVGlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2004&pages=56-59&author=Y.+Q.+Liangauthor=X.+C.+Tang&title=Comparative+effects+of+huperzine+A%2C+donepezil+and+rivastigmine+on+cortical+acetylcholine+level+and+acetylcholinesterase+activity+in+rats&doi=10.1016%2Fj.neulet.2003.12.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats</span></div><div class="casAuthors">Liang, Yan Qi; Tang, Xi Can</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">56-59</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The cholinesterase inhibitors huperzine A, donepezil and rivastigmine were compared for their effects on extracellular acetylcholine concn. and acetylcholinesterase activity in the rat cortex.  After i.p. injection, huperzine A (0.25-0.75 μmol/kg), donepezil (2-6 μmol/kg) and rivastigmine (0.75-1.5 μmol/kg) dose-dependently elevated the concn. of acetylcholine.  The duration of huperzine A was longest.  The time courses of cortical acetylcholinesterase inhibition with middle doses of these agents mirrored the increases of acetylcholine at the same doses.  However, acetylcholinesterase inhibition was disproportionately greater after middle dose of rivastigmine than doses of huperzine A and donepezil that increased acetylcholine to a similar extent.  Muscle fasciculation appeared only after donepezil with a dose-dependent incidence and intensity.  In molar terms, huperzine A was 8- and 2-fold more potent than donepezil and rivastigmine, resp., in increasing cortical acetylcholine levels, with a longer-lasting effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppQcZlJGco6LVg90H21EOLACvtfcHk0liilNE1A-IsNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVGlsbc%253D&md5=41c8d07b5ed76d944940b9942726c863</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2003.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2003.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%2BQ.%26aulast%3DTang%26aufirst%3DX.%2BC.%26atitle%3DComparative%2520effects%2520of%2520huperzine%2520A%252C%2520donepezil%2520and%2520rivastigmine%2520on%2520cortical%2520acetylcholine%2520level%2520and%2520acetylcholinesterase%2520activity%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D361%26spage%3D56%26epage%3D59%26doi%3D10.1016%2Fj.neulet.2003.12.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. C.</span></span> <span> </span><span class="NLM_article-title">Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/S0091-3057(97)00601-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2FS0091-3057%2897%2900601-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=9632220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADyaK1cXjsV2hsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1998&pages=377-386&author=D.+H.+Chengauthor=X.+C.+Tang&title=Comparative+studies+of+huperzine+A%2C+E2020%2C+and+tacrine+on+behavior+and+cholinesterase+activities&doi=10.1016%2FS0091-3057%2897%2900601-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities</span></div><div class="casAuthors">Cheng, Dong Hang; Tang, Xi Can</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">377-386</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Comparative effects of cholinesterase inhibitors (ChEI) huperzine A with E2020 and tacrine on the radial maze performance in ethylcholine mustard aziridinium ion (AF64A)-treated rat and inhibition of cholinesterase activity were studied.  The intracerebroventricular (ICV) injection of AF64A (3 nmol/side) caused significant impairment in the rat's ability to fulfill the partially baited maze paradigm.  Oral huperzine A (0.5-0.8 mg/kg), E2020 (1.0-2.0 mg/kg), and tacrine (8.0 mg/kg) effectively reversed AF64A-induced working memory deficit.  The doses that improved AF64A-induced memory deficit were correlated to about 25-30% (huperzine A) and less than 10% (E2020, tacrine) inhibition of acetylcholinesterase (AChE) activity in the cortex and hippocampus.  Huperzine A, E2020 and tacrine all produced dose-dependent inhibition of brain AChE following ICV and oral administration.  Oral huperzine A exhibited higher efficacy on the inhibition of AChE in the cortex and hippocampus than those of E2020 and tacrine.  Tacrine was more effective in inhibiting plasma butyrylcholinesterase (BuChE) than it was brain AChE.  Conversely, the BuChE activity was less affected by huperzine A and E2020.  The results showed that huperzine A had high bioavailability and more selective inhibition on AChE activity in cortex and hippocampus.  Huperzine A fits more closely with the established criteria for an ideal AChE inhibitor to be used in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMPkmHCKa9ZbVg90H21EOLACvtfcHk0ljc6UqHbd1jMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsV2hsb4%253D&md5=06e1b7d10a877d98d335688cd6c7290b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2897%2900601-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252897%252900601-1%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DD.%2BH.%26aulast%3DTang%26aufirst%3DX.%2BC.%26atitle%3DComparative%2520studies%2520of%2520huperzine%2520A%252C%2520E2020%252C%2520and%2520tacrine%2520on%2520behavior%2520and%2520cholinesterase%2520activities%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1998%26volume%3D60%26spage%3D377%26epage%3D386%26doi%3D10.1016%2FS0091-3057%2897%2900601-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. C.</span></span> <span> </span><span class="NLM_article-title">Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1111/j.1745-7254.2006.00255.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1111%2Fj.1745-7254.2006.00255.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=16364207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A280%3ADC%252BD2Mnns1CisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1-26&author=R.+Wangauthor=H.+Yanauthor=X.+C.+Tang&title=Progress+in+studies+of+huperzine+A%2C+a+natural+cholinesterase+inhibitor+from+Chinese+herbal+medicine&doi=10.1111%2Fj.1745-7254.2006.00255.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine</span></div><div class="casAuthors">Wang Rui; Yan Han; Tang Xi-can</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    </div><div class="casAbstract">Huperzine A (HupA), a novel alkaloid isolated from the Chinese herb Huperzia serrata, is a potent, highly specific and reversible inhibitor of acetylcholinesterase(AChE).  Compared with tacrine, donepezil, and rivastigmine, HupA has better penetration through the blood-brain barrier, higher oral bioavailability, and longer duration of AChE inhibitory action.  HupA has been found to improve cognitive deficits in a broad range of animal models.  HupA possesses the ability to protect cells against hydrogen peroxide, beta-amyloid protein (or peptide), glutamate, ischemia and staurosporine-induced cytotoxicity and apoptosis.  These protective effects are related to its ability to attenuate oxidative stress, regulate the expression of apoptotic proteins Bcl-2, Bax, P53, and caspase-3, protect mitochondria, upregulate nerve growth factor and its receptors, and interfere with amyloid precursor protein metabolism.  Antagonizing effects of HupA on N-methyl-D-aspartate receptors and potassium currents may also contribute to its neuroprotection as well.  Pharmacokinetic studies in rodents, canines, and healthy human volunteers indicated that HupA was absorbed rapidly, distributed widely in the body, and eliminated at a moderate rate with the property of slow and prolonged release after oral administration.  Animal and clinical safety tests showed that HupA had no unexpected toxicity, particularly the dose-limiting hepatotoxicity induced by tacrine.  The phase IV clinical trials in China have demonstrated that HupA significantly improved memory deficits in elderly people with benign senescent forgetfulness, and patients with Alzheimer disease and vascular dementia, with minimal peripheral cholinergic side effects and no unexpected toxicity.  HupA can also be used as a protective agent against organophosphate intoxication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSArR_-beAVI8RAV4D_Ins_fW6udTcc2eb1359l1yFeVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mnns1CisA%253D%253D&md5=7ec5be1704a455963a57ee996cc8b834</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7254.2006.00255.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7254.2006.00255.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DX.%2BC.%26atitle%3DProgress%2520in%2520studies%2520of%2520huperzine%2520A%252C%2520a%2520natural%2520cholinesterase%2520inhibitor%2520from%2520Chinese%2520herbal%2520medicine%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2006%26volume%3D27%26spage%3D1%26epage%3D26%26doi%3D10.1111%2Fj.1745-7254.2006.00255.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">11340</span>– <span class="NLM_lpage">11349</span>, <span class="refDoi"> DOI: 10.1021/ja029775t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja029775t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVelsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=11340-11349&author=Y.+Xuauthor=J.+Shenauthor=X.+Luoauthor=I.+Silmanauthor=J.+L.+Sussmanauthor=K.+Chenauthor=H.+Jiang&title=How+does+huperzine+A+enter+and+leave+the+binding+gorge+of+acetylcholinesterase%3F+Steered+molecular+dynamics+simulations&doi=10.1021%2Fja029775t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">How Does Huperzine A Enter and Leave the Binding Gorge of Acetylcholinesterase? Steered Molecular Dynamics Simulations</span></div><div class="casAuthors">Xu, Yechun; Shen, Jianhua; Luo, Xiaomin; Silman, Israel; Sussman, Joel L.; Chen, Kaixian; Jiang, Hualiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11340-11349</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The entering and leaving processes of Huperzine A (HupA) binding with the long active-site gorge of Torpedo californica acetylcholinesterase (TcAChE) have been investigated by using steered mol. dynamics simulations.  The anal. of the force required along the pathway shows that it is easier for HupA to bind to the active site of AChE than to disassoc. from it, which for the first time interprets at the at. level the previous exptl. that unbinding process of HupA is much slower than its binding process to AChE.  The direct hydrogen bonds, water bridges, and hydrophobic interactions were analyzed during two steered mol. dynamics (SMD) simulations.  Break of the direct hydrogen bond needs a great pulling force.  The steric hindrance of bottleneck might be the most important factor to produce the maximal rupture force for HupA to leave the binding site but it has a little effect on the binding process of HupA with AChE.  Residue Asp-72 forms a lot of water bridges with HupA leaving and entering the AChE binding gorge, acting as a clamp to take out HupA from or put HupA into the active site.  The flip of the peptide bond between Gly-117 and Gly-118 has been detected during both the conventional MD and SMD simulations.  The simulation results indicate that this flip phenomenon could be an intrinsic property of AChE and the Gly-117-Gly-118 peptide bond in both HupA bound and unbound AChE structures tends to adopt the native enzyme structure.  At last, in a vacuum the rupture force is increased up to 1500 pN while in water soln. the greatest rupture force is about 800 pN, which means water mols. in the binding gorge act as lubricant to facilitate HupA entering or leaving the binding gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdzCXUuW4K1rVg90H21EOLACvtfcHk0ljc6UqHbd1jMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVelsr4%253D&md5=57f264c29a11a1ac96e1599107b85196</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja029775t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja029775t%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DHow%2520does%2520huperzine%2520A%2520enter%2520and%2520leave%2520the%2520binding%2520gorge%2520of%2520acetylcholinesterase%253F%2520Steered%2520molecular%2520dynamics%2520simulations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D11340%26epage%3D11349%26doi%3D10.1021%2Fja029775t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onuchic, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Free energy landscape for the binding process of Huperzine A to acetylcholinesterase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">4273</span>– <span class="NLM_lpage">4278</span>, <span class="refDoi"> DOI: 10.1073/pnas.1301814110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1073%2Fpnas.1301814110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=23440190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtV2rurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=4273-4278&author=F.+Baiauthor=Y.+Xuauthor=J.+Chenauthor=Q.+Liuauthor=J.+Guauthor=X.+Wangauthor=J.+Maauthor=H.+Liauthor=J.+N.+Onuchicauthor=H.+Jiang&title=Free+energy+landscape+for+the+binding+process+of+Huperzine+A+to+acetylcholinesterase&doi=10.1073%2Fpnas.1301814110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Free energy landscape for the binding process of Huperzine A to acetylcholinesterase</span></div><div class="casAuthors">Bai, Fang; Xu, Yechun; Chen, Jing; Liu, Qiufeng; Gu, Junfeng; Wang, Xicheng; Ma, Jianpeng; Li, Honglin; Onuchic, Jose N.; Jiang, Hualiang</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4273-4278, S4273/1-S4273/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Drug-target residence time (t = 1/koff, where koff is the dissocn. rate const.) has become an important index in discovering better- or best-in-class drugs.  However, little effort has been dedicated to developing computational methods that can accurately predict this kinetic parameter or related parameters, koff and activation free energy of dissocn. (ΔG≠off).  In this paper, energy landscape theory that has been developed to understand protein folding and function is extended to develop a generally applicable computational framework that is able to construct a complete ligand-target binding free energy landscape.  This enables both the binding affinity and the binding kinetics to be accurately estd.  We applied this method to simulate the binding event of the anti-Alzheimer's disease drug (-)-Huperzine A to its target acetylcholinesterase (AChE).  The computational results are in excellent agreement with our concurrent exptl. measurements.  All of the predicted values of binding free energy and activation free energies of assocn. and dissocn. deviate from the exptl. data only by less than 1 kcal/mol.  The method also provides at. resoln. information for the (-)-Huperzine A binding pathway, which may be useful in designing more potent AChE inhibitors.  We expect this methodol. to be widely applicable to drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-lQ4SQEumbVg90H21EOLACvtfcHk0lg8csJ_h3Ja5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtV2rurY%253D&md5=c87435f191ab4c89672b5ca43cb881fc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1301814110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1301814110%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DOnuchic%26aufirst%3DJ.%2BN.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DFree%2520energy%2520landscape%2520for%2520the%2520binding%2520process%2520of%2520Huperzine%2520A%2520to%2520acetylcholinesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D4273%26epage%3D4278%26doi%3D10.1073%2Fpnas.1301814110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunwald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafferman, A.</span></span> <span> </span><span class="NLM_article-title">Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=8145739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=555-560&author=Y.+Ashaniauthor=J.+Grunwaldauthor=C.+Kronmanauthor=B.+Velanauthor=A.+Shafferman&title=Role+of+tyrosine+337+in+the+binding+of+huperzine+A+to+the+active+site+of+human+acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase</span></div><div class="casAuthors">Ashani, Yacov; Grunwald, Jacob; Kronman, Chanoch; Velan, Baruch; Shafferman, Avigdor</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">555-60</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Hyperzine A (HUP), a natural, potent, 'slow,' reversible inhibitor of antiacetylcholinesterase (AChE), has been suggested to be superior to antiacetylcholinesterase drugs now being used for management of Alzheimer's disease.  To delineate the binding site of human AChE (HuAChE) for HUP, the biochem. consts. kon, Koff, and Ki were detd. for complexes formed between HUP and single-site (YSS7F, Y337A, F295A, W296A, and E202Q) or double-site (Y337F, Y337A, F295A, W286A, and E202Q) or double-site (F295L/F297V) mutants of recombinant HuAChE (rHuAChE).  The kinetic and dissocn. consts. were compared with those obtained for wild-type rHuAChE and AChE from Torpedo californica.  Results demonstrate that the inhibition of AChE by HUP occurs through assocn. with residues located inside the active site 'gorge,' rather than at the rim of the gorge.  Tyrosine at position 337 (Y337) is essential for inhibition of rHuAChE by HUP (Ki = 26 nM).  An arom. array constituted from residues Y337, F295, and probably W86 is likely to offer a multicontact subsite that interacts with the ammonium group and with both the exo- and endocyclic double bond moieties of HUP.  Lack of the arom. side chain in the position homologous to Y337 explains the poor inhibitory potency of HUP toward human butyrylcholinesterase (Ki >20,000 nM).  Replacement of the carboxylate-contg. E202 by glutamine had only marginal effect on the stability of the complex formed between HUP and rHuAChE.  The pH-rate profiles suggest that destabilization of the complex after proton gain cannot be attributed solely to protonation of E202.  These findings are expected to establish HUP as a lead compd. for the design of new anti-AChE drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodxB5b9y9nNLVg90H21EOLACvtfcHk0lg8csJ_h3Ja5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKitrg%253D&md5=612bea38b1c55bcbd771effbab4950cf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshani%26aufirst%3DY.%26aulast%3DGrunwald%26aufirst%3DJ.%26aulast%3DKronman%26aufirst%3DC.%26aulast%3DVelan%26aufirst%3DB.%26aulast%3DShafferman%26aufirst%3DA.%26atitle%3DRole%2520of%2520tyrosine%2520337%2520in%2520the%2520binding%2520of%2520huperzine%2520A%2520to%2520the%2520active%2520site%2520of%2520human%2520acetylcholinesterase%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D555%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peggins, J. O.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doctor, B. P.</span></span> <span> </span><span class="NLM_article-title">Mechanism of inhibition of cholinesterases by huperzine A</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(92)90649-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2F0006-291X%2892%2990649-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1575745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADyaK38XktVSkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=1992&pages=719-726&author=Y.+Ashaniauthor=J.+O.+Pegginsauthor=B.+P.+Doctor&title=Mechanism+of+inhibition+of+cholinesterases+by+huperzine+A&doi=10.1016%2F0006-291X%2892%2990649-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of inhibition of cholinesterases by huperzine A</span></div><div class="casAuthors">Ashani, Yacov; Peggins, James O., III; Doctor, Bhupendra P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">719-26</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Huperzine A, an alkaloid isolated from Huperzia serrata was found to reversibly inhibit acetylcholinesterases (EC 3.1.1.7) and butyrylcholinesterases (EC 3.1.1.8) with on- and off-rates that depend on both the type and the source of enzyme.  Long-term incubation of high concns. of purified cholinesterases (1-8 μM) with huperzine A did not show any chem. modification of huperzine A.  A low dissocn. const. KI was obtained for mammalian acetylcholinesterase-huperzine (20-40 nM) compared to mammalian butyrylcholinesterase-huperzine (20-40 μM).  This indicates that the thermodn. stability of huperzine-cholinesterase complex may depend on the no. and type of arom. amino acid residues in the catalytic pocket region of the cholinesterase mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkey_zqa7K27Vg90H21EOLACvtfcHk0lg8csJ_h3Ja5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktVSkt78%253D&md5=d3f89189d5189d115139d960e487bb77</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2892%2990649-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252892%252990649-6%26sid%3Dliteratum%253Aachs%26aulast%3DAshani%26aufirst%3DY.%26aulast%3DPeggins%26aufirst%3DJ.%2BO.%26aulast%3DDoctor%26aufirst%3DB.%2BP.%26atitle%3DMechanism%2520of%2520inhibition%2520of%2520cholinesterases%2520by%2520huperzine%2520A%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D184%26spage%3D719%26epage%3D726%26doi%3D10.1016%2F0006-291X%2892%2990649-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, L.</span></span> <span> </span><span class="NLM_article-title">Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1039/C6MD00581K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1039%2FC6MD00581K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=30108770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsleitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=534-550&author=M.+Bernettiauthor=A.+Cavalliauthor=L.+Mollica&title=Protein-ligand+%28un%29binding+kinetics+as+a+new+paradigm+for+drug+discovery+at+the+crossroad+between+experiments+and+modelling&doi=10.1039%2FC6MD00581K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling</span></div><div class="casAuthors">Bernetti, M.; Cavalli, A.; Mollica, L.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">534-550</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In the last three decades, protein and nucleic acid structure detn. and comprehension of the mechanisms, leading to their physiol. and pathol. functions, have become a cornerstone of biomedical sciences.  A deep understanding of the principles governing the fates of cells and tissue at the mol. level has been gained over the years, offering a solid basis for the rational design of drugs aimed at the pharmacol. treatment of numerous diseases.  Historically, affinity indicators (i.e. Kd and IC50/EC50) have been assumed to be valid indicators of the in vivo efficacy of a drug.  However, recent studies pointed out that the kinetics of the drug-receptor binding process could be as important or even more important than affinity in detg. the drug efficacy.  This eventually led to a growing interest in the characterization and prediction of the rate consts. of protein-ligand assocn. and dissocn.  For instance, a drug with a longer residence time can kinetically select a given receptor over another, even if the affinity for both receptors is comparable, thus increasing its therapeutic index.  Therefore, understanding the mol. features underlying binding and unbinding processes is of central interest towards the rational control of drug binding kinetics.  In this review, we report the theor. framework behind protein-ligand assocn. and highlight the latest advances in the exptl. and computational approaches exploited to investigate the binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrO85mDP2s17Vg90H21EOLACvtfcHk0lg8csJ_h3Ja5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsleitbw%253D&md5=8538a9e13d7e1d2c873da236be95a811</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2FC6MD00581K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00581K%26sid%3Dliteratum%253Aachs%26aulast%3DBernetti%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DMollica%26aufirst%3DL.%26atitle%3DProtein-ligand%2520%2528un%2529binding%2520kinetics%2520as%2520a%2520new%2520paradigm%2520for%2520drug%2520discovery%2520at%2520the%2520crossroad%2520between%2520experiments%2520and%2520modelling%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D534%26epage%3D550%26doi%3D10.1039%2FC6MD00581K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borhani, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of drug-receptor binding kinetics</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">673</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.drudis.2013.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=23454741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVyrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=667-673&author=A.+C.+Panauthor=D.+W.+Borhaniauthor=R.+O.+Drorauthor=D.+E.+Shaw&title=Molecular+determinants+of+drug-receptor+binding+kinetics&doi=10.1016%2Fj.drudis.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of drug-receptor binding kinetics</span></div><div class="casAuthors">Pan, Albert C.; Borhani, David W.; Dror, Ron O.; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">667-673</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It is increasingly appreciated that the rates at which drugs assoc. with and dissoc. from receptors - the binding kinetics - directly impact drug efficacy and safety.  The mol. determinants of drug-receptor binding kinetics remain poorly understood, however, esp. when compared with the well-known factors that affect binding affinity.  The rational modulation of kinetics during lead optimization thus remains challenging.  We review some of the key factors thought to control drug-receptor binding kinetics at the mol. level - mol. size, conformational fluctuations, electrostatic interactions and hydrophobic effects - and discuss several possible approaches for the rational design of drugs with desired binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAvEt3tx06Z7Vg90H21EOLACvtfcHk0ljhwsluBnm-KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVyrtr0%253D&md5=df094bb86b1e280b9ddf5a90031b3f32</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DA.%2BC.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DMolecular%2520determinants%2520of%2520drug-receptor%2520binding%2520kinetics%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D667%26epage%3D673%26doi%3D10.1016%2Fj.drudis.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, P. J.</span></span> <span> </span><span class="NLM_article-title">Drug-target residence time: critical information for lead optimization</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2010.06.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.cbpa.2010.06.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=20663707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=467-474&author=H.+Luauthor=P.+J.+Tonge&title=Drug-target+residence+time%3A+critical+information+for+lead+optimization&doi=10.1016%2Fj.cbpa.2010.06.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time: Critical information for lead optimization</span></div><div class="casAuthors">Lu, Hao; Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-474</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Failure due to poor in vivo efficacy is a primary contributor to attrition during the development of new chemotherapeutics.  Lead optimization programs that in their quest for efficacy focus solely on improving the affinity of drug-target binding are flawed, since this approach ignores the fluctuations in drug concn. that occur in vivo.  Instead the lifetime of the drug-target complex must also be considered, since drugs only act when they are bound to their targets.  Consequently, to improve the correlation between the in vitro and in vivo activity of drugs, measurements of drug-target residence time must be incorporated into the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodk2kN_txuMLVg90H21EOLACvtfcHk0ljhwsluBnm-KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr4%253D&md5=3189f56032106db858cfb4269d3fc11f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.06.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.06.176%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DDrug-target%2520residence%2520time%253A%2520critical%2520information%2520for%2520lead%2520optimization%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D467%26epage%3D474%26doi%3D10.1016%2Fj.cbpa.2010.06.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompliano, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1038/nrd2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization&doi=10.1038%2Fnrd2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0ljhwsluBnm-KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739%26doi%3D10.1038%2Fnrd2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. C.</span></span> <span> </span><span class="NLM_article-title">Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2003.12.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.neulet.2003.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=15135892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVGlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2004&pages=56-59&author=Y.+Q.+Liangauthor=X.+C.+Tang&title=Comparative+effects+of+huperzine+A%2C+donepezil+and+rivastigmine+on+cortical+acetylcholine+level+and+acetylcholinesterase+activity+in+rats&doi=10.1016%2Fj.neulet.2003.12.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats</span></div><div class="casAuthors">Liang, Yan Qi; Tang, Xi Can</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">56-59</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The cholinesterase inhibitors huperzine A, donepezil and rivastigmine were compared for their effects on extracellular acetylcholine concn. and acetylcholinesterase activity in the rat cortex.  After i.p. injection, huperzine A (0.25-0.75 μmol/kg), donepezil (2-6 μmol/kg) and rivastigmine (0.75-1.5 μmol/kg) dose-dependently elevated the concn. of acetylcholine.  The duration of huperzine A was longest.  The time courses of cortical acetylcholinesterase inhibition with middle doses of these agents mirrored the increases of acetylcholine at the same doses.  However, acetylcholinesterase inhibition was disproportionately greater after middle dose of rivastigmine than doses of huperzine A and donepezil that increased acetylcholine to a similar extent.  Muscle fasciculation appeared only after donepezil with a dose-dependent incidence and intensity.  In molar terms, huperzine A was 8- and 2-fold more potent than donepezil and rivastigmine, resp., in increasing cortical acetylcholine levels, with a longer-lasting effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppQcZlJGco6LVg90H21EOLACvtfcHk0lhAVm11Ky130A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVGlsbc%253D&md5=41c8d07b5ed76d944940b9942726c863</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2003.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2003.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%2BQ.%26aulast%3DTang%26aufirst%3DX.%2BC.%26atitle%3DComparative%2520effects%2520of%2520huperzine%2520A%252C%2520donepezil%2520and%2520rivastigmine%2520on%2520cortical%2520acetylcholine%2520level%2520and%2520acetylcholinesterase%2520activity%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D361%26spage%3D56%26epage%3D59%26doi%3D10.1016%2Fj.neulet.2003.12.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi-Can, T.</span></span> <span> </span><span class="NLM_article-title">Anticholinesterase effects of huperzine A, E2020, and tacrine in rats</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=27-30&author=W.+Hongauthor=T.+Xi-Can&title=Anticholinesterase+effects+of+huperzine+A%2C+E2020%2C+and+tacrine+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DW.%26aulast%3DXi-Can%26aufirst%3DT.%26atitle%3DAnticholinesterase%2520effects%2520of%2520huperzine%2520A%252C%2520E2020%252C%2520and%2520tacrine%2520in%2520rats%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2016%26volume%3D19%26spage%3D27%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acena, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloshonok, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II-III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00392</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=422-518&author=Y.+Zhouauthor=J.+Wangauthor=Z.+Guauthor=S.+Wangauthor=W.+Zhuauthor=J.+L.+Acenaauthor=V.+A.+Soloshonokauthor=K.+Izawaauthor=H.+Liu&title=Next+generation+of+fluorine-containing+pharmaceuticals%2C+compounds+currently+in+phase+II-III+clinical+trials+of+major+pharmaceutical+companies%3A+new+structural+trends+and+therapeutic+areas&doi=10.1021%2Facs.chemrev.5b00392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas</span></div><div class="casAuthors">Zhou, Yu; Wang, Jiang; Gu, Zhanni; Wang, Shuni; Zhu, Wei; Acena, Jose Luis; Soloshonok, Vadim A.; Izawa, Kunisuke; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-518</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  We focus herein on a new collection of 51 fluorine-contg. mols. that either were approved after 2011 by the corresponding agencies or still are on clin. development.  These compds. cover a large no. of therapeutic areas and, on this occasion, we decided to classify them according to the no. of fluorine atoms or fluorinated moieties.  In each case, the structures and modes of action of these new drugs are revised, with a particular focus on the role of fluorine in the biol. and pharmaceutical properties, when appropriate.  Finally, representative synthetic routes are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh-rq_ZyY_jrVg90H21EOLACvtfcHk0lhAVm11Ky130A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGms7o%253D&md5=e3d07d070fcf5b69a54f70bdba99acd4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DAcena%26aufirst%3DJ.%2BL.%26aulast%3DSoloshonok%26aufirst%3DV.%2BA.%26aulast%3DIzawa%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DNext%2520generation%2520of%2520fluorine-containing%2520pharmaceuticals%252C%2520compounds%2520currently%2520in%2520phase%2520II-III%2520clinical%2520trials%2520of%2520major%2520pharmaceutical%2520companies%253A%2520new%2520structural%2520trends%2520and%2520therapeutic%2520areas%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D422%26epage%3D518%26doi%3D10.1021%2Facs.chemrev.5b00392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span> <span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry: recent therapeutic applications of fluorinated small molecules</span>. <i>J. Fluorine Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1016/j.jfluchem.2006.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.jfluchem.2006.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVSrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=1013-1029&author=K.+L.+Kirk&title=Fluorine+in+medicinal+chemistry%3A+recent+therapeutic+applications+of+fluorinated+small+molecules&doi=10.1016%2Fj.jfluchem.2006.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules</span></div><div class="casAuthors">Kirk, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1013-1029</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Advances in the development of newly developed fluorinated drugs, approved or in clin. trials, as organized by biol. targets/disease states, are reviewed.  In a few cases, compds. in early stages of development will be discussed, particularly where new promising targets are involved.  Important topics such as anticancer and antiviral drugs were covered in the two previous reviews in this series.  Included herein will be fluorinated drugs for treatment of diseases of the central nervous system, various cardiovascular diseases and obesity, antibacterial agents, and antifungal therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd1vhHrZgNN7Vg90H21EOLACvtfcHk0lhAVm11Ky130A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVSrtb8%253D&md5=890de242b8c5804fec1a9a7d35471ac1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2006.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2006.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DK.%2BL.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%253A%2520recent%2520therapeutic%2520applications%2520of%2520fluorinated%2520small%2520molecules%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2006%26volume%3D127%26spage%3D1013%26epage%3D1029%26doi%3D10.1016%2Fj.jfluchem.2006.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohm, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obst-Sander, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1002/cbic.200301023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1002%2Fcbic.200301023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=15122635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=637-643&author=H.+J.+Bohmauthor=D.+Bannerauthor=S.+Bendelsauthor=M.+Kansyauthor=B.+Kuhnauthor=K.+Mullerauthor=U.+Obst-Sanderauthor=M.+Stahl&title=Fluorine+in+medicinal+chemistry&doi=10.1002%2Fcbic.200301023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Bohm Hans-Joachim; Banner David; Bendels Stefanie; Kansy Manfred; Kuhn Bernd; Muller Klaus; Obst-Sander Ulrike; Stahl Martin</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-43</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">Fluorinated compounds are synthesized in pharmaceutical research on a routine basis and many marketed compounds contain fluorine.  The present review summarizes some of the most frequently employed strategies for using fluorine substituents in medicinal chemistry.  Quite often, fluorine is introduced to improve the metabolic stability by blocking metabolically labile sites.  However, fluorine can also be used to modulate the physicochemical properties, such as lipophilicity or basicity.  It may exert a substantial effect on the conformation of a molecule.  Increasingly, fluorine is used to enhance the binding affinity to the target protein.  Recent 3D-structure determinations of protein complexes with bound fluorinated ligands have led to an improved understanding of the nonbonding protein-ligand interactions that involve fluorine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4zDG_wo1YGtts4TFFB11gfW6udTcc2eYg64udf3Ehi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D&md5=fa5ca2cfc278b83c80d5c96b18dfe312</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200301023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200301023%26sid%3Dliteratum%253Aachs%26aulast%3DBohm%26aufirst%3DH.%2BJ.%26aulast%3DBanner%26aufirst%3DD.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D637%26epage%3D643%26doi%3D10.1002%2Fcbic.200301023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagmann, W. K.</span></span> <span> </span><span class="NLM_article-title">The many roles for fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4359</span>– <span class="NLM_lpage">4369</span>, <span class="refDoi"> DOI: 10.1021/jm800219f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800219f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4359-4369&author=W.+K.+Hagmann&title=The+many+roles+for+fluorine+in+medicinal+chemistry&doi=10.1021%2Fjm800219f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Roles for Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Hagmann, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4359-4369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkZV7sio8RhbVg90H21EOLACvtfcHk0ljqik4kvADq4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D&md5=821f8076bb0f632f687b1c90b05dd382</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm800219f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800219f%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DThe%2520many%2520roles%2520for%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4359%26epage%3D4369%26doi%3D10.1021%2Fjm800219f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Purser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouverneur, V.</span></span> <span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1039/B610213C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1039%2FB610213C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=18197348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=320-330&author=S.+Purserauthor=P.+R.+Mooreauthor=S.+Swallowauthor=V.+Gouverneur&title=Fluorine+in+medicinal+chemistry&doi=10.1039%2FB610213C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Purser, Sophie; Moore, Peter R.; Swallow, Steve; Gouverneur, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-330</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  It has become evident that fluorinated compds. have a remarkable record in medicinal chem. and will play a continuing role in providing lead compds. for therapeutic applications.  This tutorial review provides a sampling of renowned fluorinated drugs and their mode of action with a discussion clarifying the role and impact of fluorine substitution on drug potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKAqJ3UbgGbVg90H21EOLACvtfcHk0ljqik4kvADq4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsw%253D%253D&md5=e6c9e3084e454c44a4ba245b98f7f1d7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FB610213C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB610213C%26sid%3Dliteratum%253Aachs%26aulast%3DPurser%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DP.%2BR.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGouverneur%26aufirst%3DV.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2008%26volume%3D37%26spage%3D320%26epage%3D330%26doi%3D10.1039%2FB610213C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Roselló, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aceña, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Pozo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorochinsky, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fustero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloshonok, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011)</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">2432</span>– <span class="NLM_lpage">2506</span>, <span class="refDoi"> DOI: 10.1021/cr4002879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4002879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2432-2506&author=J.+Wangauthor=M.+S%C3%A1nchez-Rosell%C3%B3author=J.+L.+Ace%C3%B1aauthor=C.+del+Pozoauthor=A.+E.+Sorochinskyauthor=S.+Fusteroauthor=V.+A.+Soloshonokauthor=H.+Liu&title=Fluorine+in+pharmaceutical+industry%3A+fluorine-containing+drugs+introduced+to+the+market+in+the+last+decade+%282001%E2%80%932011%29&doi=10.1021%2Fcr4002879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001-2011)</span></div><div class="casAuthors">Wang, Jiang; Sanchez-Rosello, Maria; Acena, Jose Luis; del Pozo, Carlos; Sorochinsky, Alexander E.; Fustero, Santos; Soloshonok, Vadim A.; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2432-2506</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A historic review.  As expected from the fluorine position on the periodic table of elements, it possesses some extreme properties, in particular, ultimate electronegativity and oxidn. potential.  Therefore,elemental fluorine can not be prepd. by chem. reaction, and its isolation in 1886 by Henri Moissan required scientific ingenuity and great personal courage.  His historic effort earned him a Noble Prize (1906), and the developed electrolysis method is still in use for industrial prodn. of fluorine gas.  However, further development of fluorine chem. was extremely sluggish, pursued by a handful of experts capable of handling the violent gas using specially designed lab. equipment.  Industrial-scale prodn. of fluorochems. dates back to late 1930s.  Currently, there are about 200 pharmaceuticals containingfluorine, including the 40 new compds. discussed in this review.  One may agree that the contribution of the past decade indicates a significant 20% increase in the no. of fluorinated drugs on the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQTzcNC3MEA7Vg90H21EOLACvtfcHk0lhuxM_Sq-twRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsb7I&md5=07faac419cd090503e82c6f00d05c338</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr4002879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4002879%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DS%25C3%25A1nchez-Rosell%25C3%25B3%26aufirst%3DM.%26aulast%3DAce%25C3%25B1a%26aufirst%3DJ.%2BL.%26aulast%3Ddel%2BPozo%26aufirst%3DC.%26aulast%3DSorochinsky%26aufirst%3DA.%2BE.%26aulast%3DFustero%26aufirst%3DS.%26aulast%3DSoloshonok%26aufirst%3DV.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DFluorine%2520in%2520pharmaceutical%2520industry%253A%2520fluorine-containing%2520drugs%2520introduced%2520to%2520the%2520market%2520in%2520the%2520last%2520decade%2520%25282001%25E2%2580%25932011%2529%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2432%26epage%3D2506%26doi%3D10.1021%2Fcr4002879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burshteyn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Height, J. J.</span></span> <span> </span><span class="NLM_article-title">Structures of human acetylcholinesterase in complex with pharmacologically important ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10282</span>– <span class="NLM_lpage">10286</span>, <span class="refDoi"> DOI: 10.1021/jm300871x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300871x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10282-10286&author=J.+Cheungauthor=M.+J.+Rudolphauthor=F.+Burshteynauthor=M.+S.+Cassidyauthor=E.+N.+Garyauthor=J.+Loveauthor=M.+C.+Franklinauthor=J.+J.+Height&title=Structures+of+human+acetylcholinesterase+in+complex+with+pharmacologically+important+ligands&doi=10.1021%2Fjm300871x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span></div><div class="casAuthors">Cheung, Jonah; Rudolph, Michael J.; Burshteyn, Fiana; Cassidy, Michael S.; Gary, Ebony N.; Love, James; Franklin, Matthew C.; Height, Jude J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10282-10286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.  Here we present high resoln. crystal structures of human AChE, alone and in complexes with drug ligands; donepezil, an Alzheimer's disease drug, binds differently to human AChE than it does to Torpedo AChE.  These crystals of human AChE provide a more accurate platform for further drug development than previously available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdjhYPmZBMf7Vg90H21EOLACvtfcHk0lhuxM_Sq-twRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN&md5=c27461e0288f42ac96af354cbefd387e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm300871x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300871x%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DM.%2BJ.%26aulast%3DBurshteyn%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DM.%2BS.%26aulast%3DGary%26aufirst%3DE.%2BN.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DHeight%26aufirst%3DJ.%2BJ.%26atitle%3DStructures%2520of%2520human%2520acetylcholinesterase%2520in%2520complex%2520with%2520pharmacologically%2520important%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10282%26epage%3D10286%26doi%3D10.1021%2Fjm300871x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dvir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase: from 3D structure to function</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2010.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.cbi.2010.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=20138030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=10-22&author=H.+Dvirauthor=I.+Silmanauthor=M.+Harelauthor=T.+L.+Rosenberryauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+from+3D+structure+to+function&doi=10.1016%2Fj.cbi.2010.01.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase: From 3D structure to function</span></div><div class="casAuthors">Dvir, Hay; Silman, Israel; Harel, Michal; Rosenberry, Terrone L.; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">10-22</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  By rapid hydrolysis of the neurotransmitter, acetylcholine, acetylcholinesterase (AChE) terminates neurotransmission at cholinergic synapses.  AChE is a very fast enzyme, functioning at a rate approaching that of a diffusion-controlled reaction.  The powerful toxicity of organophosphate poisons is attributed primarily to their potent inhibition of AChE.  AChE inhibitors are utilized in the treatment of various neurol. disorders, and are the principal drugs approved thus far by the FDA for management of Alzheimer's disease.  Many organophosphates and carbamates serve as potent insecticides, by selectively inhibiting insect AChE.  The detn. of the crystal structure of Torpedo californica AChE permitted visualization, for the 1st time, at at. resoln., of a binding pocket for acetylcholine.  It also allowed identification of the active site of AChE, which, unexpectedly, is located at the bottom of a deep gorge lined largely by arom. residues.  The crystal structure of recombinant human AChE in its apo-state is similar in its overall features to that of the Torpedo enzyme; however, the unique crystal packing reveals a novel peptide sequence which blocks access to the active site gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnLqJTiC2TYrVg90H21EOLACvtfcHk0lhuxM_Sq-twRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D&md5=9a6121388b34b77af442d1f039ba9a9c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520from%25203D%2520structure%2520to%2520function%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2010%26volume%3D187%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.cbi.2010.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nambu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran-Dube, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalaie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grodsky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1 -yl)ethanol (PF-04217903) for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8091</span>– <span class="NLM_lpage">8109</span>, <span class="refDoi"> DOI: 10.1021/jm300967g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300967g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8091-8109&author=J.+J.+Cuiauthor=M.+McTigueauthor=M.+Nambuauthor=M.+Tran-Dubeauthor=M.+Pairishauthor=H.+Shenauthor=L.+Jiaauthor=H.+Chengauthor=J.+Hoffmanauthor=P.+Leauthor=M.+Jalaieauthor=G.+H.+Goetzauthor=K.+Ryanauthor=N.+Grodskyauthor=Y.+L.+Dengauthor=M.+Parkerauthor=S.+Timofeevskiauthor=B.+W.+Murrayauthor=S.+Yamazakiauthor=S.+Aguirreauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensen&title=Discovery+of+a+novel+class+of+exquisitely+selective+mesenchymal-epithelial+transition+factor+%28c-MET%29+protein+kinase+inhibitors+and+identification+of+the+clinical+candidate+2-%284-%281-%28quinolin-6-ylmethyl%29-1H-%5B1%2C2%2C3%5Dtriazolo%5B4%2C5-b%5Dpyrazin-6-yl%29-1H-pyrazol-1+-yl%29ethanol+%28PF-04217903%29+for+the+treatment+of+cancer&doi=10.1021%2Fjm300967g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer</span></div><div class="casAuthors">Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dube, Michelle; Pairish, Mason; Shen, Hong; Jia, Lei; Cheng, Hengmiao; Hoffman, Jacqui; Le, Phuong; Jalaie, Mehran; Goetz, Gilles H.; Koenig, Marcel; Vojkovsky, Tomas; Zhang, Fang-Jie; Do, Steven; Botrous, Iriny; Ryan, Kevin; Grodsky, Neil; Deng, Ya-li; Parker, Max; Timofeevski, Sergei; Murray, Brion W.; Yamazaki, Shinji; Aguirre, Shirley; Li, Qiuhua; Zou, Helen; Christensen, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8091-8109</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The c-MET receptor tyrosine kinase is an attractive oncol. target because of its crit. role in human oncogenesis and tumor progression.  An oxindole hydrazide hit 6 (VI) was identified during a c-MET HTS campaign and subsequently demonstrated to have an unusual degree of selectivity against a broad array of other kinases.  The cocrystal structure of the related oxindole hydrazide c-MET inhibitor 10 (X) with a nonphosphorylated c-MET kinase domain revealed a unique binding mode assocd. with the exquisite selectivity profile.  The chem. labile oxindole hydrazide scaffold was replaced with a chem. and metabolically stable triazolopyrazine scaffold using structure based drug design.  Medicinal chem. lead optimization produced 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (2, II, PF-04217903), an extremely potent and exquisitely selective c-MET inhibitor.  2 Demonstrated effective tumor growth inhibition in c-MET dependent tumor models with good oral PK properties and an acceptable safety profile in preclin. studies.  2 Progressed to clin. evaluation in a Phase I oncol. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9sgnBFaSHLbVg90H21EOLACvtfcHk0lghmijTzlJ3Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrrL&md5=3c3ecda1c9698f2f16f9ff7c95596105</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300967g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300967g%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DParker%26aufirst%3DM.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAguirre%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520exquisitely%2520selective%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520protein%2520kinase%2520inhibitors%2520and%2520identification%2520of%2520the%2520clinical%2520candidate%25202-%25284-%25281-%2528quinolin-6-ylmethyl%2529-1H-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-b%255Dpyrazin-6-yl%2529-1H-pyrazol-1%2520-yl%2529ethanol%2520%2528PF-04217903%2529%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8091%26epage%3D8109%26doi%3D10.1021%2Fjm300967g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridine derivatives as potent c-met inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1021/ml5004876</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5004876" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFCnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=507-512&author=C.+Liauthor=J.+Aiauthor=D.+Zhangauthor=X.+Pengauthor=X.+Chenauthor=Z.+Gaoauthor=Y.+Suauthor=W.+Zhuauthor=Y.+Jiauthor=X.+Chenauthor=M.+Gengauthor=H.+Liu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+imidazo%5B1%2C2-a%5Dpyridine+derivatives+as+potent+c-met+inhibitors&doi=10.1021%2Fml5004876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors</span></div><div class="casAuthors">Li, Chunpu; Ai, Jing; Zhang, Dengyou; Peng, Xia; Chen, Xi; Gao, Zhiwei; Su, Yi; Zhu, Wei; Ji, Yinchun; Chen, Xiaoyan; Geng, Meiyu; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-512</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of imidazo[1,2-a]pyridine derivs. against c-Met was designed by means of bioisosteric replacement.  In this study, a selective, potent c-Met inhibitor, I was identified, with IC50 values of 3.9 nM against c-Met kinase and 45.0 nM against c-Met-addicted EBC-1 cell proliferation, resp.  Compd. I inhibited c-Met phosphorylation and downstream signaling across different oncogenic forms in c-Met overactivated cancer cells and model cells.  Compd. I significantly inhibited tumor growth (TGI = 75%) with good oral bioavailability (F = 29%) and no significant hERG inhibition.  On the basis of systematic metabolic study, the pathway of all possible metabolites of I in liver microsomes of different species has been proposed, and a major NADPH-dependent metabolite was generated by liver microsomes.  To block the metabolic site, II was designed and synthesized for further evaluation.  Taken together, the imidazo[1,2-a]pyridine scaffold showed promising pharmacol. inhibition of c-Met and warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHf-imCi4cG7Vg90H21EOLACvtfcHk0lghmijTzlJ3Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFCnsbc%253D&md5=61cc6abd8598ed8c9c16763fcc0967d4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml5004876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5004876%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520imidazo%255B1%252C2-a%255Dpyridine%2520derivatives%2520as%2520potent%2520c-met%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D507%26epage%3D512%26doi%3D10.1021%2Fml5004876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borkin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purohit, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyguda-Kazimierowicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cierpicki, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of orthogonal multipolar interactions with fluorine in protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7465</span>– <span class="NLM_lpage">7474</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00975</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00975" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOju73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7465-7474&author=J.+Pollockauthor=D.+Borkinauthor=G.+Lundauthor=T.+Purohitauthor=E.+Dyguda-Kazimierowiczauthor=J.+Grembeckaauthor=T.+Cierpicki&title=Rational+design+of+orthogonal+multipolar+interactions+with+fluorine+in+protein-ligand+complexes&doi=10.1021%2Facs.jmedchem.5b00975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes</span></div><div class="casAuthors">Pollock, Jonathan; Borkin, Dmitry; Lund, George; Purohit, Trupta; Dyguda-Kazimierowicz, Edyta; Grembecka, Jolanta; Cierpicki, Tomasz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7465-7474</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multipolar interactions involving fluorine and the protein backbone have been frequently obsd. in protein-ligand complexes.  Such fluorine-backbone interactions may substantially contribute to the high affinity of small mol. inhibitors.  Here we found that introduction of trifluoromethyl groups into two different sites in the thienopyrimidine class of menin-MLL inhibitors considerably improved their inhibitory activity.  In both cases, trifluoromethyl groups are engaged in short interactions with the backbone of menin.  In order to understand the effect of fluorine, we synthesized a series of analogs by systematically changing the no. of fluorine atoms, and we detd. high-resoln. crystal structures of the complexes with menin.  We found that introduction of fluorine at favorable geometry for interactions with backbone carbonyls may improve the activity of menin-MLL inhibitors as much as 5- to 10-fold.  In order to facilitate the design of multipolar fluorine-backbone interactions in protein-ligand complexes, we developed a computational algorithm named FMAP, which calcs. fluorophilic sites in proximity to the protein backbone.  We demonstrated that FMAP could be used to rationalize improvement in the activity of known protein inhibitors upon introduction of fluorine.  Furthermore, FMAP may also represent a valuable tool for designing new fluorine substitutions and support ligand optimization in drug discovery projects.  Anal. of the menin-MLL inhibitor complexes revealed that the backbone in secondary structures is particularly accessible to the interactions with fluorine.  Considering that secondary structure elements are frequently exposed at protein interfaces, we postulate that multipolar fluorine-backbone interactions may represent a particularly attractive approach to improve inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe6g5dcLEWQLVg90H21EOLACvtfcHk0linqpZ_zOmPWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOju73F&md5=56d54cdfbf8af7d68666572a57335c51</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00975%26sid%3Dliteratum%253Aachs%26aulast%3DPollock%26aufirst%3DJ.%26aulast%3DBorkin%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DPurohit%26aufirst%3DT.%26aulast%3DDyguda-Kazimierowicz%26aufirst%3DE.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DCierpicki%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520orthogonal%2520multipolar%2520interactions%2520with%2520fluorine%2520in%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7465%26epage%3D7474%26doi%3D10.1021%2Facs.jmedchem.5b00975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Dual GSK-3beta/AChE inhibitors as a new strategy for multitargeting anti-Alzheimer’s disease drug discovery</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2gtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=171-176&author=X.+Y.+Jiangauthor=T.+K.+Chenauthor=J.+T.+Zhouauthor=S.+Y.+Heauthor=H.+Y.+Yangauthor=Y.+Chenauthor=W.+Quauthor=F.+Fengauthor=H.+P.+Sun&title=Dual+GSK-3beta%2FAChE+inhibitors+as+a+new+strategy+for+multitargeting+anti-Alzheimer%E2%80%99s+disease+drug+discovery&doi=10.1021%2Facsmedchemlett.7b00463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer's Disease Drug Discovery</span></div><div class="casAuthors">Jiang, Xue-Yang; Chen, Ting-Kai; Zhou, Jun-Ting; He, Si-Yu; Yang, Hong-Yu; Chen, Yao; Qu, Wei; Feng, Feng; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-176</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designing multitarget-directed ligands (MTDLs) is considered to be a promising approach to address complex and multifactorial maladies such as Alzheimer's disease (AD).  The concurrent inhibition of the two crucial AD targets, glycogen synthase kinase-3β (GSK-3β) and human acetylcholinesterase (hAChE), might represent a breakthrough in the quest for clin. efficacy.  Thus, a novel family of GSK-3β/AChE dual-target inhibitors was designed and synthesized.  Among these hybrids, I showed the most promising profile as a nanomolar inhibitor on both hAChE (IC50 = 6.5 nM) and hGSK-3β kinase activity (IC50 = 66 nM).  It also showed good inhibitory effect on β-amyloid self-aggregation (inhibitory rate = 46%) at 20 μM.  Western blot anal. revealed that compd. I inhibited hyperphosphorylation of tau protein in mouse neuroblastoma N2a-Tau cells.  In vivo studies confirmed that I significantly ameliorated the cognitive disorders in scopolamine-treated ICR mice and less hepatotoxicity than tacrine.  This study provides new leads for assessment of GSK-3β and AChE pathway dual inhibition as a promising strategy for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq103h9q_6uaLVg90H21EOLACvtfcHk0linqpZ_zOmPWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2gtrY%253D&md5=8858bb4cbc503c79896ccbc00fb23153</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00463%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%2BY.%26aulast%3DChen%26aufirst%3DT.%2BK.%26aulast%3DZhou%26aufirst%3DJ.%2BT.%26aulast%3DHe%26aufirst%3DS.%2BY.%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDual%2520GSK-3beta%252FAChE%2520inhibitors%2520as%2520a%2520new%2520strategy%2520for%2520multitargeting%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D171%26epage%3D176%26doi%3D10.1021%2Facsmedchemlett.7b00463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and biological evaluation of orally available first-generation dual-target selective inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=328-345&author=F.+Maoauthor=H.+Wangauthor=W.+Niauthor=X.+Zhengauthor=M.+Wangauthor=K.+Baoauthor=D.+Lingauthor=X.+Liauthor=Y.+Xuauthor=H.+Zhangauthor=J.+Li&title=Design%2C+Synthesis%2C+and+biological+evaluation+of+orally+available+first-generation+dual-target+selective+inhibitors+of+acetylcholinesterase+%28AChE%29+and+phosphodiesterase+5+%28PDE5%29+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.7b00345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Mao, Fei; Wang, Huan; Ni, Wei; Zheng, Xinyu; Wang, Manjiong; Bao, Keting; Ling, Dazheng; Li, Xiaokang; Xu, Yixiang; Zhang, Haiyan; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-345</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through drug discovery strategies of repurposing and redeveloping existing drugs, a series of novel tadalafil derivs. were rationally designed, synthesized, and evaluated to seek dual-target AChE/PDE5 inhibitors as good candidate drugs for Alzheimer's disease (AD).  Among these derivs., (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1p, I) and (6R,12aS)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1w, II) exhibited excellent selective dual-target AChE/PDE5 inhibitory activities and improved blood-brain barrier (BBB) penetrability.  Importantly, II·Cit (citrate of II) could reverse the cognitive dysfunction of scopolamine-induced AD mice and exhibited an excellent effect on enhancing cAMP response element-binding protein (CREB) phosphorylation in vivo, a crucial factor in memory formation and synaptic plasticity.  Moreover, the mol. docking simulations of II with hAChE and hPDE5A confirmed that the design strategy was rational.  In summary, the research provides a potential selective dual-target AChE/PDE5 inhibitor as a good candidate drug for the treatment of AD, and it could also be regarded as a small mol. probe to validate the novel AD therapeutic approach in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThEyISqB-vrVg90H21EOLACvtfcHk0linqpZ_zOmPWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF&md5=f681ad7b8ce0bf011d30d36a869eedd0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00345%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520orally%2520available%2520first-generation%2520dual-target%2520selective%2520inhibitors%2520of%2520acetylcholinesterase%2520%2528AChE%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D328%26epage%3D345%26doi%3D10.1021%2Facschemneuro.7b00345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinreb, O.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.neuropharm.2016.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=27984078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVWmtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=445-456&author=W.+Liuauthor=A.+Rabinovichauthor=Y.+Nashauthor=D.+Frenkelauthor=Y.+Wangauthor=M.+B.+H.+Youdimauthor=O.+Weinreb&title=Anti-inflammatory+and+protective+effects+of+MT-031%2C+a+novel+multitarget+MAO-A+and+AChE%2FBuChE+inhibitor+in+scopolamine+mouse+model+and+inflammatory+cells&doi=10.1016%2Fj.neuropharm.2016.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells</span></div><div class="casAuthors">Liu, Wei; Rabinovich, Alon; Nash, Yuval; Frenkel, Dan; Wang, Yuqiang; Youdim, Moussa B. H.; Weinreb, Orly</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">Part_A</span>),
    <span class="NLM_cas:pages">445-456</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous study demonstrated that the novel multitarget compd., MT-031 preserved in one mol. entity the beneficial properties of its parent drugs, rasagiline and rivastigmine, and exerted high dual potencies of monoamine oxidase-A (MAO-A) and cholinesterase (ChE) inhibition in acute-treated mice and neuroprotective effects against H2O2-induced neurotoxicity in human neuroblastoma SH-SY5Y cells.  The present study aimed to further investigate the anti-inflammatory and protective effects of MT-031 in scopolamine mouse model and inflammatory cell cultures.  Our findings demonstrated that once daily chronic administration of MT-031 (5-10 mg/kg) to mice antagonized scopolamine-induced memory and cognitive impairments, displayed brain selective MAO-A and AChE/BuChE inhibition, increased the levels of striatal dopamine (DA), serotonin (5-HT) and norepinephrine and prevented the metab. of DA and 5-HT.  In addn., MT-031 upregulated mRNA expression levels of Bcl-2, the neurotrophic factors, (e.g., brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF) and nerve growth factor (NGF)), the antioxidant enzyme catalase and the anti-inflammatory cytokine, neurotrophic tyrosine kinase receptor (Ntrk), and down-regulated the mRNA expression levels of the pro-inflammatory interleukin (IL)-6 in scopolamine-induced mice.  In accordance, MT-031 was shown to reduce reactive oxygen species accumulation, increase the levels of anti-inflammatory cytokines, IL-10 and decrease the levels of the pro-inflammatory cytokines, IL-1β, IL-6, IL-17 and interferon-gamma (IFN-γ) in activated mouse splenocytes and microglial cells.  Taken together, these pharmacol. properties of MT-031 can be of clin. importance for developing this novel multitarget compd. as a novel drug candidate for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfU79aZiwv7Vg90H21EOLACvtfcHk0lhK6dmwq9vo0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVWmtLnE&md5=71d3d22ba60c25b1a0fbfa55053b20a2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DRabinovich%26aufirst%3DA.%26aulast%3DNash%26aufirst%3DY.%26aulast%3DFrenkel%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinreb%26aufirst%3DO.%26atitle%3DAnti-inflammatory%2520and%2520protective%2520effects%2520of%2520MT-031%252C%2520a%2520novel%2520multitarget%2520MAO-A%2520and%2520AChE%252FBuChE%2520inhibitor%2520in%2520scopolamine%2520mouse%2520model%2520and%2520inflammatory%2520cells%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D113%26spage%3D445%26epage%3D456%26doi%3D10.1016%2Fj.neuropharm.2016.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenov, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zueva, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhamedyarov, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lushchekina, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharlamova, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petukhova, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikhailov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podyachev, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saifina, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minnekhanova, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobov, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolsky, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reznik, V. S.</span></span> <span> </span><span class="NLM_article-title">6-Methyluracil derivatives as bifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1863</span>– <span class="NLM_lpage">1874</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1002%2Fcmdc.201500334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=26412714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKns7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1863-1874&author=V.+E.+Semenovauthor=I.+V.+Zuevaauthor=M.+A.+Mukhamedyarovauthor=S.+V.+Lushchekinaauthor=A.+D.+Kharlamovaauthor=E.+O.+Petukhovaauthor=A.+S.+Mikhailovauthor=S.+N.+Podyachevauthor=L.+F.+Saifinaauthor=K.+A.+Petrovauthor=O.+A.+Minnekhanovaauthor=V.+V.+Zobovauthor=E.+E.+Nikolskyauthor=P.+Massonauthor=V.+S.+Reznik&title=6-Methyluracil+derivatives+as+bifunctional+acetylcholinesterase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fcmdc.201500334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Semenov, Vyacheslav E.; Zueva, Irina V.; Mukhamedyarov, Marat A.; Lushchekina, Sofya V.; Kharlamova, Alexandra D.; Petukhova, Elena O.; Mikhailov, Anatoly S.; Podyachev, Sergey N.; Saifina, Lilya F.; Petrov, Konstantin A.; Minnekhanova, Oksana A.; Zobov, Vladimir V.; Nikolsky, Evgeny E.; Masson, Patrick; Reznik, Vladimir S.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1863-1874</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Novel 6-methyluracil derivs. with ω-(substituted benzylethylamino)alkyl chains at the nitrogen atoms of the pyrimidine ring were designed and synthesized.  The nos. of methylene groups in the alkyl chains were varied along with the electron-withdrawing substituents on the benzyl rings.  The compds. are mixed-type reversible inhibitors of cholinesterases, and some of them show remarkable selectivity for human acetylcholinesterase (hAChE), with inhibitory potency in the nanomolar range, more than 10,000-fold higher than that for human butyrylcholinesterase (hBuChE).  Mol. modeling studies indicate that these compds. are bifunctional AChE inhibitors, spanning the enzyme active site gorge and binding to its peripheral anionic site (PAS).  In vivo expts. show that the 6-methyluracil derivs. are able to penetrate the blood-brain barrier (BBB), inhibiting brain-tissue AChE.  The most potent AChE inhibitor, (1,3-bis[5-(o-nitrobenzylethylamino)pentyl]-6-methyluracil), was found to improve working memory in scopolamine and transgenic APP/PS1 murine models of Alzheimer's disease, and to significantly decrease the no. and area of β-amyloid peptide plaques in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_iqGhIN8yfrVg90H21EOLACvtfcHk0lhK6dmwq9vo0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKns7jI&md5=25a1e1a7ce3c8794fb67f7934faf8e5f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500334%26sid%3Dliteratum%253Aachs%26aulast%3DSemenov%26aufirst%3DV.%2BE.%26aulast%3DZueva%26aufirst%3DI.%2BV.%26aulast%3DMukhamedyarov%26aufirst%3DM.%2BA.%26aulast%3DLushchekina%26aufirst%3DS.%2BV.%26aulast%3DKharlamova%26aufirst%3DA.%2BD.%26aulast%3DPetukhova%26aufirst%3DE.%2BO.%26aulast%3DMikhailov%26aufirst%3DA.%2BS.%26aulast%3DPodyachev%26aufirst%3DS.%2BN.%26aulast%3DSaifina%26aufirst%3DL.%2BF.%26aulast%3DPetrov%26aufirst%3DK.%2BA.%26aulast%3DMinnekhanova%26aufirst%3DO.%2BA.%26aulast%3DZobov%26aufirst%3DV.%2BV.%26aulast%3DNikolsky%26aufirst%3DE.%2BE.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DReznik%26aufirst%3DV.%2BS.%26atitle%3D6-Methyluracil%2520derivatives%2520as%2520bifunctional%2520acetylcholinesterase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1863%26epage%3D1874%26doi%3D10.1002%2Fcmdc.201500334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span> <span> </span><span class="NLM_article-title">Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.neuropharm.2017.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=29197516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFegtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2018&pages=77-91&author=X.+Guoauthor=J.+Lvauthor=J.+Luauthor=L.+Fanauthor=X.+Huangauthor=L.+Huauthor=J.+Wangauthor=X.+Shen&title=Protopanaxadiol+derivative+DDPU+improves+behavior+and+cognitive+deficit+in+AD+mice+involving+regulation+of+both+ER+stress+and+autophagy&doi=10.1016%2Fj.neuropharm.2017.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy</span></div><div class="casAuthors">Guo, Xiaodan; Lv, Jianlu; Lu, Jian; Fan, Lei; Huang, Xi; Hu, Lihong; Wang, Jiaying; Shen, Xu</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-91</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressively neurodegenerative disease with typical hallmarks of amyloid β (Aβ) plaque accumulation, neurofibrillary tangle (NFT) formation and neuronal death extension.  Aggressive Aβ accumulation promotes senile plaque formation and perturbs endoplasmic reticulum (ER) function to trigger the unfolded protein response (UPR) leading to neuronal apoptosis.  The stress-dependent activation of protein kinase RNA-like endoplasmic reticulum kinase (PERK) increases the phosphorylation of eukaryotic translation initiation factor-2α (eIF2α) to promote the preferential synthesis of β-site APP cleavage enzyme 1 (BACE1) and Aβ generation in turn.  Addnl., dysfunction in autophagy has been reported to contribute to several neurodegenerative diseases including AD, and impairment in autophagy-mediated pathway may constitutively stimulate the generation of Aβ in AD.  Here we discovered that protopanaxadiol deriv. 1-(3,4-dimethoxyphenethyl)-3-(3-dehydroxyl-20(s)-protopanaxadiol-3β-yl)-urea (DDPU) effectively improved the activity of daily living (ADL) and cognitive deficits in APP/PS1 transgenic mice.  The crosstalk between Aβ and ER stress has been intensively investigated by using DDPU as a probe.  DDPU reduced Aβ prodn. mainly by inhibiting the PERK/eIF2α signaling-mediated BACE1 translation and stimulated Aβ clearance by promoting autophagy as a PI3K inhibitor through PI3K/AKT/mTOR signaling pathway, while exhibited neuroprotective effect involving attenuation of ER stress.  DDPU might be the first reported ginsenoside deriv. with dual effects on both autophagy promotion and ER stress amelioration.  Our results have highlighted the potential of DDPU in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgHXkUxb09wrVg90H21EOLACvtfcHk0lhK6dmwq9vo0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFegtbvE&md5=e403e4bda9644a79932a943ce11ec61a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DX.%26atitle%3DProtopanaxadiol%2520derivative%2520DDPU%2520improves%2520behavior%2520and%2520cognitive%2520deficit%2520in%2520AD%2520mice%2520involving%2520regulation%2520of%2520both%2520ER%2520stress%2520and%2520autophagy%26jtitle%3DNeuropharmacology%26date%3D2018%26volume%3D130%26spage%3D77%26epage%3D91%26doi%3D10.1016%2Fj.neuropharm.2017.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">PSD-93 Attenuates Amyloid-beta-mediated cognitive dysfunction by promoting the catabolism of amyloid-beta</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.3233/JAD-170320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.3233%2FJAD-170320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=28697571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ghu7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2017&pages=913-927&author=L.+Yuauthor=Y.+Liuauthor=H.+Yangauthor=X.+Zhuauthor=X.+Caoauthor=J.+Gaoauthor=H.+Zhaoauthor=Y.+Xu&title=PSD-93+Attenuates+Amyloid-beta-mediated+cognitive+dysfunction+by+promoting+the+catabolism+of+amyloid-beta&doi=10.3233%2FJAD-170320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β</span></div><div class="casAuthors">Yu, Linjie; Liu, Yi; Yang, Hui; Zhu, Xiaolei; Cao, Xiang; Gao, Jun; Zhao, Hui; Xu, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">913-927</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) is a key neuropathol. hallmark of Alzheimer's disease (AD).  Postsynaptic d. protein 93 (PSD-93) is a key scaffolding protein enriched at postsynaptic sites.  The aim of the present study was to examine whether PSD-93 overexpression could alleviate Aβ-induced cognitive dysfunction in APPswe/PS1dE9 (APP/PS1) mice by reducing Aβ levels in the brain.  The level of PSD-93 was significantly decreased in the hippocampus of 6-mo-old APP/PS1 mice compared with that in wild-type mice.  Following lentivirus-mediated PSD-93 overexpression, cognitive function, synaptic function, and amyloid burden were investigated.  The open field test, Morris water maze test, and fear condition test revealed that PSD-93 overexpression ameliorated spatial memory deficits in APP/PS1 mice.  The facilitation of long-term potentiation induction was obsd. in APP/PS1 mice after PSD-93 overexpression.  The expression of somatostatin receptor 4 (SSTR4) and neprilysin was increased, while the amyloid plaque load and Aβ levels were decreased in the brains of APP/PS1 mice.  Moreover, PSD-93 interacted with SSTR4 and affected the level of SSTR4 on cell membrane, which was assocd. with the ubiquitination.  Together, these findings suggest that PSD-93 attenuates spatial memory deficits and decreases amyloid levels in APP/PS1 mice, which might be assocd. with Aβ catabolism, and overexpression of PSD-93 might be a potential therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovp5f71-A0-bVg90H21EOLACvtfcHk0lhPJYUEzvAN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ghu7zF&md5=67888e1b76432131eda3372eeb41d574</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3233%2FJAD-170320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170320%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DPSD-93%2520Attenuates%2520Amyloid-beta-mediated%2520cognitive%2520dysfunction%2520by%2520promoting%2520the%2520catabolism%2520of%2520amyloid-beta%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2017%26volume%3D59%26spage%3D913%26epage%3D927%26doi%3D10.3233%2FJAD-170320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mederos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer’s disease mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/npp.2016.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1038%2Fnpp.2016.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=27550730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=524-539&author=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+A.+Sanchez-Ariasauthor=O.+Rabalauthor=M.+Perez-Gonzalezauthor=S.+Mederosauthor=A.+Ugarteauthor=R.+Francoauthor=V.+Seguraauthor=G.+Pereaauthor=J.+Oyarzabalauthor=A.+Garcia-Osta&title=A+first-in-class+small-molecule+that+acts+as+a+dual+inhibitor+of+HDAC+and+PDE5+and+that+rescues+hippocampal+synaptic+impairment+in+Alzheimer%E2%80%99s+disease+mice&doi=10.1038%2Fnpp.2016.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice</span></div><div class="casAuthors">Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Sanchez-Arias, Juan A.; Rabal, Obdulia; Perez-Gonzalez, Marta; Mederos, Sara; Ugarte, Ana; Franco, Rafael; Segura, Victor; Perea, Gertrudis; Oyarzabal, Julen; Garcia-Osta, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">524-539</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The targeting of two independent but synergistic enzymic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer's disease (AD).  Here we report the discovery of a new first-in-class small-mol. (CM-414) that acts as a dual inhibitor of PDE5 and HDACs.  We have used this compd. as a chem. probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation.  This mol. rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice.  Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine d. on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission.  Thus, CM-414 may serve as the starting point to discover balanced dual inhibitors with an optimal efficacy and safety profile for clin. testing on AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrel_KiPL5177Vg90H21EOLACvtfcHk0lhPJYUEzvAN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP&md5=26482df7c58696a362ca1e73bab12264</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.163%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DSanchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DPerez-Gonzalez%26aufirst%3DM.%26aulast%3DMederos%26aufirst%3DS.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DPerea%26aufirst%3DG.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DA%2520first-in-class%2520small-molecule%2520that%2520acts%2520as%2520a%2520dual%2520inhibitor%2520of%2520HDAC%2520and%2520PDE5%2520and%2520that%2520rescues%2520hippocampal%2520synaptic%2520impairment%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D524%26epage%3D539%26doi%3D10.1038%2Fnpp.2016.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roden, D. M.</span></span> <span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1022</span>, <span class="refDoi"> DOI: 10.1056/NEJMra032426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval&doi=10.1056%2FNEJMra032426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0lhPJYUEzvAN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022%26doi%3D10.1056%2FNEJMra032426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Auro Pharma Inc</span>. <a href="http://www.auropharma.ca/products/monograph/Auro-Donepezil-PM.pdf" class="extLink">http://www.auropharma.ca/products/monograph/Auro-Donepezil-PM.pdf</a> (accessed Oct 25, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Auro+Pharma+Inc.+http%3A%2F%2Fwww.auropharma.ca%2Fproducts%2Fmonograph%2FAuro-Donepezil-PM.pdf+%28accessed+Oct+25%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Chinadrugtrials</span>. <a href="http://www.chinadrugtrials.org.cn/" class="extLink">http://www.chinadrugtrials.org.cn/</a> (accessed Oct 25, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chinadrugtrials.+http%3A%2F%2Fwww.chinadrugtrials.org.cn%2F+%28accessed+Oct+25%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monobe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.-Q.</span></span> <span> </span><span class="NLM_article-title">Truxene discotic liquid crystals with two different ring substituents: synthesis, mesomorphism and high charged carrier mobility</span>. <i>Liq. Cryst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1080/02678292.2012.755224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1080%2F02678292.2012.755224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFSjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=411-420&author=H.-L.+Niauthor=H.+Monobeauthor=P.+Huauthor=B.-Q.+Wangauthor=Y.+Shimizuauthor=K.-Q.+Zhao&title=Truxene+discotic+liquid+crystals+with+two+different+ring+substituents%3A+synthesis%2C+mesomorphism+and+high+charged+carrier+mobility&doi=10.1080%2F02678292.2012.755224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Truxene discotic liquid crystals with two different ring substituents: synthesis, mesomorphism and high charged carrier mobility</span></div><div class="casAuthors">Ni, Hai-Liang; Monobe, Hirosato; Hu, Ping; Wang, Bi-Qin; Shimizu, Yo; Zhao, Ke-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Liquid Crystals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">LICRE6</span>;
        ISSN:<span class="NLM_cas:issn">0267-8292</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Discotic liq. crystals as a kind of promising org. electronic materials show self-assembly property as well as high charged carrier mobility.  New truxene discotic materials, six 3,8,13-tri(alkoxy)-2,7,12-tri(methoxy)truxene derivs. and two 3,8,13-tri(alkoxy)-2,7,12-tri(hydroxy)truxene derivs. were synthesized with improved yields, they were characterized and exhibited good thermal stability.  The mesomorphism has been investigated by using polarized optical microscopy, differential scanning calorimetry and X-ray diffraction and they exhibited ordered hexagonal columnar mesophase.  More importantly, the charge carrier mobility of and have been measured by using time-of-flight technique and displayed hole drift mobility rate of 4.2 × 10-2 cm2 V-1 s-1 in the Colho phase and 0.1 cm2 V-1 s-1 at a lower temp. M mesophase.  The title compds. thus formed included a truxene deriv. (I) [tris(alkoxy)-10,15-dihydro-5H-tribenzo[a,f,k]trindene-2,7,12-triol, 2,7,12-tri(hydroxy)truxene] and related substances.  The synthesis of the target compds. was achieved using 2,3-dihydro-6-hydroxy-5-methoxy-1H-inden-1-one as a key intermediate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprW-z4vMH-hrVg90H21EOLACvtfcHk0lgVcQg978RG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFSjsg%253D%253D&md5=69bcc2f76e48524ef9835a5371432d4d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F02678292.2012.755224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02678292.2012.755224%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DH.-L.%26aulast%3DMonobe%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DB.-Q.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DK.-Q.%26atitle%3DTruxene%2520discotic%2520liquid%2520crystals%2520with%2520two%2520different%2520ring%2520substituents%253A%2520synthesis%252C%2520mesomorphism%2520and%2520high%2520charged%2520carrier%2520mobility%26jtitle%3DLiq.%2520Cryst.%26date%3D2013%26volume%3D40%26spage%3D411%26epage%3D420%26doi%3D10.1080%2F02678292.2012.755224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4462</span>– <span class="NLM_lpage">4466</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.bmcl.2012.04.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=22633691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1Squrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4462-4466&author=F.-C.+Mengauthor=F.+Maoauthor=W.-J.+Shanauthor=F.+Qinauthor=L.+Huangauthor=X.-S.+Li&title=Design%2C+synthesis%2C+and+evaluation+of+indanone+derivatives+as+acetylcholinesterase+inhibitors+and+metal-chelating+agents&doi=10.1016%2Fj.bmcl.2012.04.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents</span></div><div class="casAuthors">Meng, Fan-Chao; Mao, Fei; Shan, Wen-Jun; Qin, Fangfei; Huang, Ling; Li, Xing-Shu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4462-4466</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel indanone derivs. was designed, synthesized and evaluated as potential agents for Alzheimer's disease.  Among them, compd. I (as the Z-isomer), with a piperidine group linked to indone by a two-carbon spacer, exhibited the most potent inhibitor activity, with an IC50 of 0.0018 μM for AChE; the inhibitory activity of this compd. was 14-fold more potent than that of donepezil.  Furthermore, these compds. also exhibited good metal-chelating ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0IMwSLlGm57Vg90H21EOLACvtfcHk0lgVcQg978RG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1Squrs%253D&md5=5c21cdd9b2d6e4b82ce9ae421116adb6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.029%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.-C.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DShan%26aufirst%3DW.-J.%26aulast%3DQin%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.-S.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520indanone%2520derivatives%2520as%2520acetylcholinesterase%2520inhibitors%2520and%2520metal-chelating%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4462%26epage%3D4466%26doi%3D10.1016%2Fj.bmcl.2012.04.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Manxing  Zou</span>, <span class="hlFld-ContribAuthor ">Huanfang  Xie</span>, <span class="hlFld-ContribAuthor ">Tailiang  Lin</span>, <span class="hlFld-ContribAuthor ">Weiping  Lyu</span>, <span class="hlFld-ContribAuthor ">Jian  Xu</span>, <span class="hlFld-ContribAuthor ">Yuan  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113663. <a href="https://doi.org/10.1016/j.ejmech.2021.113663" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113663%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%252528cyclopropanecarboxamido%252529-N-%2525285-%252528%2525281-%2525284-fluorobenzyl%252529piperidin-4-yl%252529methoxy%252529pyridin-3-yl%252529isonicotinamide%252Bas%252Ba%252Bpotent%252Bdual%252BAChE%25252FGSK3%2525CE%2525B2%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252BSignificantly%252Bincreasing%252Bthe%252Blevel%252Bof%252Bacetylcholine%252Bin%252Bthe%252Bbrain%252Bwithout%252Baffecting%252Bthat%252Bin%252Bintestine%26aulast%3DJiang%26aufirst%3DXueyang%26date%3D2021%26volume%3D223%26spage%3D113663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Approved AChE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>–<b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (CH<sub>3</sub>)<sub>3</sub>SI, <i>t</i>-BuOK, DMSO; (b) 70% HF in pyridine, CH<sub>2</sub>Cl<sub>2</sub>; (c) oxalyl chloride, DMSO, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>; (d) CH<sub>3</sub>ONa, THF; (e) 10% Pd/C, H<sub>2</sub>, THF; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (g) substituted benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF; (h) substituted phenethyl bromide, K<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>25</b>–<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) malonic acid, pyridine, toluene; 10% Pd/C, H<sub>2</sub>, THF; (b) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (c) AlCl<sub>3</sub>, CS<sub>2</sub>; (d) K<sub>2</sub>CO<sub>3</sub>, DMF; (e) BBr<sub>3</sub>, −78 °C; (f) Na<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) The SPR data for the binding of selected compound-AChE at 298.15 K; (B) surface plasmon resonance (SPR) sensorgrams for the binding of compound <b>12</b> to rhAChE; (C) the time-dependent effect of compound <b>12</b> (i.g.) and donepezil (i.g.) in the cortex of mice; (D) the time-dependent effect of compound <b>12</b> and donepezil in the hippocampus of mice via i.g. administration. Data were represented as the percentage of vehicle control that was set to 100% and expressed as mean ± SEM (<i>N</i> = 11–12); <sup>##</sup><i>P</i> < 0.01, <sup>###</sup><i>P</i> < 0.001 vs the vehicle control group; *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the donepezil treatment group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Active site-bound ligands and their interactions. (A) The superposition of AChE/compound <b>2</b> complex (green, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9O">7D9O</a>), AChE/compound <b>7</b> complex (magenta, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9Q">7D9Q</a>), and AChE/<b>12</b> complex (cyan, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9P">7D9P</a>) with the AChE/donepezil complex (yellow, PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>); (B) the binding mode of compound <b>2</b> in AChE; (C) the binding mode of compound <b>7</b> in AChE; (D) the binding mode of compound 1<b>2</b> in AChE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose-dependent AChE inhibitory effects of compound <b>12</b> (i.g.) in the cortex (A) and hippocampus (B) of ICR mice. Data were represented as the percentage of vehicle control mice; they were set to 100% and presented as mean ± SEM (<i>N</i> = 6–12). **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the control group (vehicle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of compound <b>12</b> (i.g.) on scopolamine-induced cognitive deficits in the mouse channel water maze. (A) Escape latencies (time to find the escape platform); (B) the number of errors (entering the no-exit in the channel maze). Data were presented as mean ± SEM (<i>N</i> = 32–36). <sup>###</sup><i>P</i> < 0.001 vs the control group (vehicle + saline); *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the scopolamine group (vehicle + scopolamine).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/medium/jm0c01863_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of compound <b>12</b> (i.g.) on behavioral changes in the APP/PS1 mice. (A) Y maze performance (4 weeks of drug treatment); (B) time spent in the target quadrant of the probe trial of Morris water maze (6 weeks of drug treatment). Data were presented as mean ± SEM (<i>N</i> = 15–17). <sup>#</sup><i>P</i> < 0.05 vs the vehicle-treated wild type mice; *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the vehicle-treated APP/PS1 (Tg) mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01863/20210218/images/large/jm0c01863_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01863&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i33">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. B.</span></span> <span> </span><span class="NLM_article-title">Novel phosphodiesterase inhibitors for cognitive improvement in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5467</span>– <span class="NLM_lpage">5483</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01370</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5467-5483&author=Y.+Wuauthor=Z.+Liauthor=Y.+Y.+Huangauthor=D.+Wuauthor=H.+B.+Luo&title=Novel+phosphodiesterase+inhibitors+for+cognitive+improvement+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b01370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease</span></div><div class="casAuthors">Wu, Yinuo; Li, Zhe; Huang, Yi-You; Wu, Deyan; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5467-5483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is one of the greatest public health challenges.  Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).  Since several PDE subfamilies are highly expressed in the human brain, the inhibition of PDEs is involved in neurodegenerative processes by regulating the concn. of cAMP and/or cGMP.  Currently, PDEs are considered as promising targets for the treatment of AD since many PDE inhibitors have exhibited remarkable cognitive improvement effects in preclin. studies and over 15 of them have been subjected to clin. trials.  The aim of this review is to summarize the outstanding progress that has been made by PDE inhibitors as anti-AD agents with encouraging results in preclin. studies and clin. trials.  The binding affinity, pharmacokinetics, underlying mechanisms, and limitations of these PDE inhibitors in the treatment of AD are also reviewed and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom1l9eMNKCt7Vg90H21EOLACvtfcHk0ljEisklIm2RXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGqu7w%253D&md5=87cd22fa21c661f4cb5dc2155368bd7c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01370%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DY.%2BY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26atitle%3DNovel%2520phosphodiesterase%2520inhibitors%2520for%2520cognitive%2520improvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5467%26epage%3D5483%26doi%3D10.1021%2Facs.jmedchem.7b01370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagginapally, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kancharla, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Middekadi, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogaraju, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravella, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birangal, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muddana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, structure-activity relationships, and preclinical evaluation of heteroaromatic amides and 1,3,4-oxadiazole derivatives as 5-HT4 receptor partial agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4993</span>– <span class="NLM_lpage">5008</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00457</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00457" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVChsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4993-5008&author=R.+Nirogiauthor=A.+R.+Mohammedauthor=A.+K.+Shindeauthor=S.+R.+Gagginapallyauthor=D.+M.+Kancharlaauthor=V.+R.+Middekadiauthor=N.+Bogarajuauthor=S.+R.+Ravellaauthor=P.+Singhauthor=S.+R.+Birangalauthor=R.+Subramanianauthor=R.+C.+Palacharlaauthor=V.+Benadeauthor=N.+Muddanaauthor=P.+Jayarajan&title=Synthesis%2C+structure-activity+relationships%2C+and+preclinical+evaluation+of+heteroaromatic+amides+and+1%2C3%2C4-oxadiazole+derivatives+as+5-HT4+receptor+partial+agonists&doi=10.1021%2Facs.jmedchem.8b00457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists</span></div><div class="casAuthors">Nirogi, Ramakrishna; Mohammed, Abdul Rasheed; Shinde, Anil K.; Gagginapally, Shankar Reddy; Kancharla, Durga Malleshwari; Middekadi, Vanaja Reddy; Bogaraju, Narsimha; Ravella, Srinivasa Rao; Singh, Pooja; Birangal, Sumit Raosaheb; Subramanian, Ramkumar; Palacharla, Raghava Choudary; Benade, Vijay; Muddana, Nageswararao; Jayarajan, Pradeep</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4993-5008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder that has a higher prevalence and incidence in people older than 60 years.  The need for improved AD therapies is unmet as the current therapies are symptomatic with modest efficacy.  Partial agonists of the 5-HT4 receptor (5-HT4R) offer both symptomatic and disease-modifying treatments as they shift amyloid-precursor-protein (APP) processing from the amyloidogenic pathway to the nonamyloidogenic pathway by activating the α-secretase enzyme.  In addn., they also offer symptomatic treatment by increasing levels of the neurotransmitter acetylcholine in the brain.  Because of this fascinating dual mechanism of action, several chem. scaffolds having 5-HT4R pharmacophores were designed and evaluated.  Most of the synthesized compds. showed potent in vitro affinities and in vivo efficacies.  Upon anal. of focused structure-activity relationships, compd. 4o was identified as a potent 5-HT4R partial agonist with favorable ADME properties and good in vivo efficacy.  GR-125487, a selective 5-HT4R antagonist, attenuated the activity of compd. 4o in the novel-object-recognition-test cognition model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk2z2YiR_ja7Vg90H21EOLACvtfcHk0ljEisklIm2RXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVChsLk%253D&md5=b8bacee142c07a4dbb433e95b86b1d07</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00457%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DShinde%26aufirst%3DA.%2BK.%26aulast%3DGagginapally%26aufirst%3DS.%2BR.%26aulast%3DKancharla%26aufirst%3DD.%2BM.%26aulast%3DMiddekadi%26aufirst%3DV.%2BR.%26aulast%3DBogaraju%26aufirst%3DN.%26aulast%3DRavella%26aufirst%3DS.%2BR.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DBirangal%26aufirst%3DS.%2BR.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DMuddana%26aufirst%3DN.%26aulast%3DJayarajan%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520structure-activity%2520relationships%252C%2520and%2520preclinical%2520evaluation%2520of%2520heteroaromatic%2520amides%2520and%25201%252C3%252C4-oxadiazole%2520derivatives%2520as%25205-HT4%2520receptor%2520partial%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4993%26epage%3D5008%26doi%3D10.1021%2Facs.jmedchem.8b00457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molinuevo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batrla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielke, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikulskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Bryant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheltens, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevigny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojanowski, J. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zetterberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blennow, K.</span></span> <span> </span><span class="NLM_article-title">Current state of Alzheimer’s fluid biomarkers</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">821</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1007/s00401-018-1932-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1007%2Fs00401-018-1932-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=30488277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlCls7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2018&pages=821-853&author=J.+L.+Molinuevoauthor=S.+Aytonauthor=R.+Batrlaauthor=M.+M.+Bednarauthor=T.+Bittnerauthor=J.+Cummingsauthor=A.+M.+Faganauthor=H.+Hampelauthor=M.+M.+Mielkeauthor=A.+Mikulskisauthor=S.+O%E2%80%99Bryantauthor=P.+Scheltensauthor=J.+Sevignyauthor=L.+M.+Shawauthor=H.+D.+Soaresauthor=G.+Tongauthor=J.+Q.+Trojanowskiauthor=H.+Zetterbergauthor=K.+Blennow&title=Current+state+of+Alzheimer%E2%80%99s+fluid+biomarkers&doi=10.1007%2Fs00401-018-1932-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Current state of Alzheimer's fluid biomarkers</span></div><div class="casAuthors">Molinuevo, Jose Luis; Ayton, Scott; Batrla, Richard; Bednar, Martin M.; Bittner, Tobias; Cummings, Jeffrey; Fagan, Anne M.; Hampel, Harald; Mielke, Michelle M.; Mikulskis, Alvydas; O'Bryant, Sid; Scheltens, Philip; Sevigny, Jeffrey; Shaw, Leslie M.; Soares, Holly D.; Tong, Gary; Trojanowski, John Q.; Zetterberg, Henrik; Blennow, Kaj</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">821-853</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disease with a complex and heterogeneous pathophysiol.  The no. of people living with AD is predicted to increase; however, there are no disease-modifying therapies currently available and none have been successful in late-stage clin. trials.  Fluid biomarkers measured in cerebrospinal fluid (CSF) or blood hold promise for enabling more effective drug development and establishing a more personalized medicine approach for AD diagnosis and treatment.  Biomarkers used in drug development programs should be qualified for a specific context of use (COU).  These COUs include, but are not limited to, subject/patient selection, assessment of disease state and/or prognosis, assessment of mechanism of action, dose optimization, drug response monitoring, efficacy maximization, and toxicity/adverse reactions identification and minimization.  The core AD CSF biomarkers Aβ42, t-tau, and p-tau are recognized by research guidelines for their diagnostic utility and are being considered for qualification for subject selection in clin. trials.  However, there is a need to better understand their potential for other COUs, as well as identify addnl. fluid biomarkers reflecting other aspects of AD pathophysiol.  Several novel fluid biomarkers have been proposed, but their role in AD pathol. and their use as AD biomarkers have yet to be validated.  In this review, we summarize some of the pathol. mechanisms implicated in the sporadic AD and highlight the data for several established and novel fluid biomarkers (including BACE1, TREM2, YKL-40, IP-10, neurogranin, SNAP-25, synaptotagmin, α-synuclein, TDP-43, ferritin, VILIP-1, and NF-L) assocd. with each mechanism.  We discuss the potential COUs for each biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEfy0WGH51zLVg90H21EOLACvtfcHk0lhd4ARymmbpXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlCls7bK&md5=7a9182d19735345a67eb1590986c4a79</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00401-018-1932-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-018-1932-x%26sid%3Dliteratum%253Aachs%26aulast%3DMolinuevo%26aufirst%3DJ.%2BL.%26aulast%3DAyton%26aufirst%3DS.%26aulast%3DBatrla%26aufirst%3DR.%26aulast%3DBednar%26aufirst%3DM.%2BM.%26aulast%3DBittner%26aufirst%3DT.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DMielke%26aufirst%3DM.%2BM.%26aulast%3DMikulskis%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Bryant%26aufirst%3DS.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DSevigny%26aufirst%3DJ.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DSoares%26aufirst%3DH.%2BD.%26aulast%3DTong%26aufirst%3DG.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DCurrent%2520state%2520of%2520Alzheimer%25E2%2580%2599s%2520fluid%2520biomarkers%26jtitle%3DActa%2520Neuropathol.%26date%3D2018%26volume%3D136%26spage%3D821%26epage%3D853%26doi%3D10.1007%2Fs00401-018-1932-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mucke, L.</span></span> <span> </span><span class="NLM_article-title">Alzheimer mechanisms and therapeutic strategies</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1222</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.02.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.cell.2012.02.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=22424230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=1204-1222&author=Y.+Huangauthor=L.+Mucke&title=Alzheimer+mechanisms+and+therapeutic+strategies&doi=10.1016%2Fj.cell.2012.02.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer Mechanisms and Therapeutic Strategies</span></div><div class="casAuthors">Huang, Yadong; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1204-1222</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  There are still no effective treatments to prevent, halt, or reverse Alzheimer's disease, but research advances over the past three decades could change this gloomy picture.  Genetic studies demonstrate that the disease has multiple causes.  Interdisciplinary approaches combining biochem., mol. and cell biol., and transgenic modeling have revealed some of its mol. mechanisms.  Progress in chem., radiol., and systems biol. is beginning to provide useful biomarkers, and the emergence of personalized medicine is poised to transform pharmaceutical development and clin. trials.  However, investigative and drug development efforts should be diversified to fully address the multifactoriality of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx4Jw1D9na57Vg90H21EOLACvtfcHk0lhd4ARymmbpXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1CqurY%253D&md5=4f44f2d5019321a668029282777946d1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.040%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAlzheimer%2520mechanisms%2520and%2520therapeutic%2520strategies%26jtitle%3DCell%26date%3D2012%26volume%3D148%26spage%3D1204%26epage%3D1222%26doi%3D10.1016%2Fj.cell.2012.02.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mozaffarnia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teimuri-Mofrad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashidi, M.-R.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">112140</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.ejmech.2020.112140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=32088494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1OnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2020&pages=112140&author=S.+Mozaffarniaauthor=R.+Teimuri-Mofradauthor=M.-R.+Rashidi&title=Design%2C+synthesis+and+biological+evaluation+of+2%2C3-dihydro-5%2C6-dimethoxy-1H-inden-1-one+and+piperazinium+salt+hybrid+derivatives+as+hAChE+and+hBuChE+enzyme+inhibitors&doi=10.1016%2Fj.ejmech.2020.112140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors</span></div><div class="casAuthors">Mozaffarnia, Sakineh; Teimuri-Mofrad, Reza; Rashidi, Mohammad-Reza</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112140pp.</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">2,3-Dihydro-5,6-dimethoxy-2-[4-(4-alkyl-4-methylpiperazinium-1-yl)benzylidine]-1H-inden-1-one halide salt derivs. I [R = Pr, pentyl, allyl, benzyl, etc.; X = Cl, Br] as a novel donepezil hybrid analogs with the property of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzyme inhibition were designed and synthesized via N-alkylation reaction of 2,3-dihydro-5,6-dimethoxy-2-[4-(4-methylpiperazin-1-yl)benzylidene]-1H-inden-1-one with some alkyl halides.  Biol. tests demonstrated that most of the synthesized compds. I have moderate to good inhibitory activities effect on cholinesterase enzymes.  Among them, I [R = 3-chlorobenzyl] showed the best profile as a selected compd. for inhibition of hAChE (IC50 = 0.32) and hBuChE (IC50 = 0.43μM) enzymes.  Kinetic anal. and mol. docking led to a better understanding of this compd. I.  Kinetic studies disclosed that I [R = 3-chlorobenzyl] inhibited acetylcholinesterase in mixed-type and butyrylcholinesterase in non-competitive type.  The toxicity results showed that I [R = 3-chlorobenzyl] was less toxic than donepezil and has better inhibitory activity against hBuChE when compared to donepezil or Galantamine.  Other performed expts. revealed that I [R = 3-chlorobenzyl] has an anti-β amyloid effect which was capable of reducing ROS, LDH and MDA also possing pos. effect on TAC.  On the other hand, it was showed a good anti-inflammation effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnInIUobDxO7Vg90H21EOLACvtfcHk0lhd4ARymmbpXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1OnsLk%253D&md5=c4d778c468d6af502be5d66ebd2bfd2c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112140%26sid%3Dliteratum%253Aachs%26aulast%3DMozaffarnia%26aufirst%3DS.%26aulast%3DTeimuri-Mofrad%26aufirst%3DR.%26aulast%3DRashidi%26aufirst%3DM.-R.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%25202%252C3-dihydro-5%252C6-dimethoxy-1H-inden-1-one%2520and%2520piperazinium%2520salt%2520hybrid%2520derivatives%2520as%2520hAChE%2520and%2520hBuChE%2520enzyme%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D191%26spage%3D112140%26doi%3D10.1016%2Fj.ejmech.2020.112140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapposelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pi, R.</span></span> <span> </span><span class="NLM_article-title">A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.bmc.2017.12.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=29310862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslOltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=543-550&author=X.+Zhangauthor=X.+Heauthor=Q.+Chenauthor=J.+Luauthor=S.+Rapposelliauthor=R.+Pi&title=A+review+on+the+hybrids+of+hydroxycinnamic+acid+as+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2017.12.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease</span></div><div class="casAuthors">Zhang, Xiao; He, Xixin; Chen, Qiuhe; Lu, Junfeng; Rapposelli, Simona; Pi, Rongbiao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">543-550</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), a complex chronic progressive central nervous system degenerative disease and a public health problem of the world, often characters cognitive dysfunction accompanying aggression and depression, and may lead to death.  More attentions should be paid on it because there is no modified strategy against AD till now.  AD is featured with the loss of cholinergic neurons, the amyloid-beta peptide (Aβ) plaques and the neurofibrillary tangles and several hypotheses were established to explain the pathogenesis of AD.  Hydroxycinnamic acids, including caffeic acid (CA) and ferulic acid (FA) are widely distributed in natural plants and fruits.  CA and FA exert various pharmacol. activities, including anti-inflammatory, antioxidant, neuroprotection, anti-amyloid aggregation and so on.  All these pharmacol. activities are assocd. with the treatment of AD.  Here we summarized the pharmacol. activities of CA and FA, and their hybrids as multi-target-directed ligands (MTDLs) against AD.  The future application of CA and FA was also discussed, hoping to provide beneficial information for the development of CA- and FA-based MTDLs against AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi4-lyK8HNyrVg90H21EOLACvtfcHk0ljg1SwG76vDUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslOltg%253D%253D&md5=876d012130ef30122caaca8bccd2c44e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.042%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DRapposelli%26aufirst%3DS.%26aulast%3DPi%26aufirst%3DR.%26atitle%3DA%2520review%2520on%2520the%2520hybrids%2520of%2520hydroxycinnamic%2520acid%2520as%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D543%26epage%3D550%26doi%3D10.1016%2Fj.bmc.2017.12.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambhampati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraf, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badange, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyala, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojja, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reballi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasti, V.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (SUVN-502): a novel, potent, selective and orally active serotonin 6 (5-HT6) receptor antagonist for potential treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1843-1859&author=R.+Nirogiauthor=A.+Shindeauthor=R.+S.+Kambhampatiauthor=A.+R.+Mohammedauthor=S.+K.+Sarafauthor=R.+K.+Badangeauthor=T.+R.+Bandyalaauthor=V.+Bhattaauthor=K.+Bojjaauthor=V.+Reballiauthor=R.+Subramanianauthor=V.+Benadeauthor=R.+C.+Palacharlaauthor=G.+Bhyrapuneniauthor=P.+Jayarajanauthor=V.+Goyalauthor=V.+Jasti&title=Discovery+and+development+of+1-%5B%282-Bromophenyl%29sulfonyl%5D-5-methoxy-3-%5B%284-methyl-1-piperazinyl%29methyl%5D-1H-indole+dimesylate+monohydrate+%28SUVN-502%29%3A+a+novel%2C+potent%2C+selective+and+orally+active+serotonin+6+%285-HT6%29+receptor+antagonist+for+potential+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Nirogi, Ramakrishna; Shinde, Anil; Kambhampati, Rama Sastry; Mohammed, Abdul Rasheed; Saraf, Sangram Keshari; Badange, Rajesh kumar; Bandyala, Thrinath Reddy; Bhatta, Venugopalarao; Bojja, Kumar; Reballi, Veena; Subramanian, Ramkumar; Benade, Vijay; Palacharla, Raghava Choudary; Bhyrapuneni, Gopinadh; Jayarajan, Pradeep; Goyal, Vinod; Jasti, Venkat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1843-1859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a novel series of 3-(piperazinylmethyl) indole derivs. as 5-hydroxytryptamine-6 receptor (5-HT6R) antagonists resulted in identification of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (5al, SUVN-502) as a clin. candidate for potential treatment of cognitive disorders.  It has high affinity at human 5-HT6R (Ki = 2.04 nM) and selectivity over 100 target sites which include receptors, enzymes, peptides, growth factors, ion channels, steroids, immunol. factors, second messengers, and prostaglandins.  It has high selectivity over 5-HT2A receptor.  It is orally bioavailable and brain penetrant with robust preclin. efficacy.  The combination of 5al, donepezil, and memantine (triple combination) produces synergistic effects in extracellular levels of acetylcholine in the ventral hippocampus.  Preclin. efficacy in triple combination and high selectivity over 5-HT2A receptors are the differentiating features which culminated in selection of 5al for further development.  The Phase-1 evaluation of safety and pharmacokinetics has been completed, allowing for the initiation of a Phase-2 proof of concept study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_gw476vRgPbVg90H21EOLACvtfcHk0ljg1SwG76vDUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D&md5=26e4f0c1c34255ce2c2ef3bbf3c06a85</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01662%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DKambhampati%26aufirst%3DR.%2BS.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DSaraf%26aufirst%3DS.%2BK.%26aulast%3DBadange%26aufirst%3DR.%2BK.%26aulast%3DBandyala%26aufirst%3DT.%2BR.%26aulast%3DBhatta%26aufirst%3DV.%26aulast%3DBojja%26aufirst%3DK.%26aulast%3DReballi%26aufirst%3DV.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DJasti%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520development%2520of%25201-%255B%25282-Bromophenyl%2529sulfonyl%255D-5-methoxy-3-%255B%25284-methyl-1-piperazinyl%2529methyl%255D-1H-indole%2520dimesylate%2520monohydrate%2520%2528SUVN-502%2529%253A%2520a%2520novel%252C%2520potent%252C%2520selective%2520and%2520orally%2520active%2520serotonin%25206%2520%25285-HT6%2529%2520receptor%2520antagonist%2520for%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1843%26epage%3D1859%26doi%3D10.1021%2Facs.jmedchem.6b01662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, M. L.</span></span> <span> </span><span class="NLM_article-title">Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients</span>. <i>Clin. Interventions Aging</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1963</span>– <span class="NLM_lpage">1970</span>, <span class="refDoi"> DOI: 10.2147/CIA.S159920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.2147%2FCIA.S159920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=30349215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVyjurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=1963-1970&author=N.+Zhangauthor=M.+L.+Gordon&title=Clinical+efficacy+and+safety+of+donepezil+in+the+treatment+of+Alzheimer%E2%80%99s+disease+in+Chinese+patients&doi=10.2147%2FCIA.S159920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients</span></div><div class="casAuthors">Zhang, Nan; Gordon, Marc L.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1963-1970</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1178-1998</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Donepezil, an acetylcholinesterase inhibitor (AChEI), has been widely used to treat Alzheimer's disease (AD) in China.  However, there are few studies focusing on the efficacy and safety of donepezil in Chinese patients.  In this review, we discuss 1) the efficacy of donepezil and its comparison with other AChEIs or memantine, 2) the therapeutic responses to donepezil and its influencing factors, and 3) the safety and tolerability of donepezil in Chinese patients with different stages of AD and amnestic mild cognitive impairment, and further compare the similarities and differences of the results between Chinese studies and previous Western studies that predominantly enrolled Caucasian subjects.  We include Chinese clin. trials and other well-designed studies investigating donepezil or using donepezil as a pos. control, in which the efficacy and/or safety of donepezil have been analyzed.  Based on these studies, donepezil has been shown to be effective and safe in Chinese AD patients and may impact AD biomarkers, such as hippocampal atrophy, Aβ, and tau.  In addn., the therapeutic response to donepezil may be influenced by apolipoprotein E or cytochrome P 450 2D6 polymorphism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoacKXwJxhDhLVg90H21EOLACvtfcHk0ljg1SwG76vDUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVyjurvL&md5=59a7b358463ffee1fae05ecba4787ad9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2147%2FCIA.S159920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCIA.S159920%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DGordon%26aufirst%3DM.%2BL.%26atitle%3DClinical%2520efficacy%2520and%2520safety%2520of%2520donepezil%2520in%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520Chinese%2520patients%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2018%26volume%3D13%26spage%3D1963%26epage%3D1970%26doi%3D10.2147%2FCIA.S159920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Drugs.com</span>. <a href="https://www.drugs.com/mtm/donepezil.html" class="extLink">https://www.drugs.com/mtm/donepezil.html</a> (accessed Oct 25, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Drugs.com.+https%3A%2F%2Fwww.drugs.com%2Fmtm%2Fdonepezil.html+%28accessed+Oct+25%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, D.</span></span> <span> </span><span class="NLM_article-title">Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional chinese medicine origin for the treatment of Alzheimers disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2231</span>– <span class="NLM_lpage">2252</span>, <span class="refDoi"> DOI: 10.2174/0929867033456747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.2174%2F0929867033456747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=14529340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFKls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=2231-2252&author=H.+Jiangauthor=X.+Luoauthor=D.+Bai&title=Progress+in+clinical%2C+pharmacological%2C+chemical+and+structural+biological+studies+of+huperzine+A%3A+a+drug+of+traditional+chinese+medicine+origin+for+the+treatment+of+Alzheimers+disease&doi=10.2174%2F0929867033456747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in clinical, pharmacological, chemical and structural biological studies of Huperzine A: A drug of traditional Chinese medicine origin for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Jiang, Hualiang; Luo, Xiaomin; Bai, Donglu</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2231-2252</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HupA is a potent, reversible AChEI, which crosses the blood-brain barrier smoothly, and shows high specificity for AChE with a prolonged biol. half-life.  It has been approved as the drug for the treatment of AD in China, and marketed in the USA as a dietary supplement.  HupA has been the subject of investigations by an ever-increasing no. of researchers since the 1980's.  In the last 4 yr, HupA has been further studied in many aspects such as its chem. synthesis, structural modification, structure-activity relationship, various biol. effects, and mechanisms of action.  A no. of papers dealing with the computational modeling and x-ray crystallog. studies of HupA-AChE complex have also been published.  This review represents a comprehensive documentation of the progress in the studies on HupA during the period of 1999-2002.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDUGGTz1zcD7Vg90H21EOLACvtfcHk0lh6XuiZBI2C8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFKls78%253D&md5=4843f2c8f717447186972a0ef3adfdae</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F0929867033456747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033456747%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DD.%26atitle%3DProgress%2520in%2520clinical%252C%2520pharmacological%252C%2520chemical%2520and%2520structural%2520biological%2520studies%2520of%2520huperzine%2520A%253A%2520a%2520drug%2520of%2520traditional%2520chinese%2520medicine%2520origin%2520for%2520the%2520treatment%2520of%2520Alzheimers%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D2231%26epage%3D2252%26doi%3D10.2174%2F0929867033456747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. C.</span></span> <span> </span><span class="NLM_article-title">Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2003.12.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.neulet.2003.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=15135892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVGlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2004&pages=56-59&author=Y.+Q.+Liangauthor=X.+C.+Tang&title=Comparative+effects+of+huperzine+A%2C+donepezil+and+rivastigmine+on+cortical+acetylcholine+level+and+acetylcholinesterase+activity+in+rats&doi=10.1016%2Fj.neulet.2003.12.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats</span></div><div class="casAuthors">Liang, Yan Qi; Tang, Xi Can</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">56-59</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The cholinesterase inhibitors huperzine A, donepezil and rivastigmine were compared for their effects on extracellular acetylcholine concn. and acetylcholinesterase activity in the rat cortex.  After i.p. injection, huperzine A (0.25-0.75 μmol/kg), donepezil (2-6 μmol/kg) and rivastigmine (0.75-1.5 μmol/kg) dose-dependently elevated the concn. of acetylcholine.  The duration of huperzine A was longest.  The time courses of cortical acetylcholinesterase inhibition with middle doses of these agents mirrored the increases of acetylcholine at the same doses.  However, acetylcholinesterase inhibition was disproportionately greater after middle dose of rivastigmine than doses of huperzine A and donepezil that increased acetylcholine to a similar extent.  Muscle fasciculation appeared only after donepezil with a dose-dependent incidence and intensity.  In molar terms, huperzine A was 8- and 2-fold more potent than donepezil and rivastigmine, resp., in increasing cortical acetylcholine levels, with a longer-lasting effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppQcZlJGco6LVg90H21EOLACvtfcHk0lh6XuiZBI2C8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVGlsbc%253D&md5=41c8d07b5ed76d944940b9942726c863</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2003.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2003.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%2BQ.%26aulast%3DTang%26aufirst%3DX.%2BC.%26atitle%3DComparative%2520effects%2520of%2520huperzine%2520A%252C%2520donepezil%2520and%2520rivastigmine%2520on%2520cortical%2520acetylcholine%2520level%2520and%2520acetylcholinesterase%2520activity%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D361%26spage%3D56%26epage%3D59%26doi%3D10.1016%2Fj.neulet.2003.12.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. C.</span></span> <span> </span><span class="NLM_article-title">Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/S0091-3057(97)00601-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2FS0091-3057%2897%2900601-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=9632220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADyaK1cXjsV2hsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1998&pages=377-386&author=D.+H.+Chengauthor=X.+C.+Tang&title=Comparative+studies+of+huperzine+A%2C+E2020%2C+and+tacrine+on+behavior+and+cholinesterase+activities&doi=10.1016%2FS0091-3057%2897%2900601-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities</span></div><div class="casAuthors">Cheng, Dong Hang; Tang, Xi Can</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">377-386</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Comparative effects of cholinesterase inhibitors (ChEI) huperzine A with E2020 and tacrine on the radial maze performance in ethylcholine mustard aziridinium ion (AF64A)-treated rat and inhibition of cholinesterase activity were studied.  The intracerebroventricular (ICV) injection of AF64A (3 nmol/side) caused significant impairment in the rat's ability to fulfill the partially baited maze paradigm.  Oral huperzine A (0.5-0.8 mg/kg), E2020 (1.0-2.0 mg/kg), and tacrine (8.0 mg/kg) effectively reversed AF64A-induced working memory deficit.  The doses that improved AF64A-induced memory deficit were correlated to about 25-30% (huperzine A) and less than 10% (E2020, tacrine) inhibition of acetylcholinesterase (AChE) activity in the cortex and hippocampus.  Huperzine A, E2020 and tacrine all produced dose-dependent inhibition of brain AChE following ICV and oral administration.  Oral huperzine A exhibited higher efficacy on the inhibition of AChE in the cortex and hippocampus than those of E2020 and tacrine.  Tacrine was more effective in inhibiting plasma butyrylcholinesterase (BuChE) than it was brain AChE.  Conversely, the BuChE activity was less affected by huperzine A and E2020.  The results showed that huperzine A had high bioavailability and more selective inhibition on AChE activity in cortex and hippocampus.  Huperzine A fits more closely with the established criteria for an ideal AChE inhibitor to be used in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMPkmHCKa9ZbVg90H21EOLACvtfcHk0lh6XuiZBI2C8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsV2hsb4%253D&md5=06e1b7d10a877d98d335688cd6c7290b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2897%2900601-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252897%252900601-1%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DD.%2BH.%26aulast%3DTang%26aufirst%3DX.%2BC.%26atitle%3DComparative%2520studies%2520of%2520huperzine%2520A%252C%2520E2020%252C%2520and%2520tacrine%2520on%2520behavior%2520and%2520cholinesterase%2520activities%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1998%26volume%3D60%26spage%3D377%26epage%3D386%26doi%3D10.1016%2FS0091-3057%2897%2900601-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. C.</span></span> <span> </span><span class="NLM_article-title">Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1111/j.1745-7254.2006.00255.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1111%2Fj.1745-7254.2006.00255.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=16364207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A280%3ADC%252BD2Mnns1CisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=1-26&author=R.+Wangauthor=H.+Yanauthor=X.+C.+Tang&title=Progress+in+studies+of+huperzine+A%2C+a+natural+cholinesterase+inhibitor+from+Chinese+herbal+medicine&doi=10.1111%2Fj.1745-7254.2006.00255.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine</span></div><div class="casAuthors">Wang Rui; Yan Han; Tang Xi-can</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-26</span>
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    </div><div class="casAbstract">Huperzine A (HupA), a novel alkaloid isolated from the Chinese herb Huperzia serrata, is a potent, highly specific and reversible inhibitor of acetylcholinesterase(AChE).  Compared with tacrine, donepezil, and rivastigmine, HupA has better penetration through the blood-brain barrier, higher oral bioavailability, and longer duration of AChE inhibitory action.  HupA has been found to improve cognitive deficits in a broad range of animal models.  HupA possesses the ability to protect cells against hydrogen peroxide, beta-amyloid protein (or peptide), glutamate, ischemia and staurosporine-induced cytotoxicity and apoptosis.  These protective effects are related to its ability to attenuate oxidative stress, regulate the expression of apoptotic proteins Bcl-2, Bax, P53, and caspase-3, protect mitochondria, upregulate nerve growth factor and its receptors, and interfere with amyloid precursor protein metabolism.  Antagonizing effects of HupA on N-methyl-D-aspartate receptors and potassium currents may also contribute to its neuroprotection as well.  Pharmacokinetic studies in rodents, canines, and healthy human volunteers indicated that HupA was absorbed rapidly, distributed widely in the body, and eliminated at a moderate rate with the property of slow and prolonged release after oral administration.  Animal and clinical safety tests showed that HupA had no unexpected toxicity, particularly the dose-limiting hepatotoxicity induced by tacrine.  The phase IV clinical trials in China have demonstrated that HupA significantly improved memory deficits in elderly people with benign senescent forgetfulness, and patients with Alzheimer disease and vascular dementia, with minimal peripheral cholinergic side effects and no unexpected toxicity.  HupA can also be used as a protective agent against organophosphate intoxication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSArR_-beAVI8RAV4D_Ins_fW6udTcc2eZaB8d7PzZ_Q7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mnns1CisA%253D%253D&md5=7ec5be1704a455963a57ee996cc8b834</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7254.2006.00255.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7254.2006.00255.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DX.%2BC.%26atitle%3DProgress%2520in%2520studies%2520of%2520huperzine%2520A%252C%2520a%2520natural%2520cholinesterase%2520inhibitor%2520from%2520Chinese%2520herbal%2520medicine%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2006%26volume%3D27%26spage%3D1%26epage%3D26%26doi%3D10.1111%2Fj.1745-7254.2006.00255.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">11340</span>– <span class="NLM_lpage">11349</span>, <span class="refDoi"> DOI: 10.1021/ja029775t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja029775t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVelsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=11340-11349&author=Y.+Xuauthor=J.+Shenauthor=X.+Luoauthor=I.+Silmanauthor=J.+L.+Sussmanauthor=K.+Chenauthor=H.+Jiang&title=How+does+huperzine+A+enter+and+leave+the+binding+gorge+of+acetylcholinesterase%3F+Steered+molecular+dynamics+simulations&doi=10.1021%2Fja029775t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">How Does Huperzine A Enter and Leave the Binding Gorge of Acetylcholinesterase? Steered Molecular Dynamics Simulations</span></div><div class="casAuthors">Xu, Yechun; Shen, Jianhua; Luo, Xiaomin; Silman, Israel; Sussman, Joel L.; Chen, Kaixian; Jiang, Hualiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">11340-11349</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The entering and leaving processes of Huperzine A (HupA) binding with the long active-site gorge of Torpedo californica acetylcholinesterase (TcAChE) have been investigated by using steered mol. dynamics simulations.  The anal. of the force required along the pathway shows that it is easier for HupA to bind to the active site of AChE than to disassoc. from it, which for the first time interprets at the at. level the previous exptl. that unbinding process of HupA is much slower than its binding process to AChE.  The direct hydrogen bonds, water bridges, and hydrophobic interactions were analyzed during two steered mol. dynamics (SMD) simulations.  Break of the direct hydrogen bond needs a great pulling force.  The steric hindrance of bottleneck might be the most important factor to produce the maximal rupture force for HupA to leave the binding site but it has a little effect on the binding process of HupA with AChE.  Residue Asp-72 forms a lot of water bridges with HupA leaving and entering the AChE binding gorge, acting as a clamp to take out HupA from or put HupA into the active site.  The flip of the peptide bond between Gly-117 and Gly-118 has been detected during both the conventional MD and SMD simulations.  The simulation results indicate that this flip phenomenon could be an intrinsic property of AChE and the Gly-117-Gly-118 peptide bond in both HupA bound and unbound AChE structures tends to adopt the native enzyme structure.  At last, in a vacuum the rupture force is increased up to 1500 pN while in water soln. the greatest rupture force is about 800 pN, which means water mols. in the binding gorge act as lubricant to facilitate HupA entering or leaving the binding gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdzCXUuW4K1rVg90H21EOLACvtfcHk0lj0gyVbzVUf2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVelsr4%253D&md5=57f264c29a11a1ac96e1599107b85196</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja029775t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja029775t%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DHow%2520does%2520huperzine%2520A%2520enter%2520and%2520leave%2520the%2520binding%2520gorge%2520of%2520acetylcholinesterase%253F%2520Steered%2520molecular%2520dynamics%2520simulations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2003%26volume%3D125%26spage%3D11340%26epage%3D11349%26doi%3D10.1021%2Fja029775t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onuchic, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Free energy landscape for the binding process of Huperzine A to acetylcholinesterase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">4273</span>– <span class="NLM_lpage">4278</span>, <span class="refDoi"> DOI: 10.1073/pnas.1301814110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1073%2Fpnas.1301814110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=23440190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtV2rurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=4273-4278&author=F.+Baiauthor=Y.+Xuauthor=J.+Chenauthor=Q.+Liuauthor=J.+Guauthor=X.+Wangauthor=J.+Maauthor=H.+Liauthor=J.+N.+Onuchicauthor=H.+Jiang&title=Free+energy+landscape+for+the+binding+process+of+Huperzine+A+to+acetylcholinesterase&doi=10.1073%2Fpnas.1301814110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Free energy landscape for the binding process of Huperzine A to acetylcholinesterase</span></div><div class="casAuthors">Bai, Fang; Xu, Yechun; Chen, Jing; Liu, Qiufeng; Gu, Junfeng; Wang, Xicheng; Ma, Jianpeng; Li, Honglin; Onuchic, Jose N.; Jiang, Hualiang</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4273-4278, S4273/1-S4273/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Drug-target residence time (t = 1/koff, where koff is the dissocn. rate const.) has become an important index in discovering better- or best-in-class drugs.  However, little effort has been dedicated to developing computational methods that can accurately predict this kinetic parameter or related parameters, koff and activation free energy of dissocn. (ΔG≠off).  In this paper, energy landscape theory that has been developed to understand protein folding and function is extended to develop a generally applicable computational framework that is able to construct a complete ligand-target binding free energy landscape.  This enables both the binding affinity and the binding kinetics to be accurately estd.  We applied this method to simulate the binding event of the anti-Alzheimer's disease drug (-)-Huperzine A to its target acetylcholinesterase (AChE).  The computational results are in excellent agreement with our concurrent exptl. measurements.  All of the predicted values of binding free energy and activation free energies of assocn. and dissocn. deviate from the exptl. data only by less than 1 kcal/mol.  The method also provides at. resoln. information for the (-)-Huperzine A binding pathway, which may be useful in designing more potent AChE inhibitors.  We expect this methodol. to be widely applicable to drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS-lQ4SQEumbVg90H21EOLACvtfcHk0lj0gyVbzVUf2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtV2rurY%253D&md5=c87435f191ab4c89672b5ca43cb881fc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1301814110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1301814110%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DOnuchic%26aufirst%3DJ.%2BN.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DFree%2520energy%2520landscape%2520for%2520the%2520binding%2520process%2520of%2520Huperzine%2520A%2520to%2520acetylcholinesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D4273%26epage%3D4278%26doi%3D10.1073%2Fpnas.1301814110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunwald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kronman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafferman, A.</span></span> <span> </span><span class="NLM_article-title">Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=8145739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1994&pages=555-560&author=Y.+Ashaniauthor=J.+Grunwaldauthor=C.+Kronmanauthor=B.+Velanauthor=A.+Shafferman&title=Role+of+tyrosine+337+in+the+binding+of+huperzine+A+to+the+active+site+of+human+acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase</span></div><div class="casAuthors">Ashani, Yacov; Grunwald, Jacob; Kronman, Chanoch; Velan, Baruch; Shafferman, Avigdor</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">555-60</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Hyperzine A (HUP), a natural, potent, 'slow,' reversible inhibitor of antiacetylcholinesterase (AChE), has been suggested to be superior to antiacetylcholinesterase drugs now being used for management of Alzheimer's disease.  To delineate the binding site of human AChE (HuAChE) for HUP, the biochem. consts. kon, Koff, and Ki were detd. for complexes formed between HUP and single-site (YSS7F, Y337A, F295A, W296A, and E202Q) or double-site (Y337F, Y337A, F295A, W286A, and E202Q) or double-site (F295L/F297V) mutants of recombinant HuAChE (rHuAChE).  The kinetic and dissocn. consts. were compared with those obtained for wild-type rHuAChE and AChE from Torpedo californica.  Results demonstrate that the inhibition of AChE by HUP occurs through assocn. with residues located inside the active site 'gorge,' rather than at the rim of the gorge.  Tyrosine at position 337 (Y337) is essential for inhibition of rHuAChE by HUP (Ki = 26 nM).  An arom. array constituted from residues Y337, F295, and probably W86 is likely to offer a multicontact subsite that interacts with the ammonium group and with both the exo- and endocyclic double bond moieties of HUP.  Lack of the arom. side chain in the position homologous to Y337 explains the poor inhibitory potency of HUP toward human butyrylcholinesterase (Ki >20,000 nM).  Replacement of the carboxylate-contg. E202 by glutamine had only marginal effect on the stability of the complex formed between HUP and rHuAChE.  The pH-rate profiles suggest that destabilization of the complex after proton gain cannot be attributed solely to protonation of E202.  These findings are expected to establish HUP as a lead compd. for the design of new anti-AChE drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodxB5b9y9nNLVg90H21EOLACvtfcHk0lg7Y_zgYap9Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKitrg%253D&md5=612bea38b1c55bcbd771effbab4950cf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshani%26aufirst%3DY.%26aulast%3DGrunwald%26aufirst%3DJ.%26aulast%3DKronman%26aufirst%3DC.%26aulast%3DVelan%26aufirst%3DB.%26aulast%3DShafferman%26aufirst%3DA.%26atitle%3DRole%2520of%2520tyrosine%2520337%2520in%2520the%2520binding%2520of%2520huperzine%2520A%2520to%2520the%2520active%2520site%2520of%2520human%2520acetylcholinesterase%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D45%26spage%3D555%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peggins, J. O.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doctor, B. P.</span></span> <span> </span><span class="NLM_article-title">Mechanism of inhibition of cholinesterases by huperzine A</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(92)90649-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2F0006-291X%2892%2990649-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1575745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADyaK38XktVSkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=1992&pages=719-726&author=Y.+Ashaniauthor=J.+O.+Pegginsauthor=B.+P.+Doctor&title=Mechanism+of+inhibition+of+cholinesterases+by+huperzine+A&doi=10.1016%2F0006-291X%2892%2990649-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of inhibition of cholinesterases by huperzine A</span></div><div class="casAuthors">Ashani, Yacov; Peggins, James O., III; Doctor, Bhupendra P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">719-26</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Huperzine A, an alkaloid isolated from Huperzia serrata was found to reversibly inhibit acetylcholinesterases (EC 3.1.1.7) and butyrylcholinesterases (EC 3.1.1.8) with on- and off-rates that depend on both the type and the source of enzyme.  Long-term incubation of high concns. of purified cholinesterases (1-8 μM) with huperzine A did not show any chem. modification of huperzine A.  A low dissocn. const. KI was obtained for mammalian acetylcholinesterase-huperzine (20-40 nM) compared to mammalian butyrylcholinesterase-huperzine (20-40 μM).  This indicates that the thermodn. stability of huperzine-cholinesterase complex may depend on the no. and type of arom. amino acid residues in the catalytic pocket region of the cholinesterase mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkey_zqa7K27Vg90H21EOLACvtfcHk0lg7Y_zgYap9Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XktVSkt78%253D&md5=d3f89189d5189d115139d960e487bb77</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2892%2990649-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252892%252990649-6%26sid%3Dliteratum%253Aachs%26aulast%3DAshani%26aufirst%3DY.%26aulast%3DPeggins%26aufirst%3DJ.%2BO.%26aulast%3DDoctor%26aufirst%3DB.%2BP.%26atitle%3DMechanism%2520of%2520inhibition%2520of%2520cholinesterases%2520by%2520huperzine%2520A%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D184%26spage%3D719%26epage%3D726%26doi%3D10.1016%2F0006-291X%2892%2990649-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, L.</span></span> <span> </span><span class="NLM_article-title">Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1039/C6MD00581K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1039%2FC6MD00581K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=30108770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsleitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=534-550&author=M.+Bernettiauthor=A.+Cavalliauthor=L.+Mollica&title=Protein-ligand+%28un%29binding+kinetics+as+a+new+paradigm+for+drug+discovery+at+the+crossroad+between+experiments+and+modelling&doi=10.1039%2FC6MD00581K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling</span></div><div class="casAuthors">Bernetti, M.; Cavalli, A.; Mollica, L.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">534-550</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In the last three decades, protein and nucleic acid structure detn. and comprehension of the mechanisms, leading to their physiol. and pathol. functions, have become a cornerstone of biomedical sciences.  A deep understanding of the principles governing the fates of cells and tissue at the mol. level has been gained over the years, offering a solid basis for the rational design of drugs aimed at the pharmacol. treatment of numerous diseases.  Historically, affinity indicators (i.e. Kd and IC50/EC50) have been assumed to be valid indicators of the in vivo efficacy of a drug.  However, recent studies pointed out that the kinetics of the drug-receptor binding process could be as important or even more important than affinity in detg. the drug efficacy.  This eventually led to a growing interest in the characterization and prediction of the rate consts. of protein-ligand assocn. and dissocn.  For instance, a drug with a longer residence time can kinetically select a given receptor over another, even if the affinity for both receptors is comparable, thus increasing its therapeutic index.  Therefore, understanding the mol. features underlying binding and unbinding processes is of central interest towards the rational control of drug binding kinetics.  In this review, we report the theor. framework behind protein-ligand assocn. and highlight the latest advances in the exptl. and computational approaches exploited to investigate the binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrO85mDP2s17Vg90H21EOLACvtfcHk0lg7Y_zgYap9Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsleitbw%253D&md5=8538a9e13d7e1d2c873da236be95a811</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2FC6MD00581K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00581K%26sid%3Dliteratum%253Aachs%26aulast%3DBernetti%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DMollica%26aufirst%3DL.%26atitle%3DProtein-ligand%2520%2528un%2529binding%2520kinetics%2520as%2520a%2520new%2520paradigm%2520for%2520drug%2520discovery%2520at%2520the%2520crossroad%2520between%2520experiments%2520and%2520modelling%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D534%26epage%3D550%26doi%3D10.1039%2FC6MD00581K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pan, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borhani, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span> <span> </span><span class="NLM_article-title">Molecular determinants of drug-receptor binding kinetics</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">673</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.drudis.2013.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=23454741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVyrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=667-673&author=A.+C.+Panauthor=D.+W.+Borhaniauthor=R.+O.+Drorauthor=D.+E.+Shaw&title=Molecular+determinants+of+drug-receptor+binding+kinetics&doi=10.1016%2Fj.drudis.2013.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of drug-receptor binding kinetics</span></div><div class="casAuthors">Pan, Albert C.; Borhani, David W.; Dror, Ron O.; Shaw, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13-14</span>),
    <span class="NLM_cas:pages">667-673</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It is increasingly appreciated that the rates at which drugs assoc. with and dissoc. from receptors - the binding kinetics - directly impact drug efficacy and safety.  The mol. determinants of drug-receptor binding kinetics remain poorly understood, however, esp. when compared with the well-known factors that affect binding affinity.  The rational modulation of kinetics during lead optimization thus remains challenging.  We review some of the key factors thought to control drug-receptor binding kinetics at the mol. level - mol. size, conformational fluctuations, electrostatic interactions and hydrophobic effects - and discuss several possible approaches for the rational design of drugs with desired binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAvEt3tx06Z7Vg90H21EOLACvtfcHk0lg8ppmk-VaC-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVyrtr0%253D&md5=df094bb86b1e280b9ddf5a90031b3f32</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DA.%2BC.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26atitle%3DMolecular%2520determinants%2520of%2520drug-receptor%2520binding%2520kinetics%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2013%26volume%3D18%26spage%3D667%26epage%3D673%26doi%3D10.1016%2Fj.drudis.2013.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonge, P. J.</span></span> <span> </span><span class="NLM_article-title">Drug-target residence time: critical information for lead optimization</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2010.06.176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.cbpa.2010.06.176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=20663707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=467-474&author=H.+Luauthor=P.+J.+Tonge&title=Drug-target+residence+time%3A+critical+information+for+lead+optimization&doi=10.1016%2Fj.cbpa.2010.06.176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time: Critical information for lead optimization</span></div><div class="casAuthors">Lu, Hao; Tonge, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-474</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Failure due to poor in vivo efficacy is a primary contributor to attrition during the development of new chemotherapeutics.  Lead optimization programs that in their quest for efficacy focus solely on improving the affinity of drug-target binding are flawed, since this approach ignores the fluctuations in drug concn. that occur in vivo.  Instead the lifetime of the drug-target complex must also be considered, since drugs only act when they are bound to their targets.  Consequently, to improve the correlation between the in vitro and in vivo activity of drugs, measurements of drug-target residence time must be incorporated into the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodk2kN_txuMLVg90H21EOLACvtfcHk0lg8ppmk-VaC-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVyqtr4%253D&md5=3189f56032106db858cfb4269d3fc11f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.06.176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.06.176%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DH.%26aulast%3DTonge%26aufirst%3DP.%2BJ.%26atitle%3DDrug-target%2520residence%2520time%253A%2520critical%2520information%2520for%2520lead%2520optimization%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D467%26epage%3D474%26doi%3D10.1016%2Fj.cbpa.2010.06.176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pompliano, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span> <span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1038/nrd2082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization&doi=10.1038%2Fnrd2082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lg8ppmk-VaC-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739%26doi%3D10.1038%2Fnrd2082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X. C.</span></span> <span> </span><span class="NLM_article-title">Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2003.12.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.neulet.2003.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=15135892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjvVGlsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2004&pages=56-59&author=Y.+Q.+Liangauthor=X.+C.+Tang&title=Comparative+effects+of+huperzine+A%2C+donepezil+and+rivastigmine+on+cortical+acetylcholine+level+and+acetylcholinesterase+activity+in+rats&doi=10.1016%2Fj.neulet.2003.12.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats</span></div><div class="casAuthors">Liang, Yan Qi; Tang, Xi Can</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">56-59</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The cholinesterase inhibitors huperzine A, donepezil and rivastigmine were compared for their effects on extracellular acetylcholine concn. and acetylcholinesterase activity in the rat cortex.  After i.p. injection, huperzine A (0.25-0.75 μmol/kg), donepezil (2-6 μmol/kg) and rivastigmine (0.75-1.5 μmol/kg) dose-dependently elevated the concn. of acetylcholine.  The duration of huperzine A was longest.  The time courses of cortical acetylcholinesterase inhibition with middle doses of these agents mirrored the increases of acetylcholine at the same doses.  However, acetylcholinesterase inhibition was disproportionately greater after middle dose of rivastigmine than doses of huperzine A and donepezil that increased acetylcholine to a similar extent.  Muscle fasciculation appeared only after donepezil with a dose-dependent incidence and intensity.  In molar terms, huperzine A was 8- and 2-fold more potent than donepezil and rivastigmine, resp., in increasing cortical acetylcholine levels, with a longer-lasting effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppQcZlJGco6LVg90H21EOLACvtfcHk0lh-TTNu5lN78w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjvVGlsbc%253D&md5=41c8d07b5ed76d944940b9942726c863</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2003.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2003.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DY.%2BQ.%26aulast%3DTang%26aufirst%3DX.%2BC.%26atitle%3DComparative%2520effects%2520of%2520huperzine%2520A%252C%2520donepezil%2520and%2520rivastigmine%2520on%2520cortical%2520acetylcholine%2520level%2520and%2520acetylcholinesterase%2520activity%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D361%26spage%3D56%26epage%3D59%26doi%3D10.1016%2Fj.neulet.2003.12.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi-Can, T.</span></span> <span> </span><span class="NLM_article-title">Anticholinesterase effects of huperzine A, E2020, and tacrine in rats</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=27-30&author=W.+Hongauthor=T.+Xi-Can&title=Anticholinesterase+effects+of+huperzine+A%2C+E2020%2C+and+tacrine+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DW.%26aulast%3DXi-Can%26aufirst%3DT.%26atitle%3DAnticholinesterase%2520effects%2520of%2520huperzine%2520A%252C%2520E2020%252C%2520and%2520tacrine%2520in%2520rats%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2016%26volume%3D19%26spage%3D27%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acena, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloshonok, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II-III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">518</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00392</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=422-518&author=Y.+Zhouauthor=J.+Wangauthor=Z.+Guauthor=S.+Wangauthor=W.+Zhuauthor=J.+L.+Acenaauthor=V.+A.+Soloshonokauthor=K.+Izawaauthor=H.+Liu&title=Next+generation+of+fluorine-containing+pharmaceuticals%2C+compounds+currently+in+phase+II-III+clinical+trials+of+major+pharmaceutical+companies%3A+new+structural+trends+and+therapeutic+areas&doi=10.1021%2Facs.chemrev.5b00392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas</span></div><div class="casAuthors">Zhou, Yu; Wang, Jiang; Gu, Zhanni; Wang, Shuni; Zhu, Wei; Acena, Jose Luis; Soloshonok, Vadim A.; Izawa, Kunisuke; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-518</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  We focus herein on a new collection of 51 fluorine-contg. mols. that either were approved after 2011 by the corresponding agencies or still are on clin. development.  These compds. cover a large no. of therapeutic areas and, on this occasion, we decided to classify them according to the no. of fluorine atoms or fluorinated moieties.  In each case, the structures and modes of action of these new drugs are revised, with a particular focus on the role of fluorine in the biol. and pharmaceutical properties, when appropriate.  Finally, representative synthetic routes are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh-rq_ZyY_jrVg90H21EOLACvtfcHk0lh-TTNu5lN78w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGms7o%253D&md5=e3d07d070fcf5b69a54f70bdba99acd4</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DAcena%26aufirst%3DJ.%2BL.%26aulast%3DSoloshonok%26aufirst%3DV.%2BA.%26aulast%3DIzawa%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DNext%2520generation%2520of%2520fluorine-containing%2520pharmaceuticals%252C%2520compounds%2520currently%2520in%2520phase%2520II-III%2520clinical%2520trials%2520of%2520major%2520pharmaceutical%2520companies%253A%2520new%2520structural%2520trends%2520and%2520therapeutic%2520areas%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D422%26epage%3D518%26doi%3D10.1021%2Facs.chemrev.5b00392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, K. L.</span></span> <span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry: recent therapeutic applications of fluorinated small molecules</span>. <i>J. Fluorine Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1029</span>, <span class="refDoi"> DOI: 10.1016/j.jfluchem.2006.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.jfluchem.2006.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVSrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=1013-1029&author=K.+L.+Kirk&title=Fluorine+in+medicinal+chemistry%3A+recent+therapeutic+applications+of+fluorinated+small+molecules&doi=10.1016%2Fj.jfluchem.2006.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules</span></div><div class="casAuthors">Kirk, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1013-1029</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Advances in the development of newly developed fluorinated drugs, approved or in clin. trials, as organized by biol. targets/disease states, are reviewed.  In a few cases, compds. in early stages of development will be discussed, particularly where new promising targets are involved.  Important topics such as anticancer and antiviral drugs were covered in the two previous reviews in this series.  Included herein will be fluorinated drugs for treatment of diseases of the central nervous system, various cardiovascular diseases and obesity, antibacterial agents, and antifungal therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd1vhHrZgNN7Vg90H21EOLACvtfcHk0lh-TTNu5lN78w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVSrtb8%253D&md5=890de242b8c5804fec1a9a7d35471ac1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2006.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2006.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DK.%2BL.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%253A%2520recent%2520therapeutic%2520applications%2520of%2520fluorinated%2520small%2520molecules%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2006%26volume%3D127%26spage%3D1013%26epage%3D1029%26doi%3D10.1016%2Fj.jfluchem.2006.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohm, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obst-Sander, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1002/cbic.200301023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1002%2Fcbic.200301023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=15122635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=637-643&author=H.+J.+Bohmauthor=D.+Bannerauthor=S.+Bendelsauthor=M.+Kansyauthor=B.+Kuhnauthor=K.+Mullerauthor=U.+Obst-Sanderauthor=M.+Stahl&title=Fluorine+in+medicinal+chemistry&doi=10.1002%2Fcbic.200301023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Bohm Hans-Joachim; Banner David; Bendels Stefanie; Kansy Manfred; Kuhn Bernd; Muller Klaus; Obst-Sander Ulrike; Stahl Martin</div><div class="citationInfo"><span class="NLM_cas:title">Chembiochem : a European journal of chemical biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-43</span>
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    </div><div class="casAbstract">Fluorinated compounds are synthesized in pharmaceutical research on a routine basis and many marketed compounds contain fluorine.  The present review summarizes some of the most frequently employed strategies for using fluorine substituents in medicinal chemistry.  Quite often, fluorine is introduced to improve the metabolic stability by blocking metabolically labile sites.  However, fluorine can also be used to modulate the physicochemical properties, such as lipophilicity or basicity.  It may exert a substantial effect on the conformation of a molecule.  Increasingly, fluorine is used to enhance the binding affinity to the target protein.  Recent 3D-structure determinations of protein complexes with bound fluorinated ligands have led to an improved understanding of the nonbonding protein-ligand interactions that involve fluorine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4zDG_wo1YGtts4TFFB11gfW6udTcc2eby2SohMMMARrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3it1egug%253D%253D&md5=fa5ca2cfc278b83c80d5c96b18dfe312</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200301023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200301023%26sid%3Dliteratum%253Aachs%26aulast%3DBohm%26aufirst%3DH.%2BJ.%26aulast%3DBanner%26aufirst%3DD.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26spage%3D637%26epage%3D643%26doi%3D10.1002%2Fcbic.200301023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagmann, W. K.</span></span> <span> </span><span class="NLM_article-title">The many roles for fluorine in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4359</span>– <span class="NLM_lpage">4369</span>, <span class="refDoi"> DOI: 10.1021/jm800219f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800219f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4359-4369&author=W.+K.+Hagmann&title=The+many+roles+for+fluorine+in+medicinal+chemistry&doi=10.1021%2Fjm800219f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Roles for Fluorine in Medicinal Chemistry</span></div><div class="casAuthors">Hagmann, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4359-4369</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkZV7sio8RhbVg90H21EOLACvtfcHk0lg5rlDG7X4vBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1WjtLo%253D&md5=821f8076bb0f632f687b1c90b05dd382</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm800219f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800219f%26sid%3Dliteratum%253Aachs%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26atitle%3DThe%2520many%2520roles%2520for%2520fluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4359%26epage%3D4369%26doi%3D10.1021%2Fjm800219f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Purser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouverneur, V.</span></span> <span> </span><span class="NLM_article-title">Fluorine in medicinal chemistry</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1039/B610213C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1039%2FB610213C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=18197348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=320-330&author=S.+Purserauthor=P.+R.+Mooreauthor=S.+Swallowauthor=V.+Gouverneur&title=Fluorine+in+medicinal+chemistry&doi=10.1039%2FB610213C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in medicinal chemistry</span></div><div class="casAuthors">Purser, Sophie; Moore, Peter R.; Swallow, Steve; Gouverneur, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">320-330</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  It has become evident that fluorinated compds. have a remarkable record in medicinal chem. and will play a continuing role in providing lead compds. for therapeutic applications.  This tutorial review provides a sampling of renowned fluorinated drugs and their mode of action with a discussion clarifying the role and impact of fluorine substitution on drug potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKAqJ3UbgGbVg90H21EOLACvtfcHk0lg5rlDG7X4vBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVGgsw%253D%253D&md5=e6c9e3084e454c44a4ba245b98f7f1d7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FB610213C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB610213C%26sid%3Dliteratum%253Aachs%26aulast%3DPurser%26aufirst%3DS.%26aulast%3DMoore%26aufirst%3DP.%2BR.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGouverneur%26aufirst%3DV.%26atitle%3DFluorine%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2008%26volume%3D37%26spage%3D320%26epage%3D330%26doi%3D10.1039%2FB610213C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Roselló, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aceña, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Pozo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorochinsky, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fustero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloshonok, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011)</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">2432</span>– <span class="NLM_lpage">2506</span>, <span class="refDoi"> DOI: 10.1021/cr4002879</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr4002879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2432-2506&author=J.+Wangauthor=M.+S%C3%A1nchez-Rosell%C3%B3author=J.+L.+Ace%C3%B1aauthor=C.+del+Pozoauthor=A.+E.+Sorochinskyauthor=S.+Fusteroauthor=V.+A.+Soloshonokauthor=H.+Liu&title=Fluorine+in+pharmaceutical+industry%3A+fluorine-containing+drugs+introduced+to+the+market+in+the+last+decade+%282001%E2%80%932011%29&doi=10.1021%2Fcr4002879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001-2011)</span></div><div class="casAuthors">Wang, Jiang; Sanchez-Rosello, Maria; Acena, Jose Luis; del Pozo, Carlos; Sorochinsky, Alexander E.; Fustero, Santos; Soloshonok, Vadim A.; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2432-2506</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A historic review.  As expected from the fluorine position on the periodic table of elements, it possesses some extreme properties, in particular, ultimate electronegativity and oxidn. potential.  Therefore,elemental fluorine can not be prepd. by chem. reaction, and its isolation in 1886 by Henri Moissan required scientific ingenuity and great personal courage.  His historic effort earned him a Noble Prize (1906), and the developed electrolysis method is still in use for industrial prodn. of fluorine gas.  However, further development of fluorine chem. was extremely sluggish, pursued by a handful of experts capable of handling the violent gas using specially designed lab. equipment.  Industrial-scale prodn. of fluorochems. dates back to late 1930s.  Currently, there are about 200 pharmaceuticals containingfluorine, including the 40 new compds. discussed in this review.  One may agree that the contribution of the past decade indicates a significant 20% increase in the no. of fluorinated drugs on the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQTzcNC3MEA7Vg90H21EOLACvtfcHk0ljC5SIvRUdKgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegsb7I&md5=07faac419cd090503e82c6f00d05c338</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr4002879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr4002879%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DS%25C3%25A1nchez-Rosell%25C3%25B3%26aufirst%3DM.%26aulast%3DAce%25C3%25B1a%26aufirst%3DJ.%2BL.%26aulast%3Ddel%2BPozo%26aufirst%3DC.%26aulast%3DSorochinsky%26aufirst%3DA.%2BE.%26aulast%3DFustero%26aufirst%3DS.%26aulast%3DSoloshonok%26aufirst%3DV.%2BA.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DFluorine%2520in%2520pharmaceutical%2520industry%253A%2520fluorine-containing%2520drugs%2520introduced%2520to%2520the%2520market%2520in%2520the%2520last%2520decade%2520%25282001%25E2%2580%25932011%2529%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2432%26epage%3D2506%26doi%3D10.1021%2Fcr4002879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burshteyn, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Height, J. J.</span></span> <span> </span><span class="NLM_article-title">Structures of human acetylcholinesterase in complex with pharmacologically important ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10282</span>– <span class="NLM_lpage">10286</span>, <span class="refDoi"> DOI: 10.1021/jm300871x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300871x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10282-10286&author=J.+Cheungauthor=M.+J.+Rudolphauthor=F.+Burshteynauthor=M.+S.+Cassidyauthor=E.+N.+Garyauthor=J.+Loveauthor=M.+C.+Franklinauthor=J.+J.+Height&title=Structures+of+human+acetylcholinesterase+in+complex+with+pharmacologically+important+ligands&doi=10.1021%2Fjm300871x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands</span></div><div class="casAuthors">Cheung, Jonah; Rudolph, Michael J.; Burshteyn, Fiana; Cassidy, Michael S.; Gary, Ebony N.; Love, James; Franklin, Matthew C.; Height, Jude J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10282-10286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human acetylcholinesterase (AChE) is a significant target for therapeutic drugs.  Here we present high resoln. crystal structures of human AChE, alone and in complexes with drug ligands; donepezil, an Alzheimer's disease drug, binds differently to human AChE than it does to Torpedo AChE.  These crystals of human AChE provide a more accurate platform for further drug development than previously available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdjhYPmZBMf7Vg90H21EOLACvtfcHk0ljC5SIvRUdKgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGqtLnN&md5=c27461e0288f42ac96af354cbefd387e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm300871x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300871x%26sid%3Dliteratum%253Aachs%26aulast%3DCheung%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DM.%2BJ.%26aulast%3DBurshteyn%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DM.%2BS.%26aulast%3DGary%26aufirst%3DE.%2BN.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DHeight%26aufirst%3DJ.%2BJ.%26atitle%3DStructures%2520of%2520human%2520acetylcholinesterase%2520in%2520complex%2520with%2520pharmacologically%2520important%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10282%26epage%3D10286%26doi%3D10.1021%2Fjm300871x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dvir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase: from 3D structure to function</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2010.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.cbi.2010.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=20138030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=10-22&author=H.+Dvirauthor=I.+Silmanauthor=M.+Harelauthor=T.+L.+Rosenberryauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+from+3D+structure+to+function&doi=10.1016%2Fj.cbi.2010.01.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase: From 3D structure to function</span></div><div class="casAuthors">Dvir, Hay; Silman, Israel; Harel, Michal; Rosenberry, Terrone L.; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">10-22</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  By rapid hydrolysis of the neurotransmitter, acetylcholine, acetylcholinesterase (AChE) terminates neurotransmission at cholinergic synapses.  AChE is a very fast enzyme, functioning at a rate approaching that of a diffusion-controlled reaction.  The powerful toxicity of organophosphate poisons is attributed primarily to their potent inhibition of AChE.  AChE inhibitors are utilized in the treatment of various neurol. disorders, and are the principal drugs approved thus far by the FDA for management of Alzheimer's disease.  Many organophosphates and carbamates serve as potent insecticides, by selectively inhibiting insect AChE.  The detn. of the crystal structure of Torpedo californica AChE permitted visualization, for the 1st time, at at. resoln., of a binding pocket for acetylcholine.  It also allowed identification of the active site of AChE, which, unexpectedly, is located at the bottom of a deep gorge lined largely by arom. residues.  The crystal structure of recombinant human AChE in its apo-state is similar in its overall features to that of the Torpedo enzyme; however, the unique crystal packing reveals a novel peptide sequence which blocks access to the active site gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnLqJTiC2TYrVg90H21EOLACvtfcHk0lhYgYxVjKVgbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D&md5=9a6121388b34b77af442d1f039ba9a9c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520from%25203D%2520structure%2520to%2520function%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2010%26volume%3D187%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.cbi.2010.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nambu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran-Dube, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalaie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goetz, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grodsky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1 -yl)ethanol (PF-04217903) for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8091</span>– <span class="NLM_lpage">8109</span>, <span class="refDoi"> DOI: 10.1021/jm300967g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300967g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8091-8109&author=J.+J.+Cuiauthor=M.+McTigueauthor=M.+Nambuauthor=M.+Tran-Dubeauthor=M.+Pairishauthor=H.+Shenauthor=L.+Jiaauthor=H.+Chengauthor=J.+Hoffmanauthor=P.+Leauthor=M.+Jalaieauthor=G.+H.+Goetzauthor=K.+Ryanauthor=N.+Grodskyauthor=Y.+L.+Dengauthor=M.+Parkerauthor=S.+Timofeevskiauthor=B.+W.+Murrayauthor=S.+Yamazakiauthor=S.+Aguirreauthor=Q.+Liauthor=H.+Zouauthor=J.+Christensen&title=Discovery+of+a+novel+class+of+exquisitely+selective+mesenchymal-epithelial+transition+factor+%28c-MET%29+protein+kinase+inhibitors+and+identification+of+the+clinical+candidate+2-%284-%281-%28quinolin-6-ylmethyl%29-1H-%5B1%2C2%2C3%5Dtriazolo%5B4%2C5-b%5Dpyrazin-6-yl%29-1H-pyrazol-1+-yl%29ethanol+%28PF-04217903%29+for+the+treatment+of+cancer&doi=10.1021%2Fjm300967g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer</span></div><div class="casAuthors">Cui, J. Jean; McTigue, Michele; Nambu, Mitchell; Tran-Dube, Michelle; Pairish, Mason; Shen, Hong; Jia, Lei; Cheng, Hengmiao; Hoffman, Jacqui; Le, Phuong; Jalaie, Mehran; Goetz, Gilles H.; Koenig, Marcel; Vojkovsky, Tomas; Zhang, Fang-Jie; Do, Steven; Botrous, Iriny; Ryan, Kevin; Grodsky, Neil; Deng, Ya-li; Parker, Max; Timofeevski, Sergei; Murray, Brion W.; Yamazaki, Shinji; Aguirre, Shirley; Li, Qiuhua; Zou, Helen; Christensen, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8091-8109</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The c-MET receptor tyrosine kinase is an attractive oncol. target because of its crit. role in human oncogenesis and tumor progression.  An oxindole hydrazide hit 6 (VI) was identified during a c-MET HTS campaign and subsequently demonstrated to have an unusual degree of selectivity against a broad array of other kinases.  The cocrystal structure of the related oxindole hydrazide c-MET inhibitor 10 (X) with a nonphosphorylated c-MET kinase domain revealed a unique binding mode assocd. with the exquisite selectivity profile.  The chem. labile oxindole hydrazide scaffold was replaced with a chem. and metabolically stable triazolopyrazine scaffold using structure based drug design.  Medicinal chem. lead optimization produced 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (2, II, PF-04217903), an extremely potent and exquisitely selective c-MET inhibitor.  2 Demonstrated effective tumor growth inhibition in c-MET dependent tumor models with good oral PK properties and an acceptable safety profile in preclin. studies.  2 Progressed to clin. evaluation in a Phase I oncol. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9sgnBFaSHLbVg90H21EOLACvtfcHk0lhYgYxVjKVgbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KjsrrL&md5=3c3ecda1c9698f2f16f9ff7c95596105</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300967g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300967g%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DNambu%26aufirst%3DM.%26aulast%3DTran-Dube%26aufirst%3DM.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DJalaie%26aufirst%3DM.%26aulast%3DGoetz%26aufirst%3DG.%2BH.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DGrodsky%26aufirst%3DN.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DParker%26aufirst%3DM.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAguirre%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520exquisitely%2520selective%2520mesenchymal-epithelial%2520transition%2520factor%2520%2528c-MET%2529%2520protein%2520kinase%2520inhibitors%2520and%2520identification%2520of%2520the%2520clinical%2520candidate%25202-%25284-%25281-%2528quinolin-6-ylmethyl%2529-1H-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-b%255Dpyrazin-6-yl%2529-1H-pyrazol-1%2520-yl%2529ethanol%2520%2528PF-04217903%2529%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8091%26epage%3D8109%26doi%3D10.1021%2Fjm300967g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridine derivatives as potent c-met inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">512</span>, <span class="refDoi"> DOI: 10.1021/ml5004876</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5004876" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFCnsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=507-512&author=C.+Liauthor=J.+Aiauthor=D.+Zhangauthor=X.+Pengauthor=X.+Chenauthor=Z.+Gaoauthor=Y.+Suauthor=W.+Zhuauthor=Y.+Jiauthor=X.+Chenauthor=M.+Gengauthor=H.+Liu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+imidazo%5B1%2C2-a%5Dpyridine+derivatives+as+potent+c-met+inhibitors&doi=10.1021%2Fml5004876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors</span></div><div class="casAuthors">Li, Chunpu; Ai, Jing; Zhang, Dengyou; Peng, Xia; Chen, Xi; Gao, Zhiwei; Su, Yi; Zhu, Wei; Ji, Yinchun; Chen, Xiaoyan; Geng, Meiyu; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-512</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of imidazo[1,2-a]pyridine derivs. against c-Met was designed by means of bioisosteric replacement.  In this study, a selective, potent c-Met inhibitor, I was identified, with IC50 values of 3.9 nM against c-Met kinase and 45.0 nM against c-Met-addicted EBC-1 cell proliferation, resp.  Compd. I inhibited c-Met phosphorylation and downstream signaling across different oncogenic forms in c-Met overactivated cancer cells and model cells.  Compd. I significantly inhibited tumor growth (TGI = 75%) with good oral bioavailability (F = 29%) and no significant hERG inhibition.  On the basis of systematic metabolic study, the pathway of all possible metabolites of I in liver microsomes of different species has been proposed, and a major NADPH-dependent metabolite was generated by liver microsomes.  To block the metabolic site, II was designed and synthesized for further evaluation.  Taken together, the imidazo[1,2-a]pyridine scaffold showed promising pharmacol. inhibition of c-Met and warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHf-imCi4cG7Vg90H21EOLACvtfcHk0lho7NCrl7uTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFCnsbc%253D&md5=61cc6abd8598ed8c9c16763fcc0967d4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml5004876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5004876%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520imidazo%255B1%252C2-a%255Dpyridine%2520derivatives%2520as%2520potent%2520c-met%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D507%26epage%3D512%26doi%3D10.1021%2Fml5004876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borkin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purohit, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyguda-Kazimierowicz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grembecka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cierpicki, T.</span></span> <span> </span><span class="NLM_article-title">Rational design of orthogonal multipolar interactions with fluorine in protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7465</span>– <span class="NLM_lpage">7474</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00975</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00975" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOju73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7465-7474&author=J.+Pollockauthor=D.+Borkinauthor=G.+Lundauthor=T.+Purohitauthor=E.+Dyguda-Kazimierowiczauthor=J.+Grembeckaauthor=T.+Cierpicki&title=Rational+design+of+orthogonal+multipolar+interactions+with+fluorine+in+protein-ligand+complexes&doi=10.1021%2Facs.jmedchem.5b00975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes</span></div><div class="casAuthors">Pollock, Jonathan; Borkin, Dmitry; Lund, George; Purohit, Trupta; Dyguda-Kazimierowicz, Edyta; Grembecka, Jolanta; Cierpicki, Tomasz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7465-7474</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multipolar interactions involving fluorine and the protein backbone have been frequently obsd. in protein-ligand complexes.  Such fluorine-backbone interactions may substantially contribute to the high affinity of small mol. inhibitors.  Here we found that introduction of trifluoromethyl groups into two different sites in the thienopyrimidine class of menin-MLL inhibitors considerably improved their inhibitory activity.  In both cases, trifluoromethyl groups are engaged in short interactions with the backbone of menin.  In order to understand the effect of fluorine, we synthesized a series of analogs by systematically changing the no. of fluorine atoms, and we detd. high-resoln. crystal structures of the complexes with menin.  We found that introduction of fluorine at favorable geometry for interactions with backbone carbonyls may improve the activity of menin-MLL inhibitors as much as 5- to 10-fold.  In order to facilitate the design of multipolar fluorine-backbone interactions in protein-ligand complexes, we developed a computational algorithm named FMAP, which calcs. fluorophilic sites in proximity to the protein backbone.  We demonstrated that FMAP could be used to rationalize improvement in the activity of known protein inhibitors upon introduction of fluorine.  Furthermore, FMAP may also represent a valuable tool for designing new fluorine substitutions and support ligand optimization in drug discovery projects.  Anal. of the menin-MLL inhibitor complexes revealed that the backbone in secondary structures is particularly accessible to the interactions with fluorine.  Considering that secondary structure elements are frequently exposed at protein interfaces, we postulate that multipolar fluorine-backbone interactions may represent a particularly attractive approach to improve inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe6g5dcLEWQLVg90H21EOLACvtfcHk0lho7NCrl7uTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOju73F&md5=56d54cdfbf8af7d68666572a57335c51</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00975%26sid%3Dliteratum%253Aachs%26aulast%3DPollock%26aufirst%3DJ.%26aulast%3DBorkin%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DPurohit%26aufirst%3DT.%26aulast%3DDyguda-Kazimierowicz%26aufirst%3DE.%26aulast%3DGrembecka%26aufirst%3DJ.%26aulast%3DCierpicki%26aufirst%3DT.%26atitle%3DRational%2520design%2520of%2520orthogonal%2520multipolar%2520interactions%2520with%2520fluorine%2520in%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7465%26epage%3D7474%26doi%3D10.1021%2Facs.jmedchem.5b00975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. P.</span></span> <span> </span><span class="NLM_article-title">Dual GSK-3beta/AChE inhibitors as a new strategy for multitargeting anti-Alzheimer’s disease drug discovery</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00463</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisF2gtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=171-176&author=X.+Y.+Jiangauthor=T.+K.+Chenauthor=J.+T.+Zhouauthor=S.+Y.+Heauthor=H.+Y.+Yangauthor=Y.+Chenauthor=W.+Quauthor=F.+Fengauthor=H.+P.+Sun&title=Dual+GSK-3beta%2FAChE+inhibitors+as+a+new+strategy+for+multitargeting+anti-Alzheimer%E2%80%99s+disease+drug+discovery&doi=10.1021%2Facsmedchemlett.7b00463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer's Disease Drug Discovery</span></div><div class="casAuthors">Jiang, Xue-Yang; Chen, Ting-Kai; Zhou, Jun-Ting; He, Si-Yu; Yang, Hong-Yu; Chen, Yao; Qu, Wei; Feng, Feng; Sun, Hao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-176</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designing multitarget-directed ligands (MTDLs) is considered to be a promising approach to address complex and multifactorial maladies such as Alzheimer's disease (AD).  The concurrent inhibition of the two crucial AD targets, glycogen synthase kinase-3β (GSK-3β) and human acetylcholinesterase (hAChE), might represent a breakthrough in the quest for clin. efficacy.  Thus, a novel family of GSK-3β/AChE dual-target inhibitors was designed and synthesized.  Among these hybrids, I showed the most promising profile as a nanomolar inhibitor on both hAChE (IC50 = 6.5 nM) and hGSK-3β kinase activity (IC50 = 66 nM).  It also showed good inhibitory effect on β-amyloid self-aggregation (inhibitory rate = 46%) at 20 μM.  Western blot anal. revealed that compd. I inhibited hyperphosphorylation of tau protein in mouse neuroblastoma N2a-Tau cells.  In vivo studies confirmed that I significantly ameliorated the cognitive disorders in scopolamine-treated ICR mice and less hepatotoxicity than tacrine.  This study provides new leads for assessment of GSK-3β and AChE pathway dual inhibition as a promising strategy for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq103h9q_6uaLVg90H21EOLACvtfcHk0lho7NCrl7uTPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisF2gtrY%253D&md5=8858bb4cbc503c79896ccbc00fb23153</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00463%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%2BY.%26aulast%3DChen%26aufirst%3DT.%2BK.%26aulast%3DZhou%26aufirst%3DJ.%2BT.%26aulast%3DHe%26aufirst%3DS.%2BY.%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DH.%2BP.%26atitle%3DDual%2520GSK-3beta%252FAChE%2520inhibitors%2520as%2520a%2520new%2520strategy%2520for%2520multitargeting%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D171%26epage%3D176%26doi%3D10.1021%2Facsmedchemlett.7b00463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and biological evaluation of orally available first-generation dual-target selective inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=328-345&author=F.+Maoauthor=H.+Wangauthor=W.+Niauthor=X.+Zhengauthor=M.+Wangauthor=K.+Baoauthor=D.+Lingauthor=X.+Liauthor=Y.+Xuauthor=H.+Zhangauthor=J.+Li&title=Design%2C+Synthesis%2C+and+biological+evaluation+of+orally+available+first-generation+dual-target+selective+inhibitors+of+acetylcholinesterase+%28AChE%29+and+phosphodiesterase+5+%28PDE5%29+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.7b00345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Mao, Fei; Wang, Huan; Ni, Wei; Zheng, Xinyu; Wang, Manjiong; Bao, Keting; Ling, Dazheng; Li, Xiaokang; Xu, Yixiang; Zhang, Haiyan; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-345</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through drug discovery strategies of repurposing and redeveloping existing drugs, a series of novel tadalafil derivs. were rationally designed, synthesized, and evaluated to seek dual-target AChE/PDE5 inhibitors as good candidate drugs for Alzheimer's disease (AD).  Among these derivs., (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1p, I) and (6R,12aS)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1w, II) exhibited excellent selective dual-target AChE/PDE5 inhibitory activities and improved blood-brain barrier (BBB) penetrability.  Importantly, II·Cit (citrate of II) could reverse the cognitive dysfunction of scopolamine-induced AD mice and exhibited an excellent effect on enhancing cAMP response element-binding protein (CREB) phosphorylation in vivo, a crucial factor in memory formation and synaptic plasticity.  Moreover, the mol. docking simulations of II with hAChE and hPDE5A confirmed that the design strategy was rational.  In summary, the research provides a potential selective dual-target AChE/PDE5 inhibitor as a good candidate drug for the treatment of AD, and it could also be regarded as a small mol. probe to validate the novel AD therapeutic approach in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThEyISqB-vrVg90H21EOLACvtfcHk0lhCpRiUAbhfMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF&md5=f681ad7b8ce0bf011d30d36a869eedd0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00345%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520orally%2520available%2520first-generation%2520dual-target%2520selective%2520inhibitors%2520of%2520acetylcholinesterase%2520%2528AChE%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D328%26epage%3D345%26doi%3D10.1021%2Facschemneuro.7b00345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinreb, O.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">456</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.neuropharm.2016.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=27984078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVWmtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2017&pages=445-456&author=W.+Liuauthor=A.+Rabinovichauthor=Y.+Nashauthor=D.+Frenkelauthor=Y.+Wangauthor=M.+B.+H.+Youdimauthor=O.+Weinreb&title=Anti-inflammatory+and+protective+effects+of+MT-031%2C+a+novel+multitarget+MAO-A+and+AChE%2FBuChE+inhibitor+in+scopolamine+mouse+model+and+inflammatory+cells&doi=10.1016%2Fj.neuropharm.2016.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells</span></div><div class="casAuthors">Liu, Wei; Rabinovich, Alon; Nash, Yuval; Frenkel, Dan; Wang, Yuqiang; Youdim, Moussa B. H.; Weinreb, Orly</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">Part_A</span>),
    <span class="NLM_cas:pages">445-456</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous study demonstrated that the novel multitarget compd., MT-031 preserved in one mol. entity the beneficial properties of its parent drugs, rasagiline and rivastigmine, and exerted high dual potencies of monoamine oxidase-A (MAO-A) and cholinesterase (ChE) inhibition in acute-treated mice and neuroprotective effects against H2O2-induced neurotoxicity in human neuroblastoma SH-SY5Y cells.  The present study aimed to further investigate the anti-inflammatory and protective effects of MT-031 in scopolamine mouse model and inflammatory cell cultures.  Our findings demonstrated that once daily chronic administration of MT-031 (5-10 mg/kg) to mice antagonized scopolamine-induced memory and cognitive impairments, displayed brain selective MAO-A and AChE/BuChE inhibition, increased the levels of striatal dopamine (DA), serotonin (5-HT) and norepinephrine and prevented the metab. of DA and 5-HT.  In addn., MT-031 upregulated mRNA expression levels of Bcl-2, the neurotrophic factors, (e.g., brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF) and nerve growth factor (NGF)), the antioxidant enzyme catalase and the anti-inflammatory cytokine, neurotrophic tyrosine kinase receptor (Ntrk), and down-regulated the mRNA expression levels of the pro-inflammatory interleukin (IL)-6 in scopolamine-induced mice.  In accordance, MT-031 was shown to reduce reactive oxygen species accumulation, increase the levels of anti-inflammatory cytokines, IL-10 and decrease the levels of the pro-inflammatory cytokines, IL-1β, IL-6, IL-17 and interferon-gamma (IFN-γ) in activated mouse splenocytes and microglial cells.  Taken together, these pharmacol. properties of MT-031 can be of clin. importance for developing this novel multitarget compd. as a novel drug candidate for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfU79aZiwv7Vg90H21EOLACvtfcHk0lhCpRiUAbhfMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVWmtLnE&md5=71d3d22ba60c25b1a0fbfa55053b20a2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DRabinovich%26aufirst%3DA.%26aulast%3DNash%26aufirst%3DY.%26aulast%3DFrenkel%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinreb%26aufirst%3DO.%26atitle%3DAnti-inflammatory%2520and%2520protective%2520effects%2520of%2520MT-031%252C%2520a%2520novel%2520multitarget%2520MAO-A%2520and%2520AChE%252FBuChE%2520inhibitor%2520in%2520scopolamine%2520mouse%2520model%2520and%2520inflammatory%2520cells%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D113%26spage%3D445%26epage%3D456%26doi%3D10.1016%2Fj.neuropharm.2016.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenov, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zueva, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhamedyarov, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lushchekina, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharlamova, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petukhova, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikhailov, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podyachev, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saifina, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minnekhanova, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zobov, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolsky, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reznik, V. S.</span></span> <span> </span><span class="NLM_article-title">6-Methyluracil derivatives as bifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1863</span>– <span class="NLM_lpage">1874</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1002%2Fcmdc.201500334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=26412714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKns7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1863-1874&author=V.+E.+Semenovauthor=I.+V.+Zuevaauthor=M.+A.+Mukhamedyarovauthor=S.+V.+Lushchekinaauthor=A.+D.+Kharlamovaauthor=E.+O.+Petukhovaauthor=A.+S.+Mikhailovauthor=S.+N.+Podyachevauthor=L.+F.+Saifinaauthor=K.+A.+Petrovauthor=O.+A.+Minnekhanovaauthor=V.+V.+Zobovauthor=E.+E.+Nikolskyauthor=P.+Massonauthor=V.+S.+Reznik&title=6-Methyluracil+derivatives+as+bifunctional+acetylcholinesterase+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fcmdc.201500334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Semenov, Vyacheslav E.; Zueva, Irina V.; Mukhamedyarov, Marat A.; Lushchekina, Sofya V.; Kharlamova, Alexandra D.; Petukhova, Elena O.; Mikhailov, Anatoly S.; Podyachev, Sergey N.; Saifina, Lilya F.; Petrov, Konstantin A.; Minnekhanova, Oksana A.; Zobov, Vladimir V.; Nikolsky, Evgeny E.; Masson, Patrick; Reznik, Vladimir S.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1863-1874</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Novel 6-methyluracil derivs. with ω-(substituted benzylethylamino)alkyl chains at the nitrogen atoms of the pyrimidine ring were designed and synthesized.  The nos. of methylene groups in the alkyl chains were varied along with the electron-withdrawing substituents on the benzyl rings.  The compds. are mixed-type reversible inhibitors of cholinesterases, and some of them show remarkable selectivity for human acetylcholinesterase (hAChE), with inhibitory potency in the nanomolar range, more than 10,000-fold higher than that for human butyrylcholinesterase (hBuChE).  Mol. modeling studies indicate that these compds. are bifunctional AChE inhibitors, spanning the enzyme active site gorge and binding to its peripheral anionic site (PAS).  In vivo expts. show that the 6-methyluracil derivs. are able to penetrate the blood-brain barrier (BBB), inhibiting brain-tissue AChE.  The most potent AChE inhibitor, (1,3-bis[5-(o-nitrobenzylethylamino)pentyl]-6-methyluracil), was found to improve working memory in scopolamine and transgenic APP/PS1 murine models of Alzheimer's disease, and to significantly decrease the no. and area of β-amyloid peptide plaques in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_iqGhIN8yfrVg90H21EOLACvtfcHk0lhCpRiUAbhfMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKns7jI&md5=25a1e1a7ce3c8794fb67f7934faf8e5f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500334%26sid%3Dliteratum%253Aachs%26aulast%3DSemenov%26aufirst%3DV.%2BE.%26aulast%3DZueva%26aufirst%3DI.%2BV.%26aulast%3DMukhamedyarov%26aufirst%3DM.%2BA.%26aulast%3DLushchekina%26aufirst%3DS.%2BV.%26aulast%3DKharlamova%26aufirst%3DA.%2BD.%26aulast%3DPetukhova%26aufirst%3DE.%2BO.%26aulast%3DMikhailov%26aufirst%3DA.%2BS.%26aulast%3DPodyachev%26aufirst%3DS.%2BN.%26aulast%3DSaifina%26aufirst%3DL.%2BF.%26aulast%3DPetrov%26aufirst%3DK.%2BA.%26aulast%3DMinnekhanova%26aufirst%3DO.%2BA.%26aulast%3DZobov%26aufirst%3DV.%2BV.%26aulast%3DNikolsky%26aufirst%3DE.%2BE.%26aulast%3DMasson%26aufirst%3DP.%26aulast%3DReznik%26aufirst%3DV.%2BS.%26atitle%3D6-Methyluracil%2520derivatives%2520as%2520bifunctional%2520acetylcholinesterase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1863%26epage%3D1874%26doi%3D10.1002%2Fcmdc.201500334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span> <span> </span><span class="NLM_article-title">Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.neuropharm.2017.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=29197516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFegtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2018&pages=77-91&author=X.+Guoauthor=J.+Lvauthor=J.+Luauthor=L.+Fanauthor=X.+Huangauthor=L.+Huauthor=J.+Wangauthor=X.+Shen&title=Protopanaxadiol+derivative+DDPU+improves+behavior+and+cognitive+deficit+in+AD+mice+involving+regulation+of+both+ER+stress+and+autophagy&doi=10.1016%2Fj.neuropharm.2017.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy</span></div><div class="casAuthors">Guo, Xiaodan; Lv, Jianlu; Lu, Jian; Fan, Lei; Huang, Xi; Hu, Lihong; Wang, Jiaying; Shen, Xu</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-91</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a progressively neurodegenerative disease with typical hallmarks of amyloid β (Aβ) plaque accumulation, neurofibrillary tangle (NFT) formation and neuronal death extension.  Aggressive Aβ accumulation promotes senile plaque formation and perturbs endoplasmic reticulum (ER) function to trigger the unfolded protein response (UPR) leading to neuronal apoptosis.  The stress-dependent activation of protein kinase RNA-like endoplasmic reticulum kinase (PERK) increases the phosphorylation of eukaryotic translation initiation factor-2α (eIF2α) to promote the preferential synthesis of β-site APP cleavage enzyme 1 (BACE1) and Aβ generation in turn.  Addnl., dysfunction in autophagy has been reported to contribute to several neurodegenerative diseases including AD, and impairment in autophagy-mediated pathway may constitutively stimulate the generation of Aβ in AD.  Here we discovered that protopanaxadiol deriv. 1-(3,4-dimethoxyphenethyl)-3-(3-dehydroxyl-20(s)-protopanaxadiol-3β-yl)-urea (DDPU) effectively improved the activity of daily living (ADL) and cognitive deficits in APP/PS1 transgenic mice.  The crosstalk between Aβ and ER stress has been intensively investigated by using DDPU as a probe.  DDPU reduced Aβ prodn. mainly by inhibiting the PERK/eIF2α signaling-mediated BACE1 translation and stimulated Aβ clearance by promoting autophagy as a PI3K inhibitor through PI3K/AKT/mTOR signaling pathway, while exhibited neuroprotective effect involving attenuation of ER stress.  DDPU might be the first reported ginsenoside deriv. with dual effects on both autophagy promotion and ER stress amelioration.  Our results have highlighted the potential of DDPU in the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgHXkUxb09wrVg90H21EOLACvtfcHk0lhw1OH9IQ02cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFegtbvE&md5=e403e4bda9644a79932a943ce11ec61a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DLv%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DX.%26atitle%3DProtopanaxadiol%2520derivative%2520DDPU%2520improves%2520behavior%2520and%2520cognitive%2520deficit%2520in%2520AD%2520mice%2520involving%2520regulation%2520of%2520both%2520ER%2520stress%2520and%2520autophagy%26jtitle%3DNeuropharmacology%26date%3D2018%26volume%3D130%26spage%3D77%26epage%3D91%26doi%3D10.1016%2Fj.neuropharm.2017.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">PSD-93 Attenuates Amyloid-beta-mediated cognitive dysfunction by promoting the catabolism of amyloid-beta</span>. <i>J. Alzheimer’s Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.3233/JAD-170320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.3233%2FJAD-170320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=28697571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Ghu7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2017&pages=913-927&author=L.+Yuauthor=Y.+Liuauthor=H.+Yangauthor=X.+Zhuauthor=X.+Caoauthor=J.+Gaoauthor=H.+Zhaoauthor=Y.+Xu&title=PSD-93+Attenuates+Amyloid-beta-mediated+cognitive+dysfunction+by+promoting+the+catabolism+of+amyloid-beta&doi=10.3233%2FJAD-170320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β</span></div><div class="casAuthors">Yu, Linjie; Liu, Yi; Yang, Hui; Zhu, Xiaolei; Cao, Xiang; Gao, Jun; Zhao, Hui; Xu, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">913-927</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ) is a key neuropathol. hallmark of Alzheimer's disease (AD).  Postsynaptic d. protein 93 (PSD-93) is a key scaffolding protein enriched at postsynaptic sites.  The aim of the present study was to examine whether PSD-93 overexpression could alleviate Aβ-induced cognitive dysfunction in APPswe/PS1dE9 (APP/PS1) mice by reducing Aβ levels in the brain.  The level of PSD-93 was significantly decreased in the hippocampus of 6-mo-old APP/PS1 mice compared with that in wild-type mice.  Following lentivirus-mediated PSD-93 overexpression, cognitive function, synaptic function, and amyloid burden were investigated.  The open field test, Morris water maze test, and fear condition test revealed that PSD-93 overexpression ameliorated spatial memory deficits in APP/PS1 mice.  The facilitation of long-term potentiation induction was obsd. in APP/PS1 mice after PSD-93 overexpression.  The expression of somatostatin receptor 4 (SSTR4) and neprilysin was increased, while the amyloid plaque load and Aβ levels were decreased in the brains of APP/PS1 mice.  Moreover, PSD-93 interacted with SSTR4 and affected the level of SSTR4 on cell membrane, which was assocd. with the ubiquitination.  Together, these findings suggest that PSD-93 attenuates spatial memory deficits and decreases amyloid levels in APP/PS1 mice, which might be assocd. with Aβ catabolism, and overexpression of PSD-93 might be a potential therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovp5f71-A0-bVg90H21EOLACvtfcHk0lhw1OH9IQ02cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Ghu7zF&md5=67888e1b76432131eda3372eeb41d574</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3233%2FJAD-170320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170320%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DPSD-93%2520Attenuates%2520Amyloid-beta-mediated%2520cognitive%2520dysfunction%2520by%2520promoting%2520the%2520catabolism%2520of%2520amyloid-beta%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2017%26volume%3D59%26spage%3D913%26epage%3D927%26doi%3D10.3233%2FJAD-170320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mederos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segura, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perea, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer’s disease mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1038/npp.2016.163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1038%2Fnpp.2016.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=27550730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=524-539&author=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+A.+Sanchez-Ariasauthor=O.+Rabalauthor=M.+Perez-Gonzalezauthor=S.+Mederosauthor=A.+Ugarteauthor=R.+Francoauthor=V.+Seguraauthor=G.+Pereaauthor=J.+Oyarzabalauthor=A.+Garcia-Osta&title=A+first-in-class+small-molecule+that+acts+as+a+dual+inhibitor+of+HDAC+and+PDE5+and+that+rescues+hippocampal+synaptic+impairment+in+Alzheimer%E2%80%99s+disease+mice&doi=10.1038%2Fnpp.2016.163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice</span></div><div class="casAuthors">Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Sanchez-Arias, Juan A.; Rabal, Obdulia; Perez-Gonzalez, Marta; Mederos, Sara; Ugarte, Ana; Franco, Rafael; Segura, Victor; Perea, Gertrudis; Oyarzabal, Julen; Garcia-Osta, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">524-539</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The targeting of two independent but synergistic enzymic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer's disease (AD).  Here we report the discovery of a new first-in-class small-mol. (CM-414) that acts as a dual inhibitor of PDE5 and HDACs.  We have used this compd. as a chem. probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation.  This mol. rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice.  Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine d. on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission.  Thus, CM-414 may serve as the starting point to discover balanced dual inhibitors with an optimal efficacy and safety profile for clin. testing on AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrel_KiPL5177Vg90H21EOLACvtfcHk0lh6Bwy_FPLF3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntLfP&md5=26482df7c58696a362ca1e73bab12264</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.163%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DSanchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DPerez-Gonzalez%26aufirst%3DM.%26aulast%3DMederos%26aufirst%3DS.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DSegura%26aufirst%3DV.%26aulast%3DPerea%26aufirst%3DG.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DA%2520first-in-class%2520small-molecule%2520that%2520acts%2520as%2520a%2520dual%2520inhibitor%2520of%2520HDAC%2520and%2520PDE5%2520and%2520that%2520rescues%2520hippocampal%2520synaptic%2520impairment%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D524%26epage%3D539%26doi%3D10.1038%2Fnpp.2016.163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roden, D. M.</span></span> <span> </span><span class="NLM_article-title">Drug-induced prolongation of the QT interval</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1022</span>, <span class="refDoi"> DOI: 10.1056/NEJMra032426</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1056%2FNEJMra032426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=14999113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1013-1022&author=D.+M.+Roden&title=Drug-induced+prolongation+of+the+QT+interval&doi=10.1056%2FNEJMra032426"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced prolongation of the QT interval</span></div><div class="casAuthors">Roden, Dan M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1013-1022</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA8PoMXlMg57Vg90H21EOLACvtfcHk0lh6Bwy_FPLF3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFGjs7Y%253D&md5=a020a545700649d9914ed8dc61910244</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1056%2FNEJMra032426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra032426%26sid%3Dliteratum%253Aachs%26aulast%3DRoden%26aufirst%3DD.%2BM.%26atitle%3DDrug-induced%2520prolongation%2520of%2520the%2520QT%2520interval%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1013%26epage%3D1022%26doi%3D10.1056%2FNEJMra032426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Auro Pharma Inc</span>. <a href="http://www.auropharma.ca/products/monograph/Auro-Donepezil-PM.pdf" class="extLink">http://www.auropharma.ca/products/monograph/Auro-Donepezil-PM.pdf</a> (accessed Oct 25, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Auro+Pharma+Inc.+http%3A%2F%2Fwww.auropharma.ca%2Fproducts%2Fmonograph%2FAuro-Donepezil-PM.pdf+%28accessed+Oct+25%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Chinadrugtrials</span>. <a href="http://www.chinadrugtrials.org.cn/" class="extLink">http://www.chinadrugtrials.org.cn/</a> (accessed Oct 25, <span class="NLM_year">2020</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chinadrugtrials.+http%3A%2F%2Fwww.chinadrugtrials.org.cn%2F+%28accessed+Oct+25%2C+2020%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, H.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monobe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.-Q.</span></span> <span> </span><span class="NLM_article-title">Truxene discotic liquid crystals with two different ring substituents: synthesis, mesomorphism and high charged carrier mobility</span>. <i>Liq. Cryst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1080/02678292.2012.755224</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1080%2F02678292.2012.755224" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFSjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=411-420&author=H.-L.+Niauthor=H.+Monobeauthor=P.+Huauthor=B.-Q.+Wangauthor=Y.+Shimizuauthor=K.-Q.+Zhao&title=Truxene+discotic+liquid+crystals+with+two+different+ring+substituents%3A+synthesis%2C+mesomorphism+and+high+charged+carrier+mobility&doi=10.1080%2F02678292.2012.755224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Truxene discotic liquid crystals with two different ring substituents: synthesis, mesomorphism and high charged carrier mobility</span></div><div class="casAuthors">Ni, Hai-Liang; Monobe, Hirosato; Hu, Ping; Wang, Bi-Qin; Shimizu, Yo; Zhao, Ke-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Liquid Crystals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">LICRE6</span>;
        ISSN:<span class="NLM_cas:issn">0267-8292</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Discotic liq. crystals as a kind of promising org. electronic materials show self-assembly property as well as high charged carrier mobility.  New truxene discotic materials, six 3,8,13-tri(alkoxy)-2,7,12-tri(methoxy)truxene derivs. and two 3,8,13-tri(alkoxy)-2,7,12-tri(hydroxy)truxene derivs. were synthesized with improved yields, they were characterized and exhibited good thermal stability.  The mesomorphism has been investigated by using polarized optical microscopy, differential scanning calorimetry and X-ray diffraction and they exhibited ordered hexagonal columnar mesophase.  More importantly, the charge carrier mobility of and have been measured by using time-of-flight technique and displayed hole drift mobility rate of 4.2 × 10-2 cm2 V-1 s-1 in the Colho phase and 0.1 cm2 V-1 s-1 at a lower temp. M mesophase.  The title compds. thus formed included a truxene deriv. (I) [tris(alkoxy)-10,15-dihydro-5H-tribenzo[a,f,k]trindene-2,7,12-triol, 2,7,12-tri(hydroxy)truxene] and related substances.  The synthesis of the target compds. was achieved using 2,3-dihydro-6-hydroxy-5-methoxy-1H-inden-1-one as a key intermediate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprW-z4vMH-hrVg90H21EOLACvtfcHk0lh6Bwy_FPLF3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFSjsg%253D%253D&md5=69bcc2f76e48524ef9835a5371432d4d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F02678292.2012.755224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F02678292.2012.755224%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DH.-L.%26aulast%3DMonobe%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DB.-Q.%26aulast%3DShimizu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DK.-Q.%26atitle%3DTruxene%2520discotic%2520liquid%2520crystals%2520with%2520two%2520different%2520ring%2520substituents%253A%2520synthesis%252C%2520mesomorphism%2520and%2520high%2520charged%2520carrier%2520mobility%26jtitle%3DLiq.%2520Cryst.%26date%3D2013%26volume%3D40%26spage%3D411%26epage%3D420%26doi%3D10.1080%2F02678292.2012.755224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-S.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">4462</span>– <span class="NLM_lpage">4466</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.04.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=10.1016%2Fj.bmcl.2012.04.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=22633691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;key=1%3ACAS%3A528%3ADC%252BC38Xns1Squrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4462-4466&author=F.-C.+Mengauthor=F.+Maoauthor=W.-J.+Shanauthor=F.+Qinauthor=L.+Huangauthor=X.-S.+Li&title=Design%2C+synthesis%2C+and+evaluation+of+indanone+derivatives+as+acetylcholinesterase+inhibitors+and+metal-chelating+agents&doi=10.1016%2Fj.bmcl.2012.04.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents</span></div><div class="casAuthors">Meng, Fan-Chao; Mao, Fei; Shan, Wen-Jun; Qin, Fangfei; Huang, Ling; Li, Xing-Shu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4462-4466</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel indanone derivs. was designed, synthesized and evaluated as potential agents for Alzheimer's disease.  Among them, compd. I (as the Z-isomer), with a piperidine group linked to indone by a two-carbon spacer, exhibited the most potent inhibitor activity, with an IC50 of 0.0018 μM for AChE; the inhibitory activity of this compd. was 14-fold more potent than that of donepezil.  Furthermore, these compds. also exhibited good metal-chelating ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0IMwSLlGm57Vg90H21EOLACvtfcHk0lh6Bwy_FPLF3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xns1Squrs%253D&md5=5c21cdd9b2d6e4b82ce9ae421116adb6</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.04.029%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.-C.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DShan%26aufirst%3DW.-J.%26aulast%3DQin%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.-S.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520indanone%2520derivatives%2520as%2520acetylcholinesterase%2520inhibitors%2520and%2520metal-chelating%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4462%26epage%3D4466%26doi%3D10.1016%2Fj.bmcl.2012.04.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7','PDB','4EY7'); return false;">PDB: 4EY7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9O','PDB','7D9O'); return false;">PDB: 7D9O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9Q','PDB','7D9Q'); return false;">PDB: 7D9Q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9P','PDB','7D9P'); return false;">PDB: 7D9P</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i28"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01863">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_85373"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01863?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01863</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplemental figures and tables; characterization data for all target compounds <b>1</b><b>–44</b> and key intermediates; experimental operation description for all bioassay; X-ray crystal structure study and surface plasmon resonance determination; <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and HPLC spectra of all target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula stings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_001.pdf">jm0c01863_si_001.pdf (10.84 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01863/suppl_file/jm0c01863_si_002.csv">jm0c01863_si_002.csv (2.94 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">All data are available in the main text or the Supporting Information. Compounds <b>2</b>, <b>7</b>, and <b>12</b> are available from H.L. under a material transfer agreement with Shanghai Institute of Materia Medica. The PDB accession number for the coordinates of rhAChE in complex with compound <b>2</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9O">7D9O</a>, for the coordinates of rhAChE in complex with compound <b>7</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9Q">7D9Q</a>, and for the coordinates of rhAChE in complex with compound <b>12</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7D9P">7D9P</a>. Authors will release the atomic coordinates upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01863&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-4%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01863%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01863" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a9e547ed13cd6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
